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Abstract
Our understanding of why biological systems are designed in a particular way
would benefit from biophysically-realistic models that can make accurate predictions on
the time-evolution of molecular events given arbitrary arrangements of genetic
components. This thesis is focused on constructing such models for gene expression
during bacteriophage T7 infection. T7 gene expression is a particularly well suited model
system because knowledge of how the phage functions is thought to be relatively
complete. My work focuses on two questions in particular. First, can we address
deficiencies in past simulations and measurements of bacteriophage T7 to improve
models of gene expression? Second, can we design and build refactored surrogates of T7
that are easier to understand and model?
To address deficiencies in past simulations and measurements, I developed a new
single-molecule, base-pair-resolved gene expression simulator named Tabasco that can
faithfully represent mechanisms thought to govern phage gene expression. I used
Tabasco to construct a model of T7 gene expression that encodes our mechanistic
understanding. The model displayed significant discrepancies from new system-wide
measurements of absolute T7 mRNA levels during infection. I fit transcript-specific
degradation rates to match the measured RNA levels and as a result corrected
discrepancies in protein synthesis rates that confounded previous models. I also
developed and used a fitting procedure to the data that let us evaluate assumptions related
to promoter strengths, mRNA degradation, and polymerase interactions.
To construct surrogates of T7 that are easier to understand and model, I began the
process of refactoring the T7 genome to construct an organism that is a more direct
representation of the models that we build. In other words, instead of making our models
evermore detailed to explain wild-type T7, we started to construct new phage that are
more direct representations of our models. The goal of our original design, T7. 1, was to
physically define, separate, and enable unique manipulation of primary genetic elements.
To test our initial design, we replaced the left 11,515 bp of the wild-type genome with
12,179 bp of engineered DNA. The resulting chimeric genome encodes a viable
bacteriophage that appears to maintain key features of the original while being simpler to
model and easier to manipulate. I also present a second generation design, T7.2, that
extends the original goals of T7.1 by constructing a more direct physical representation of
the T7 model.
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Chapter 1. Introduction
Chapter 1.1. Overview
The development of natural biological organisms provides a stunning example of
how genetically-identical organisms that have inherent chemical and environmental
variation can arrive at complex, deterministic outcomes. The precision and
reproducibility of development imply reproducible molecular and cellular events
governed by their evolved genome designs. The ability to produce accurate model-based
predictions of these molecular and cellular events given arbitrary arrangements of genetic
components would allow us to explore why biological systems might be designed in a
particular way, and help us build novel, intentional, and useful biological organisms
[Carlson R, 2,001]. However, making reliable computational model-based predictions
remains very difficult [Endy & Brent, 2001]. What remains unclear is what information
we are missing, and to what detail do we have to understand it in order to construct
predictive molecular models of biological systems [Sharp, 2000].
Our lack of accurate model-based predictions may be due to several reasons. For
example, our models may be incomplete, missing details that are important in system
function. Also, since models typically are for small subsystems within organisms, the
proper boundaries and interfaces between these subsystems and the organism as a whole
are poorly defined. We also lack precise experimental data describing the physical state
of our system over time, and when we attempt to model the dynamic behavior of the
system, make use of limited modeling frameworks that are often poor approximations for
the inside of a cell. Not surprisingly, as our models increase in size and complexity, their
utility in helping us to predict the behavior that results from novel perturbations is
limited.
This thesis is focused on trying to understand the program of gene expression
during the development of bacteriophage T7. T7 is particularly well suited as a model
system for the development of an entire organism because knowledge of how the phage
functions is thought to be relatively complete. My work focuses on two questions in
particular. First, can we address deficiencies in past simulations and measurements of
bacteriophage T7 to improve past models of gene expression during development?
Second, can we design and build refactored surrogates of T7 that are easier to model and
understand?
The remainder of this chapter introduces bacteriophage T7 and past efforts to
construct models of T7 development. Chapter 2 introduces a new simulator I developed
called Tabasco that allows us to explicitly encode gene expression mechanisms
commensurate with our putative understanding of T7 biology. Chapter 3 describes our
efforts to build detailed models of T7 gene expression using Tabasco and analyze the
models with respect to new system-wide measurements of mRNA levels. In Chapter 4, I
present our work on refactoring the T7 genome in order to construct a self-replicating
developmental system that is easier to understand. Finally, Chapter 5 describes ongoing
extensions of this work and where it stands in relation to my original goals.
Chapter 1.2. Background
Bacteriophage T7 (T7) is an obligate lytic phage that infects Escherichia coli
[Dunn & Studier, 1983; Studier & Dunn, 1983]. T7 was twice isolated from Ward
MacNeal's 'standard anti-coli-phage' mixture [Demerec & Fano, 1945; Delbriick, 1946].
MacNeal's 'mixture' may have been cultured in series - T7 was the only identifiable
isolate [Studier, 1979]. One of the two original T7 isolates was reportedly chosen for
future use and master cultures of 'wild-type' T7 have been maintained since. Genetics,
and then biochemistry, enabled the discovery and characterization of some of the
individual elements that participate in T7 development [Molineux, 2005]. Sequencing of
the T7 genome revealed additional elements [Dunn & Studier, 1983], not all of which
have obvious functions [Chan et al., 2005].
Chapter 1.2.1. Discovering the Parts of T7
T7 is a good model system for learning what fraction of the functional
information encoded on the genome of a natural biological system has been discovered,
and how much of what is unknown is likely to matter. For example, the T7 protein
coding domains were first characterized by the isolation and analysis of randomly
generated amber mutants. Nineteen genes were identified by mapping mutants that
disrupt T7 DNA synthesis, particle maturation, and lysis [Studier, 1969; Hausmann &
Gomez, 1967; Hausmann & LaRue, 1969]. Two additional genes, T7 DNA ligase and
protein kinase, were isolated via loss of function and deletion, respectively [Masamune et
al., 1971;Ritchie & Malcolm, 1970]; the genetic analysis of ligase and kinase mutants
was carried out using mutant host strains that do not support the growth of ligase or
kinase defective phage [Studier, 1973a]. As many as 30 T7 proteins were observed by
pulsing phage- infected cells with radioactive amino acids [Studier & Maizel, 1969;
Studier, 1973b]. Further experiments, such as electrophoretic mobility shifts of amber
mutants, provided evidence for as many as 38 T7 proteins [Studier, 1981]. Sequencing of
the genome confirmed the previously constructed genetic maps [Dunn & Studier, 1983].
But, analysis of the complete genome sequence also revealed that the set of protein
coding domains found via mutagenesis, screening, and mapping was not exhaustive, and
that additional unidentified open reading frames occupied most of the remainder of the
genome. Some of these unidentified open reading frames can be labeled as putative
protein coding domains based on the inferred strengths of adjacent upstream ribosome
binding sites. In all, up to 57 genes encoding 60 potential proteins have been found or
postulated [Molineux, 2005]. However, only 35 of these 60 proteins have at least one
known function. And, of the 25 non-essential proteins, only 12 are conserved across the
family of T7-like phage [Molineux, 2005]. Can we ignore these uncharacterized proteins
in our models'? Should we edit the genome to get rid of them [Chan et al., 2005]?
As a second example of where our knowledge stands, the E. coli RNA polymerase
promoters on the T7 genome (AO, Al- 3, B, C, and E) were first mapped by in vitro
transcription studies [Davis & Hyman, 1970; Minkley & Pribnow, 1973; Golomb &
Chamberlin, 1974a, b; Niles & Condit, 1975; McAllister & McCarron, 1977; Stahl &
Chamberlin, 1977; Kassavetis & Chamberlin, 1979; Panayotatos & Wells, 1979] and
subsequently confirmed by sequencing [Oakley & Coleman, 1977; Boothroyd &
Hayward, 1979; Rosa, 1979; Rosa, 1981a; Rosa, 1981b; Osterman & Coleman; Carter &
McAllister, 1981; Dunn & Studier, 1983]. Results of in vitro transcription reactions
using T7 genomic DNA as template agreed with the available in vivo transcription data
[Studier, 1973a; Summers et al., 1973; McAllister & Wu, 1978; McAllister et al., 1981].
However, the cloning of random sections of the T7 genome into a plasmid that selected
for transcription activity from the cloned fragment identified other possible promoters
[Studier & Rosenburg, 1981]. Sequence analysis of the cloned sections identified ~10
regions with similarity to known promoters (the identifiable sites are labeled with an S 1-
S6 in our own annotations); footprinting assays identified two additional promoters (these
promoters are labeled F1 and F2 in our own annotations) [Dunn & Studier, 1983; http://
web.mit.edu/endy/www/ncbi]. But, any contribution of these putative promoters to wild-
type T7 infection is not now defined. As with some of the T7 genes, should we ignore
these promoters in our models? Should we delete them from the T7 genome? Is there
other information encoded on the wild-type T7 genome that we should include in our
models, ignore, or actively remove [Chan et al., 2005]?
Chapter 1.2.2. Putting the Parts Together
The experimentalists who originally discovered much of how T7 works developed
the best descriptive, system-level models for T7 infection. Their models were made by
integrating knowledge of the individual parts and mechanisms that act during infection,
from genome entry to phage particle formation [Studier & Dunn, 1983]. Two features
specific to T7 biology made the construction of their system-level models easier. First,
compared to other phage, T7 is relatively independent of complex host physiology. For
example, T7 encodes phage-specific RNA and DNA polymerases, and mRNA and protein
synthesis of host genes is shut down during the first ~6 minutes of T7 infection. Second,
RNA polymerase pulls most of the T7 genome into the newly infected cell [Zavriev &
Shemyakin, 1982; Garcia & Molineux, 1995]. Polymerase mediated genome entry is a
relatively slow process that results in the direct physical coupling of gene expression
dynamics to gene position. For example, a gene cannot be expressed until its coding
domain enters the newly infected cell [Chan et al., 2005].
Chapter 1.2.3. Models of Bacteriophage T7 Infection
Building on this work, Drew Endy with John Yin (UW Madison) and Ian
Molineux (UT Austin) constructed a model that enables computer-based simulation of T7
development at the 'molecular level' [Endy et al., 1997]. Here, molecular level means
that the model captures the expression of individual genes and the interactions among
distinct biochemical species such as proteins, mRNA, amino acids, nucleotides, etc. The
model starts with a single phage particle bound to a single host cell and follows T7
infection up to intracellular progeny production. The model was built using a best-faith
effort at encoding the current scientific understanding of how T7 actually works. Any
estimated parameter values were chosen independent of system-level model behavior.
Chapter 1.2.4. How Good is the Model?
Endy's model provides a reasonable estimate of many aspects of gene expression,
but several significant discrepancies remained. For example, Figure 1-1 shows the
observed and computed rates of protein synthesis during T7 infection. The computed time
of first synthesis is correct for most proteins, suggesting that the models for T7 genome
entry are good, but that the computed synthesis profiles for a few proteins continue
beyond the data (e.g., gpl, the T7 RNA polymerase).
Endy and colleagues then implemented a general form of the T7 simulation that
can compute the expected growth dynamics for any permutation of the genetic elements
that comprise the wild-type T7 genome [Endy et al., 2000]. Using the new simulator,
they computed the expected effects of repositioning each of the essential T7 genes at all
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Figure 1-1. Observed and computed rates of phage T7 protein synthesis. (a)
Experimental data. 35S pulse-chase protein synthesis gel for wild-type T7 infection. (b)
Simulation output. Comparison of observed and computed T7 protein synthesis rates
reveals that during an actual phage infection, synthesis of the T7 proteins gpl, gpl.3, gp2.5
and gp5 is down regulated by an unknown mechanism(s) [Endy & Brent, 2001].
possible positions within an array of 72 moveable genetic elements. The simulations
predicted that moving gene 1, encoding the T7 RNA polymerase, immediately
downstream of its natural position would produce a mutant phage that grows faster than
the wild type under laboratory conditions [Figure 1-2]. The prediction was based on the
observation that moving gene 1 to its new position would create a weak T7 autogene
[Dubendorff & Studier, 1991], and that modest self-expression of the T7 RNA
polymerase would accelerate phage infection. In order to test the prediction, they
constructed a series of ectopic gene 1 strains in the lab and, upon characterization, found
that all the ectopic phage grew slower than the wild type [Endy et al., 2000].
Disagreement between model-based predictions and the observed system behavior
could have occurred for at least three reasons. First, past computational approaches to
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modeling T7 gene expression
could have been inappropriate.
For example, studies suggest that
noise in gene expression for a
system may lead to variation in
system behavior [Arkin et al.,
1998]. If gene expression noise is
significant during T7 development,
the creation of the weak autogene
in the predicted faster-than-wild-
type gene I strain, could lead to
stochastic differences in phenotype
[Thattai & van Oudenaarden,
2001]. For example, one sub-
population could produce the
autogene behavior, while a second
sub-population of cells produces
slower-than-wild type infections,
and the resulting observed
population average growth rate is
slower than wild type. Second, the
resolution of past models may
have been insufficient. Past
models were constrained by
simulation technologies, and thus
were unable to explicitly represent
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Figure 1-2. (a) Simulation results showing the
expected phage T7 growth rate as a function of the
position of gene 1, encoding T7 RNA polymerase, on
(b) the T7 genome. (c) A mutant T7 genome in which
all the T7 genetic elements are permuted [Endy et al.,
2000].
mechanisms that are thought to govern gene expression. For example, polymerase-
mediated entry of the genome was modeled as a constant rate process, rather than as a
result of transcription of the genome. Incorrect representation of such processes can
mask problems with the models that would be made clear by explicit simulation. Third,
models for T7 development could be incomplete or wrong. For example, unknown
i
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genetic elements and regulation mechanisms may play a role in the shutdown of class I
and II protein synthesis that the models failed to account for. Using models that do not
account for unknown processes could debase any predictions of the models.
In this thesis, I have attempted to address these problems. I developed a new
gene expression simulator named Tabasco in order to allow stochastic simulation of the
mechanisms thought to govern phage gene expression [§2]. I used Tabasco to make a
model of phage gene expression that more directly encodes our understanding of T7 gene
expression [§3]. In addition, I coupled this model with comparisons to new system-wide
measurements of T7 mRNA levels during development to better evaluate the model's
validity. Finally, I began the process of refactoring the T7 genome to construct an
organism that is a more direct representation of the models that we build [§4].
Chapter 2. Tabasco
Chapter 2.1. Introduction
Mechanistic models for gene expression are quite detailed and are continuously
improving. For example, kinetic studies of promoter initiation and single molecule
studies of processive protein movements on DNA give us mechanistic understanding of
gene expression at an unprecedented level of detail [for review, Bai et al., 2006]. Those
interested in studying the consequences of this understanding on system-level behavior
would benefit from the ability to integrate these detailed biophysical models into system-
level simulation. Currently available simulation techniques are sufficient to study the
expression from a single operon, but become computational infeasible if the system is of
much greater complexity [Arkin, 1998].
There are many approaches for encoding systems of biochemical reactions into a
mathematical framework. One common approach is to consider the chemical species
involved in the reactions as a continuous function of time, for example by expressing the
reactions as a set of coupled ordinary differential equations (ODEs) [§2.2.1 ]. Another
approach is to explicitly account for each member of a species, for example by using
stochastic simulation algorithms [§2.2.2]. Stochastic simulation algorithms have some
theoretical advantages over continuous formulations. For example, the accuracy of ODE
simulations can break down when the numbers of any particular reactant in a system are
low [Samoilov & Arkin, 2006]. In this situation, an individual reaction event can make a
large difference to the likelihood that other reactions will occur, and so the precise order
and timing of reaction events matters. Almost any reaction involving a single copy of a
gene will have this problem.
Both stochastic and continuous formulations, however, share the problem of the
so-called "combinatorial explosion" of individual species and states in a complex system.
For example, the spatial and temporal control of the gene endol6 expression during S.
purpuratu development is controlled by a 2300 bp sequence [Yuh & Davidson, 1996].
This control sequence contains 33 sites that bind 15 distinct proteins [Yuh et al., 2001].
Simulating this system requires enumerating the possible states of the DNA with proteins
bound, which in the case of the regulatory region of endol6 exceeds 1013 distinct species
-- far more species than copies of the individual DNA, proteins, and/or complexes in an
individual cell. Explicitly enumerating this number of distinct species is currently
computationally intractable.
Several groups have addressed the combinatorial explosion problem specifically
with respect to protein complex formation [Morton-Firth & Bray 1998; Andrews & Bray,
2004; Lok & Brent 2005]. The simulators designed by these groups (single-molecule
simulators) track individual molecules and what they are bound to, so that the only
complexes formed at any given time are enumerated, and not all possible states. The
rules for moving from one state to another are simplified by defining classes of
complexes that undergo the same set of reactions, with reaction rates modulated by the
presence or absence of individual components. For example, in the yeast pheromone
response pathway, Ste5, a scaffolding protein, can form over 25,000 distinct complexes
with other proteins, far exceeding the 5000 complexes estimated to be in the cell at any
time [Endy & Brent, 2001; Bardwell et al., 1996]. Using their single-molecule simulator,
Moleculizer, Lok and Brent were able to enhance the efficiency of simulating the
pathway many fold by in part reducing the number of initial species specified and
generating them dynamically as needed [Lok & Brent, 2005].
Current single-molecule simulators deal well with binding and unbinding within
complexes. However, they do not deal well with situations in which the elements of the
complex are processive (i.e., complexes move along many binding states) or when the
number of binding states is large. For example, simulating a single RNA polymerase
transcribing a 3,000-base pair gene would require a DNA molecule of over 3,000
different states with enumerated rules for the transitions from one base to the next. In
order to simulate detailed models of gene expression, I developed, with Jason Kelly, a
single-molecule stochastic simulator, Tabasco, which explicitly deals with reactions
specific to gene expression such as the initiation, elongation and termination of RNA
transcripts and polypeptide chains and interactions between polymerases [Kosuri S,
Kelly, JR, Endy D, in preparation].
Our motivations for creating Tabasco stem from our interest in simulating the
dynamics of bacteriophage T7 gene expression during phage infection. Past attempts at
constructing models of T7 infection used ODEs to simulate gene expression dynamics,
which prevented representation of the details of transcription and entry [Endy et al, 1997,
2001]. For example, the E. coli RNA polymerase initiates expression of early T7 genes,
including T7 RNA polymerase. T7 RNA polymerase first initiates transcription behind
already transcribing E. coli RNA polymerase molecules. E. coli RNA polymerase has a
~45 nucleotide per second elongation rate; T7 RNA polymerase has a ~250 nucleotide
per second elongation rate. What happens when a T7 RNA polymerase molecule catches
up to an E. coli RNA polymerase? The transition from E. coli to T7 RNA polymerase
mediated genome entry will impact the timing of expression across the genome; cell-cell
variation in the entry transition will limit the precision by which T7 can control infection.
Using Tabasco, we are able to explore the dynamics of gene expression during T7
development at single-base resolution. The increased resolution of these computational
models allows for direct evaluation of assumptions concerning polymerase interactions,
transcriptional coupling to genome entry, and stochastic fluctuations on T7 development.
Chapter 2.2. Background
Chapter 2.2.1. Mathematical Models of Gene Expression
The history of mathematical and biophysical models of gene expression began at
the very start of our understanding of the molecular nature of genetic information [Luria
& Delbriick, 1943]. I will focus this section primarily on the development of biophysical
models of the transcriptional control of prokaryotic gene expression through experiments
and the parallel development of mathematical models.
In 1961, Francois Jacob and Jacques Monod showed through a series of
experiments and logical formulations that the control of 3-galactosidase expression is
dependant upon negative regulation by lac repressor (Jacob & Monod, 1961).
Furthermore they hypothesized that these interactions depend upon a secondary
messenger, which acted as a temporary intermediary between the genetic code and
protein synthesis by the ribosomes. Sydney Brenner, Monod, and Matthew Meselson
experimentally verified the existence of this messenger RNA (mRNA) soon afterwards,
which solidified the "central dogma" of biology [Brenner et al., 1961]. Work on the lac
system has since continued, leading to such discoveries as the notion of the operon as a
module of control for genetic systems, positive control of gene expression, and
technologies such as DNA sequencing [reviewed in Muller-Hill, 1996].
Soon afterwards, Stuart Kauffman constructed some of the earliest mathematical
models of gene expression in order to study how large-scale biological systems might be
organized [Kauffman, 1969]. Kauffman treated the expression state of each gene as a
binary variable (on/off), whose output is dependent upon some Boolean function of its
inputs. Others, such as Rene Thomas, formalized these studies and extended them to
include delays that represented times between initial signal and output protein production
[Thomas, 1973; Thomas et. al., 1976]. Also around this time, Michael Savageau began to
study feedback control in genetic systems using ordinary differential equations
[Savageau, 1974; 1975; §2.2.2]. Savageau's approach was to model gene expression as a
system of chemical species governed by synthesis and degradation terms that were
dependent upon power-law relationships with other species. These studies formed the
basis for the mathematical modeling of gene expression using coupled sets of differential
equations.
Alongside these mathematical studies, experiments attempting to understand the
biophysical process of transcription initiation were ongoing. For example, two regions,
the Pribnow box and the -35 region, located 10 and 35 bases from the transcription start
respectively, were found to be conserved in E. coli promoter regions and thought to
function as the DNA binding site for RNA polymerase [Pribnow, 1975; Gilbert, 1976].
This information was brought together into what was called the "bipartite model" for
promoter initiation. In this model, sequence specific binding was in fast equilibrium
relative to the slower process of DNA open complex formation, which together
determined the initiation rate of the polymerase [McClure, 1982]. In addition, details
were uncovered on the abortive initiation of polymerases, which showed that polymerase
seem to start, abort, and then restart a number of times before the formation of a
productive elongation complex [Johnston & McClure, 1976; Cech et. al., 1980].
Based on these new biophysical models, a new class of mathematical models was
emerging. Shea and Ackers' work on modeling the gene regulation of the bacteriophage
lambda OR control region created a framework based on statistical mechanics [Ackers et.
al., 1982; Shea & Ackers, 1985]. They postulated that since the binding of operators to
DNA was very fast when compared to downstream processes such as transcription
initiation, a probabilistic model of binding could be created based on proportionality of
the equilibrium binding constants of proteins to the DNA.
The importance of the Shea-Ackers' model was not fully appreciated until work
on understanding the role of random fluctuations in biochemical systems began. Though
the phenomenon of cell-cell variation in the bacterial response to chemical stimuli has
been apparent for some time, little progress was made in trying to mathematically model
it [Luria & Delbriick, 1943; Chock & Stadtman, 1977; Goldbeter & Koshland, 1981].
However, a number of improvements allowed for the development of stochastic
simulations that could probe such behavior. First, the development of exact stochastic
simulation algorithms (SSAs), when coupled to increases in computational power,
allowed for the efficient simulation of random fluctuations in larger chemical systems
[Gillespie, 1976, 1977; §2.2.2]. In addition, the Shea-Ackers model allowed for the
treatment of fast DNA-binding reactions as being in equilibrium, easing the
computational burden. Adam Arkin and Harley McAdams showed that stochastic effects
can be successfully modeled using these new simulation tools, and that cell-cell variation
due to uncertainty in the timing of individual reaction events might qualitatively impact
developmental pathways [McAdams & Arkin, 1997; Arkin et. al., 1998]. Several groups
have subsequently experimentally and theoretically explored the effects of stochastic
variation on gene expression [Thattai & van Oudenaarden, 2001; Ozbdak et al., 2002;
Elowitz et al., 2002; Paulsson, 2004; Rosenfeld et al., 2005; Pedraza et al., 2005; Kaern et
al., 2005; Mettetal et al., 2006].
Most mathematical models of gene expression still lag behind our experimental
understanding of gene expression. For example in vitro single-molecule studies revealed
that pauses and arrests of E. coli RNA polymerase transcribing along DNA occur often,
and that pausing is a step in the route towards termination [Forde et. al., 2002; Adelman
et. al., 2002; Skinner et al., 2004]. However, such mechanisms are difficult to account for
with current simulators. In another example, interactions between transcribing
polymerases on the genome are known to affect gene expression [Adhya & Gottesman,
1982; Horowitz & Platt, 1982; Nomura et al., 1985; Epshtein et al., 2003]. Again,
simulating interaction of transcribing polymerases is difficult. In both cases, the near
base-pair resolution needed to analyze these models is difficult because of the large
number of species that need to be enumerated in such a detailed simulation.
Chapter 2.2.2. Stochastic Simulation
Simulating the time course of a set of coupled chemical reactions is often carried
out using ordinary differential equations. This approach to representing biological
systems approximates all species as continuous functions of time. However, in some
cases, the continuous approximation breaks down. When individual reaction events
cause large changes in the probability of future reactions, the precise order and timing of
reaction events matters. Variation in the timing of individual reactions due to thermal
fluctuations can produce variation in system behavior that is not accounted for in
deterministic formulations. For example, variation can be large when there are low
numbers of any individual reactants, as in the case of single-copy genomic DNA.
Stochastic formulations, on the other hand, are able to account for this variation by
treating all species as discrete variables and reaction rates as probabilities per unit time
(i.e., propensities). Solving these stochastic formulations analytically is very difficult and
practically impossible except for the most simple of systems [e.g., Thattai & van
Oudenaarden, 2001]. Thus, the most common approach is to use computational methods
developed by Dan Gillespie in the 1970's to approximate solutions [Gillespie, 1976,
1977].
Gillespie's stochastic simulation algorithm (SSA) allows for exact simulation of a
system of elementary chemical reactions [Gillespie, 1976]. For each reaction, the SSA
generates a tentative execution time by mapping a randomly generated number to the
reaction time's probability density function (PDF). In the case of an elementary chemical
reaction, the reaction time's PDF is defined as an exponential distribution with
characteristic time proportional to the inverse of the reaction's propensity. A reaction
propensity is related to the macroscopic rate constant of the reaction and is also
dependent upon the number of reactant molecules and cell volume. In a system of
reactions, the algorithm first executes the reaction with the earliest tentative reaction time,
and updates the copy numbers of the reactant and product species. The overall simulation
time is then incremented by the tentative reaction time, and the propensities of all the
reactions are recalculated. This process is repeated and, in this manner, one potential
time course of the system is generated. When averaged over many runs, the distribution
created is equivalent to the analytical solution obtained through the chemical master
equation, which describes all the probabilistic states of the system [Gillespie, 1977].
Subsequently, there have been improvements to Gillespie's SSA that help increase
the computational efficiency, such as Gibson and Bruck's accelerations to the Gillespie's
SSA in the Next Reaction Method (NRM) [Gibson & Bruck, 2000]. First, instead of
recalculating all reaction propensities and times, the NRM efficiently transformed them
from one cycle to the next. Second, the NRM created a data structure, called the reaction
graph, in order to only update those reactions whose substrates' copy numbers have
changed after any particular reaction has occurred. Third, more efficient data structures,
priority queues, were used to search for the first reaction. Finally, Gibson and coworkers
outlined the use of the NRM to model a series of reactions that have identical exponential
propensities (e.g., polymerization) as a single reaction described by the gamma
distribution.
Chapter 2.3. Results
Chapter 2.3.1. Features and Structure of Tabasco
Tabasco is a stochastic simulator that tracks individual molecules of DNA and
associated proteins at single base-pair resolution. By defining logical rules of
transcription and translation that govern initiation, elongation, termination, and
interactions of polymerases, ribosomes, and proteins at the start of simulation, Tabasco is
able to dynamically update the state of the system and generate the appropriate reactions
[Fig 2-1]. For example, if a polymerase transcribes over another protein's DNA-binding
site, the simulator makes the site unavailable for binding other proteins until the
polymerase is no longer overlapping the binding site. Tabasco makes use of a Gibson-
accelerated Gillespie stochastic simulation algorithm (SSA) to compute the reaction event
timing and the resultant time-evolution of the genetic system [Gibson & Bruck, 2000].
Tabasco's structure confers a number of advantages [Figure 2-2; Methods]. First,
tracking the state of individual molecules on DNA eliminates the need to enumerate all
the possible states of polymerases and proteins associated with the DNA. Second,
protein-protein interactions that may occur on DNA, such as collisions between different
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Figure 2-1. Structure of Tabasco Simulator. A simplified flow diagram of gene
expression shows how Tabasco transitions from tracking individual molecules (Single
Molecule Resolution) to grouping them into species (Species Level Resolution). The
arrows represent reactions that can occur (process labeled in blue). See §2.5.2 for an
explanation of
polymerases or between polymerases and other proteins, can be accounted for and
simulated based on explicitly defined rules. Third, Tabasco allows us to consider and
integrate a very large number of factors that may influence the rate of RNA
polymerization for any particular gene, such as the binding of multiple transcription
factors or the contribution of RNA polymerases that initiated transcription at a promoter
connected to an upstream gene. Fourth, Tabasco can be used to visualize the location and
progress of the polymerases transcribing DNA. Two advantages of Tabasco that are
particularly relevant to T7 are that the simulator allows one to define multiple
polymerases with different characteristics (such as transcription speed) and that Tabasco
tracks the time course of the entry of the T7 genome, allowing us to see how the stage of
entry changes the dynamics of gene expression [see movie at http://openwetware.org/
wiki/Tabasco; §3].
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Figure 2-2. Advantages of Single Molecule Resolution. Tracking individual molecules
of DNA at a base-pair resolution allows for enumeration of mechanisms that were
previously not examinable through simulation. For example, when a traversing
polymerase passes over a genetic element such as a protein-DNA binding site, the
binding site is inactivated and prevented from binding a protein until the polymerase
completely passes over (a). Activation of genetic elements by entry of DNA into the cell
(b) and inter-polymerase interactions (c) can be directly simulated as well. Finally, in
complex genetic environments (d), a priori transcription levels for each protein need not
be calculated, for they are generated implicitly (Promoter arrows with different sizes and
colors represent different activities and polymerase specificities, respectively).
While treating DNA with single-molecule and single base-pair resolution provides a
number of advantages, treating RNA and protein species at the same resolution is both
unnecessary and computationally expensive because of the large number of RNA
molecules compared with DNA. To increase computational efficiency Tabasco
transitions from single-molecule simulation, where individual molecules and their states
are tracked, to species-level simulation for RNA and protein molecules, akin to traditional
SSAs. Only those RNA molecules that are still attached to transcribing RNA
polymerases are treated as single molecules. As each coding domain on an RNA
molecule is completed, it becomes part of the species-level simulation. In essence, each
of the coding domains is treated separately as a species, and ribosomes that initiate
translation on a coding domain are assumed not to interfere with one another [§2.4].
Translation is treated as a series of single amino acid polymerization steps, with the
number of steps depending on the length of the coding domain. This gives a more
accurate distribution of times for protein production than treating the whole elongation
process as a single step. Based on the work of Gibson and Bruck, we model these steps
in aggregate using the gamma distribution [Gibson & Bruck, 2000; Figure 2-3]. Protein
interactions are all treated at the species-level.
Chapter 2.3.2. Simple Gene Expression Models
As an initial test, Tabasco was used to simulate expression of a 1000 amino acid
protein and compared against results from a standard species-level SSA [Figure 2-4].
The structure of the Gillespie-based species-level SSA is comparable to the Tabasco
structure, except that processive movements on the DNA are treated as a lumped, single-
step reaction sampled from an exponential distribution [Figure 2-1; Figure 2-6]. Care
was taken to make the simulations as close as possible for comparison; some differences
were unavoidable, but they were insignificant [Table 2-1; §2.5.5.2; §7.3.1]. In the steady
state, both simulators produce similar results. However, a difference arises in the pre-
steady state kinetics of the system. The species-level simulation first starts producing
protein by ~30 seconds. This is unrealistic; RNA polymerase transcribes at an average
rate of 40 bp per second, so production of a 3,000 bases of messenger RNA should take
~75 seconds. Even if a ribosome follows directly behind the RNA polymerase, protein
production should not take less time than RNA production. Tabasco produces protein
only after a more realistic -~100 seconds.
The discrepancy in time to the first protein production between the species-level
and Tabasco simulators occurs for two reasons [Gibson & Bruck, 2000]. First, since the
RNA polymerase and ribosome elongation steps in the species-level simulation are
treated as single exponential elementary reactions, 63% of the reactions happen earlier
than the average reaction time. The second reason, which is more substantial, is that
SSAs assume that the reactions are Markov, i.e., reaction timings do not depend on
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Figure 2-3. Differences in single-step and multi-step elongation processes.
Treating elongation of polymerase on DNA along 50 bases as a one step elongation
process versus a chain of individual reaction steps gives the same average
elongation time, but has marked differences in the distribution of those elongation
times. The process shown here is either a single 1 second elongation step (red) or
fifty 1/50 second elongation steps (blue). Each histogram is the distribution of
resulting times from 20,000 independent simulations.
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history. In an SSA that treats elongation as a single step, a ribosome has a chance of
entering the elongating state, and a chance of leaving it; the greater the number of
ribosomes that have entered elongation, the greater the chance that a protein will be
completed. Thus, there is a chance that a protein will be completed in a very short time
after elongation begins; especially if many ribosomes enter an elongating state before
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Figure 2-4. Comparison of Tabasco to species-level simulations for a simple gene. I
simulated expression of a 1000 amino acid protein using Tabasco (blue) and a standard
species level simulator (red), where the processes of elongation (transcription and
translation) were lumped into single steps. While the steady-state averages are quite similar
(a-b), the pre-steady state kinetics are quite different (c). The distribution of times to
produce the first protein for all the simulations is shown in (d). The species-level simulator
generates unrealistic times to produce a protein of this size; elongation of the polymerase
alone should take ~75 seconds (see text). The data shown are averages of 500 simulations.
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ever leaving the elongating state. The fact that Tabasco treats each elongation reaction as
a series of elongation steps alleviates both of these problems. These improvements
provide a more realistic timing for simulation of pre-steady state kinetics of protein
production that are important during dynamic phenomena such as signal transduction or
embryonic development.
Chapter 2.3.3. Polymerase Interactions
The specific system I have chosen to study using Tabasco is bacteriophage T7.
During bacteriophage T7 infection, the E. coli RNA polymerase initiates expression of
early T7 proteins, including T7 RNA polymerase [Studier & Dunn, 1983]. T7 RNA
polymerase first initiates transcription behind already transcribing E. coli RNA
polymerase molecules. At 37"C, E. coli RNA polymerase transcribes at ~45 bp per
second; T7 RNA polymerase transcribes at ~250 bp per second [Garcia & Molineux,
1995]. Thus it is almost inevitable that the T7 RNA polymerase will collide with E. coli
RNA polymerases ahead of it.
Tracking the DNA at a single-molecule level allows us to simulate how protein
output might change as a result of the assumptions made on the outcome of RNA
polymerase collisions [Adhya & Gottesman, 1982; Horowitz & Platt, 1982; Nomura et
al., 1985; Epshtein et al., 2003]. Figure 2-5 shows the results of simulation of a simple
genetic system where two different polymerases transcribe the same piece of DNA,
mimicking the layout of the T7 genetic architecture. The simulations describe three
possible outcomes of collision: (1) the downstream polymerase in the collision
terminates, (2) the upstream polymerase terminates, or (3) the upstream polymerase
follows at the speed of the downstream polymerase. Each assumption leads to different
levels of steady state protein production. For example, in cases where the upstream
polymerase terminates upon the collision of polymerases, most of the T7 polymerases
will prematurely terminate because they will catch up with a slower, previously
transcribing host polymerase. In this case, the resulting gene expression levels are
similar to the situation where there is no T7 polymerase at all.
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Figure 2-5. Simulating models for inter-polymerase interactions. Average steady-
state protein levels of simulations of the DNA molecule with promoters for different
polymerases (T7 and E. coli RNA polymerases) that are expected to interact on the DNA
as they transcribe. The T7 RNA polymerase is ~5 times faster than the E. coli RNA
polymerase. Shown above are the results of simulations where different assumptions are
used as to the nature of the interaction that occurs between the polymerases upon
collision. The 'Downstream falloff' model specifies that the downstream polymerase
upon a collision between two transcribing polymerases will fall terminate transcription
and release from the DNA. The 'Upstream falloff' model describes the opposite
situation when the upstream polymerase falls off. Finally, the 'Traffic jam' model is
when the upstream polymerase follows the downstream polymerase at the speed of the
downstream polymerase. The 'Only T7' and 'Only E. coli' are controls that show
expression without E. coli and T7 RNA polymerase, respectively.
Chapter 2.3.4. Genome-scale Models - Bacteriophage T7
In order to test the effectiveness of using Tabasco on larger, more biologically
realistic systems, I simulated gene expression during bacteriophage T7 infection. The
39,937 base-pair genome, as represented by the simulation, contains 52 coding domains,
22 host and phage promoters, two transcriptional terminators, and three distinct
transcriptional feedback loops for each infecting phage molecule [Dunn & Studier, 1983].
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Because there are relatively few transcriptional terminators and many promoters, the rate
of transcription of individual genes in this system depends on the rates of transcription of
the upstream genes, as well as the presence of different polymerases. In the case of T7,
there is a further complication in that not all genes are available for transcription at once,
since the entry of the T7 genome is a relatively slow process.
Tracking the development of T7 from entry to the end of gene expression is thus a
good test for simulation of genomic level models in Tabasco. Using realistic parameter
sets, I simulated the simultaneous infection of three phage into a single cell [§2.5.5.3].
Jason Kelly and I developed a method to visualize the results of these simulations that
allows graphical display of Tabasco output [see http://openwetware.org/wiki/Tabasco].
Simulation of a full scale genomic model of T7 gene expression during infection on
a single AMD Athlon MP 2100+ 1.8 GHz processor takes on the between 1-2 hours for
30 minutes of simulated infection time. For the first time, we are able to simulate gene
expression at single base resolution for all gene expression in a particular organism
during development. In particular, we can explore specific hypothesis of polymerase
interactions, stochastic gene expression, and coupling of entry and transcription.
Chapter 2.4. Discussion
I designed and built Tabasco in response to the inability of currently available
simulation tools to represent biophysical mechanisms at a level of resolution
commensurate with our understanding. Tabasco allows simulation of T7 genome scale
models of gene expression at single base-pair resolution. Previous tools required either
modeling smaller systems at increased resolution, or simplifications and assumptions of
the biophysical models that result in less accuracy. For example, Tabasco's implemention
of a Gibson-accelerated Gillespie SSA allowed us to bypass standard simplifications that
are often made for promoter binding and initiation [Shea & Ackers, 1985]. I have shown
here that the increased resolution provides more accurate pre-steady state kinetics of gene
expression, gives us the ability to test models of polymerase and protein interactions on
the DNA, and allows us to fully simulate the dynamics of gene expression during
development of bacteriophage T7.
Executables, source code, documentation, and usage notes for Tabasco are freely
available, and should facilitate future extensions on the current design [http://
openwetware.org/wiki/Tabasco]. While requiring significant processing power, Tabasco
is computationally tractable in regimes where the effects of perturbations are highest; i.e.,
when the number of DNA molecules in the system is low. The simulator should be a
good base to further study interactions on DNA that lead to transcription and translation.
For example, Tabasco should provide a platform to explicitly simulate hypotheses how
many transcription factors can interact to direct eukaryotic gene expression, such as in
control of endol6 expression [Yuh et al., 2001]
There are many other tools for stochastic simulation available; Tabasco specifically
enables simulation of high-resolution models of gene expression. Other single molecule
simulation tools, such as StochSim and Moleculizer, are available and primarily focus on
binding and activation of protein complexes in signaling. In addition, others have been
working on increasing the efficiency of the SSA without significantly sacrificing accuracy
[Rao & Arkin, 2003; Gillespie & Petzold, 2003; Cao et al., 2005]. Finally, I am helping
to construct a simulator that uses rule-based logic like Tabasco to simulate proteoglycan
formation and modification (§5.1). As our models for system level behavior become
more encompassing, future work will require combining the efficiencies gained from
these individual simulators to create more general tools for high-resolution models of
system behavior.
Chapter 2.5. Methods
Chapter 2.5.1. Overall Structure and Gillespie Integration Simulator
Structure
Tabasco implements a modified version of the Next Reaction Method (NRM)
[§2.2.2; Gibson & Bruck, 2000]. Briefly, at the start of the NRM, the reactions are
defined and their tentative time of next execution is calculated and stored within a priority
queue containing all the defined reactions. The priority queue sorts these reactions
efficiently to allow quick searches for the minimum tentative time. The reaction with the
next tentative reaction time relative to the current simulation time is executed, any
tentative reaction times that are affected by the current reaction's execution are updated,
and the priority queue structure is reordered to reflect the new times. The process is
repeated to compute the time evolution of the system.
The NRM uses a dependency graph to determine which reactions are affected by
any particular reaction's execution. In the NRM, the dependency graph is calculated a
priori, and remains unchanged throughout the simulation. However, since Tabasco
creates reactions and complexes at the single-molecule level dynamically during
simulation, a static dependency graph and priority queue will not work. In order to solve
this problem, Tabasco contains two specialized reactions per DNA molecule within the
priority queue and dependency graph that are used to track a set of dynamically generated
reactions. These reactions are placeholders for all the dynamically generated
transcriptional and translational events that occur at the single-molecule level. The
placeholder reactions have tentative reaction times that are equal to the minimum
tentative reaction time of set of dynamically generated reactions the placeholder is
tracking. These placeholder reactions are described below [§2.4.2].
Chapter 2.5.2. Transcription and Translation
There are two specialized placeholder reactions within the priority queue in the
NRM that are used to track DNA-protein complexes and RNA-ribosome complexes at
the single-molecule level. The DNA-protein complex reaction tracks the position and
state of polymerases, or other proteins, as they traverse the DNA. The RNA-ribosome
complex reaction tracks the state of those ribosomes elongating along mRNAs that are
still being transcribed by RNA polymerases. Here state refers to whether the polymerase
or ribosome is just bound, initiating, or elongating, as well as the time they will next
perform an action such as termination or elongation. All the complexes, and the events
that they may generate, are stored in a different priority queue contained within these
specialized reactions. The minimum tentative reaction time for any of the complexes to
change state or position is used as the tentative time for the entire placeholder reaction in
the NRM.
It is within these specialized entries that the logic of transcription and translation is
encoded. In the simulation, polymerases bind free promoters to form a protein-DNA
complexes, which are stored within the specialized NRM entry. These bound complexes
can then either form an initiation complex or fall off the DNA. Once an initiation
complex is formed, the polymerase can undergo abortive initiation steps, or it can begin
transcription. The promoter is not freed until the footprint of the polymerase has left the
entire promoter region. If two elongating polymerases collide, they act according to the
polymerase interaction model chosen at the start of simulation. Upon arriving at a
transcriptional terminator, a polymerase will either continue transcribing or terminate
depending on a stochastic decision that is weighted by the termination efficiency.
Polymerases that reach the end of a particular piece of DNA also terminate transcription.
In addition, transcribing polymerases that are on functional protein binding sites such as
other promoters, block binding of the site by other proteins until the polymerase footprint
clears the site.
Transcribing RNA polymerases produce mRNA, which must be tracked by
Tabasco. I used two classes to represent ribosome binding sites (RBSs) on the genome,
Nascent RBSs and Mature RBSs, to differentiate when mRNA is tracked at the single-
molecule level or the species-level, respectively. The Nascent and Mature RBSs both
represent a single RBS on the DNA, and the two are distinguished here in order to deal
with the computational structure of Tabasco. When an RNA polymerase first transcribes
an RBS, a Nascent RBS is created. If, for example, a RNA polymerase prematurely
terminates before reaching the translation stop of the Nascent RBS, the mRNA and the
ribosomes translating it must be deleted from the simulation as well. Thus, while the
coding sequence is still being transcribed, we must treat all translation events at the
single-molecule level as well. Once the polymerase arrives at the corresponding
translation termination site, the Nascent RBS is converted to a Mature RBS which is
tracked at the species-level.
Translation occurs in three steps. First, ribosomes can bind either Nascent or
Mature RBSs. There is an initial reaction to form the Initiation Complex. Second, these
initiation complexes are converted to Elongation Complexes and an RBS (Nascent or
Mature) at a rate dependent upon the speed of the ribosome and the length the ribosome
must travel to clear the ribosome binding site. This reaction is treated as a single step,
however the distribution of times are chosen from the gamma distribution, in order to
represent a series of exponential reactions. Third, the Elongation Complex then forms a
finished protein and a free ribosome at a rate proportional to the remaining length of the
open reading frame. This reaction also is represented using the gamma distribution.
Chapter 2.5.3. DNA entry
In order to simulate mechanisms of bacteriophage T7 entry into the cell, we used a
two-step DNA entry model. First, DNA can enter at a constant rate, up to a certain site,
which is meant to represent a molecular motor based entry of phage DNA. Second,
RNA polymerases have been implicated as molecular motors that drive phage DNA entry
[Zavriev & Shemyakin, 1982; Garcia & Molineux, 1995]. In Tabasco, RNA polymerases
that reach the end of the DNA that has not yet entered the cell cause DNA internalization
at the rate of polymerization. These mechanisms were added to Tabasco, because they
are thought to govern bacteriophage T7 entry.
Chapter 2.5.4. Simulation, Data Output, Visualization, Code
Tabasco is written in Java® 1.4. The input file to the simulator is an XML file that
describes and parameterizes the relevant genetic elements, initial conditions, and any
other reactions that occur. The visualization is created by producing images that are then
merged using Quicktime® to create a movie. The source code, executables, along with
documentation and instructions for use, are available online at http://openwetware.org/
wiki/Tabasco
Chapter 2.5.5. Parameterization
All constants used are provided for completeness. For a discussion on the sources
and/or derivations of the constants used, see Chapter 3.
Chapter 2.5.5.1. Gamma versus Exponential distribution
The distribution of expected times for a reaction to occur in a stochastic simulator
depends on the underlying model [Figure 2-3]. Elementary chemical reactions will
follow an exponential distribution in arrival times. However, this is not true of non-
elementary reactions. Treating an imaginary elongation process as one step versus 50
individual steps has significant consequences. To obtain the distribution time for the two
cases, I use uniformly-distributed pseudorandom numbers and transform them into
exponential- or gamma-distributed random numbers. The exponential distribution is used
for the single step representation. Exponentially distributed numbers are calculated by
simply taking the negative natural log of a uniformly-distributed pseudorandom number.
A series of exponentially distributed arrival times, as in the case of the multi-step
elongation process, is given exactly by the gamma distribution. Gamma distributed
numbers are calculated from uniformly-distributed pseudorandom numbers by an
implementation of the rejection method [Press et al., 1992]. Pseudorandom numbers are
generated from Java's implementation (java.util.Random) of a linear congruential
pseudorandom number generator with a 48-bit seed [Knuth, 1997].
Chapter 2.5.5.2. Simple Gene Expression model
I simulated two models of a promoter driving expression of a coding domain.
The first model, termed single-molecule simulation, used the described Tabasco simulator
to account for each reaction step during transcription and translation. The model uses the
schemes shown in Figures 2-1 and 2-6a. The second model, termed the species-level
simulation, treats transcriptional and translational elongation as a single step as shown in
Figure 2-6b. The main parameters used in both models are shown in Table 2-1.
Constants were adjusted slightly to account for small differences in model structure to
give equal steady state values of mRNA and protein levels. Finally, the input files for the
simulations can be found in the Appendix [§7.3.1].
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Figure 2-6. Different models representing gene
expression. We can represent a simple model for
gene expression differently based on the simulator.
The Tabasco simulator treats expression at the
molecular level. The molecular-level Tabasco-based
simulation uses the general schematic used in Figure
2-1, and transcription initiation as shown in (a). The
species-level simulation uses the schematic shown
in (b). Care was taken to make sure the constants
were equivalent in both simulations.
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Table 2-1. Constants used in simple
gene expression model. The two models
tested used the both a species-level SSA
and Tabasco to represent gene expression
for a simple system shown in Figure 2-6.
The Tabasco constants for kprot and
kclear were adjusted to ensure the steady-
state levels of mRNA and protein were
equivalent in both simulations. The
constants do not exactly match because of
small variations in the structure of the
simulator.
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Chapter 2.5.5.3. Polymerase Interactions & Bacteriophage T7
The simulations for the polymerase interactions and bacteriophage T7 used
parameters that can be found in the input files in the Appendix [§7.3.2]. The parameters
used were based on the derivations described in the next chapter [§3.6]. However, in
general, the exact values of the constants are ancillary to this section, which is to show
that Tabasco is able to simulate processes such as polymerase interactions and entire
genetic systems such as T7.
Chapter 3. Models
Chapter 3.1. Introduction
Biological systems are physical systems that replicate themselves faithfully. The
precision and reproducibility of biological behaviors such as development imply
reproducible molecular events that govern their processes. However, precise knowledge
of an entire biological system with all the numbers, interactions, and dynamics of
individual components does not exist. Through genetics, we have information on
identity, essentiality, and connectivity of some of the components of biological systems.
Biochemistry provides detailed kinetics on individual components of these pathways.
Sequencing and modern bioinformatics give us further information on identifying
uncharacterized components and the components' evolutionary relationships. However,
few successful examples exist for combining this knowledge to construct accurate,
biophysically realistic models of entire organisms [Endy & Brent, 2001]. Such models
could be used to make model-based predictions to explore questions such as why a
particular organism is designed the way it is, and give us better substrate from which to
engineer future biological systems.
Bacteriophage T7 is a convenient organism from which to develop such system-
level models for several reasons [§ 1.2]. First, T7 is well studied. The genome has been
sequenced, annotated, and many important factors involved in RNA processing, DNA
replication, and protein expression have been described in detail [Dunn & Studier, 1983;
Studier & Dunn, 1983]. Second, compared to other pathogens, T7 is relatively
independent of host physiology. T7 encodes phage-specific RNA and DNA polymerases,
inhibits transcription and translation of most host genes early in infection, and degrades
most of the host genome. Third, transcription and replication of the T7 genome are
mostly independent processes, thus simplifying analysis of gene expression [Zhang &
Studier, 2004]. Fourth, complete internalization of the T7 genome takes under 10 min at
30"C, or about one third of the latent period [Zavriev & Shemyakin, 1982; Garcia &
Molineux, 1995]. As genes obviously cannot be transcribed before they leave the phage
capsid and enter the cell, the slow entry of the T7 genome also provides a direct
mechanism for regulating the timing and levels of gene expression. Based on their
spatial location and temporal expression patterns, T7 genes are divided into three classes,
which also correlate with the gene's function [Studier, 1972]. Class I genes (genes 0.3 to
1.3) are expressed first and mostly transcribed by the E. coli RNA Polymerase. The class
II genes (genes 1.4 to 6.3) followed by the class III genes (genes 6.5 to 19.5) are
expressed next and mostly transcribed by the T7 RNA polymerase.
Previous modeling efforts encoded the aggregate knowledge of T7 biology to
make computer simulations of an entire biological organism [Buchholtz & Schneider,
1987; Endy et al., 1997]. These simulations provided encouraging results, but also
showed a number of troubling inconsistencies with experimental measurements. Using
the model to predict the effects of gene repositioning led to failures in certain predictions
of phage growth [Endy et al., 2001]. For example, protein synthesis of most class I and II
genes was observed to spike and then fall-off as infection proceeded, whereas the model
predicted sustained expression. The model assumed that T7 mRNA was stable based on
previous measurements that showed that the total cellular RNA lifetime is greater than 20
minutes during infection [Summers, 1970]. However, individual transcript degradation
could be obscured in such bulk mRNA measurements and perhaps is the cause for drop-
off in protein synthesis rates.
This chapter describes our work to revisit these original models, specifically
focusing on the program of gene expression during T7 infection [Keller et al., in
preparation]. To do this work, I developed and used a new simulator, Tabasco, to explore
in greater detail mechanisms that are thought to govern phage gene expression [§2]. I
coupled this analysis with Heather Keller's real-time RT-PCR measurements of the
absolute RNA levels over the course of infection for 21 of the 56 known T7 genes. The
measurements strongly indicate that T7 mRNA is decaying during infection. I used the
model to estimate degradation rates and show that the resultant mRNA profiles correct
the previous discrepancies in protein synthesis rates. I use the quantitative mRNA
measurements to further constrain different assumptions in the model, and discuss what
challenges lie ahead.
Chapter 3.2. Background on T7 Gene Expression
Chapter 3.2.1. General
Bacteriophage T7 is an obligate lytic phage that infects B strains of E. coli [Dunn
& Studier, 1983; Studier & Dunn, 1983]. The initial genetic studies of T7 found 19 genes
to be essential for the viability of the phage, which were numbered 1-19. Further screens
and eventually the sequencing of the DNA revealed more genes, which were numbered
appropriate to their locations relative to the original 19. In total, the 39,937 base pair (bp)
genome encodes 56 genes predicted to specify 60 proteins, of which 45 have been
observed by polyacrylamide gel electrophoresis. These genes are separated into three
classes called early (class I), middle (class II), and late (class III), depending on their
location on the genome. To clarify the naming conventions, the genes are simply written
as gene I or gene 0.3. The protein products are labeled gpl or gp0.3 (for gene product
0.3). Promoters specific to the E. coli RNA polymerase (RNAP) are labeled with a
capital letter sometimes followed by a number such as Al or B. Promoters specific to the
T7 RNA polymerase (gpl) are labeled with a '0' in front of an italicized number
representing the gene the promoter precedes (e.g., 010).
Chapter 3.2.2. Gene Regulation by DNA Entry:
T7 development begins with adsorption of the phage particle to the E. coli lipo-
polysaccharide, creation of a channel for DNA entry (~1 min), and entry of DNA at a rate
of -75 base pairs per second (bp/s) [Garcia & Molineux, 1995; Molineux, 2001]. Wild-
type T7 DNA translocation effectively stops after 850bp has entered the cell, while the
remainder of the genome is internalized by transcription, first by RNAP at 40 bp/sec and
then by gpl at -200-300 bp/sec [Garcia & Molineux, 1995]. Complete internalization of
the T7 genome takes under 10 min at 30*C, or about one third of the entire developmental
cycle.
Genes cannot be transcribed before they enter the cell, thus, the slow entry of the
T7 genome regulates the time of first expression (e.g., early genes are expressed first,
etc.). The organization of gene functions on the genome are mostly grouped by when
they are expressed. The early genes, whose functions involve evading host restriction,
expression of gene 1, and blocking E. coli RNAP activity, are among the first to enter the
cell and thus the first to get expressed. Whereas genes that control particle
morphogenesis, DNA packaging, and cell lysis, are all middle or late genes and
consequently their expression is prohibited during early infection.
Chapter 3.2.3. Gene Regulation by Promoter Specificities and
Strengths:
The amount of gene expression is dependent upon the type, strengths, and
locations of the promoters on the genome. Class I genes are expressed early by RNAP
using the class I promoters, while class II and then class III promoters are utilized by gpl
later during development. Using one or more of three strong class I promoters (A1, A2,
A3), RNAP transcribes about 7 kb containing the first 10 genes of T7, including gpl.
Two weaker promoters (B and C) provide no detectable transcripts of T7 DNA in vivo but
are known to be active in the absence of the A promoters. Transcription by RNAP is
thought to stop at the early terminator TE, which is ~ 80% efficient in vitro, or at least
90% in vivo [Chamberlin, et. al., 1979; Dunn & Studier, 1980; Briat & Chamberlin,
1984]. Gpl transcribes both class II and III genes. Ten T7 promoters lie within the class
II region of the genome, fewer are present in close relatives of T7 but the significance for
any given number of class II promoters is unclear. Transcription from all 10 promoters
terminate, both in vitro and in vivo, at ~ 80% efficiency at To, the major late
transcriptional terminator. Five 23-base conserved class III promoters direct primary
expression of all late genes, three of these lie upstream of To and thus provide
overlapping transcripts with those from class II promoters. Class III promoters are,
however, stronger than their class II counterparts because they are less susceptible to
abortive initiation [Ikeda, 1992; Lopez et al., 1997]. Two additional T7 promoters lie
close to each genome end; OOL is thought to be very weak and does not yield detectable
transcripts from T7 DNA in vivo but it is known to be active in certain mutant infections
[Moffatt & Studier, 1988; Garcia & Molineux, 1995]. OOR has a class III consensus
sequence but transcribes only a single non-essential gene, and thus its possible role in
DNA replication and DNA packaging is likely more important than its transcriptional
activity.
Chapter 3.2.4. Gene Regulation by Protein-level Feedback
Mechanisms:
T7 gene expression is regulated by feedback controls enacted at the level of
protein-protein interactions. First gp0.7, through an unknown mechanism, and then gp2,
by direct binding, act in concert to shut down transcription by RNAP and thus expression
from host DNA [Nechaev & Severinov, 1999; Hesselbach & Nakada, 1977b; Brunovskis
& Summers, 1972]. This feedback mechanism also allows for further differentiation
between class I genes and those genes transcribed by gpl (class II and class III genes).
Later in the infection cycle, T7 lysozyme (gp3.5) inhibits the function of gpl by the
formation of a 1:1 complex. At, low gp3.5 concentrations, class III promoters are
preferentially expressed over class II promoters [Villemain & Sousa, 1998], whereas at
high concentrations of gp3.5, most transcription is repressed and only short abortive
transcripts, which are involved in the initiation of T7 DNA replication, are produced
[Moffatt & Studier, 1987; Zhang & Studier, 1997, 2004]. Because gp3.5-mediated
inhibition of gpl is required to initiate DNA replication, most phage mRNA is produced
from the original infecting copy, and not subsequent copies of the DNA. Thus unlike
most phage, T7 DNA replication and late transcription are not coupled (at least at high
multiplicity of infection). RNA synthesis, as measured by 3H-uridine incorporation, is
mostly finished by the start of DNA replication, as measured by 3H-thymidine
incorporation [Zhang & Studier, 2004]. This aspect of T7 biology is particularly useful
because T7 gene expression be studied and modeled fairly independently of DNA
replication, capsid assembly, packaging, and lysis.
Chapter 3.2.5. Other Factors:
Little is known about regulation of T7 gene expression at the level of translation
other than it is likely to occur. For example, experiments in vivo and in vitro show that
gene 0.3 mRNA is out-competed for translational machinery by late T7 mRNA [Strome
& Young, 1978,1980a,b]. Due to the number of overlapping genes, translational coupling
may play a role as well. T7 mRNA seems to be stable in E. coli, possibly by the
modification of the major mRNA degradation enzyme in E. coli, RNase E [Summers
1970; Marss & Yanofsky, 1971, Marchand et. al., 2001]. In addition, there are a number
of RNase III recognition sites on the genome that may stabilize mRNA transcripts in vivo
[for review, see Grungerg-Manago, 1999]. Also, RNase III activity is increased upon
phosphorylation by gp0.7 [Mayer & Schweiger, 1983].
Chapter 3.3. Results
Chapter 3.3.1. Absolute Measurements of T7 mRNA Transcripts
For completeness, I describe Heather Keller's measurements of T7 mRNA during
infection [Keller et al., in preparation]. Keller used real-time RT-PCR to measure 21 T7
genes over the course of infections. To help constrain the model, this study measured
absolute numbers of the average number of mRNA copies per cell. To calculate absolute
numbers of mRNA, known amounts of in vitro transcribed RNA were used to generate
gene-specific standard curves that the experimental samples were compared against. In
addition, exogenous B. subtilis mRNA was spiked into the crude RNA samples in order to
account for differences in extraction efficiencies between samples.
The real-time RT-PCR measurements agree with previously reported trends in the
timing of T7 gene expression. As shown in Figure 3-1, the timing of expression is
directly correlated with genome position; class I genes are expressed first and show early
peaks, followed by class II and then class III genes. This pattern of expression is in
accordance with the prevailing theory regarding T7 genome entry with expression
proceeding from left to right across the genome [Zavriev & Shemyakin, 1982; Garcia &
Molineux, 1995]. Additionally, the timing of the measurements closely matches previous
gene expression studies which have shown that at 30"C: class I RNA synthesis begins 0-4
minutes and ceases 4-8 minutes post-infection; class II transcription begins 4-8 minutes
and falls 8-12 minutes post-infection; class III genes are transcribed between 8 minutes
post-infection and lysis, with the expression of genes 8, 9, and 10 initiating with class II
genes, but persisting through late times of infection [McAllister & Wu, 1978].
In addition to the timing of expression, the relative amounts of mRNAs agree well
with expectation. Four of the class III genes measured encode key structural components
of the T7 phage virion, including the head-tail connector (gene 8), the scaffolding protein
(gene 9), the capsid protein (gene 10), and one of the tail proteins (gene 11). Each T7
virion requires 12, 139, 415, and -~12 copies of these proteins respectively [Endy et al.,
1997; Kemp et al., 2005]. Our mRNA measurements show that the peak expression
levels of these genes correspond with the levels of protein required during infection, with
gene 8 < gene 11 << gene 9 < gene 10 [Figure 3-1]. In addition to quantifying individual
transcript levels, the real-time RT-PCR approach allows us to probe other characteristics
of T7 gene expression, such as terminator efficiency. T7 genes 11 and 12 are only
transcribed when the T7 RNA polymerase reads through the To terminator downstream
Figure 3-1 (next page). Real time measurements and simulation results showing
absolute, gene-specific mRNA levels per cell during T7 infection. Each plot shows the
measured (green) and computed (red;blue;purple) number of T7 mRNA per cell
throughout infection. Measurements were made using real-time RT-PCR. The solid lines
show the average all of all replicates (2-4 extractions per gene, each extraction measured
in triplicate). Shaded regions represent the range of the measurements, with the standard
deviation show by error bars. Simulation data represents the Unfit model (blue), initial fit
(red), and best fit model (purple; Traffic Jam model with increased promoter strength).
The width of the computed curves shows the variation (± standard deviation) from the
average of 25 simulations.
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of gene 10. The ratio of the gene 11 to gene 10 measurements (between 6 and 25 minutes
post-infection) indicates an in vivo terminator efficiency for the phage specific terminator
T0. The measured average value of 78% ± 5% is consistent with previous in vitro
measurements of ~80% [Lyakhov et al., 1997]. Previous in vivo measurements on
plasmids give a range of termination efficiencies when transcribing T7 DNA (66-98%)
depending on the promoter used to initiate transcription [Macdonald et al., 1993, 1994].
Unlike previous reports, many of the T7 genes measured show reduction in
absolute transcript levels during middle and late infection, which is visually apparent in
Figure 3-1. 19 of 21 genes show meaningful reduction from the peak expression levels
(as measured by a Student T-test) [Keller et al., in preparation]. The rates of decline are
transcript-specific with the class III genes displaying the greatest stability.
Measurement locations within genes were chosen to ensure specificity of the
primers; consistent positioning within the gene was not a design criterion. To test the
possibility that different regions of a given transcript show non-uniform behavior, Keller
designed a series of five primer pairs spaced throughout gene 1. Each primer pair
displayed different absolute levels of expression for gene 1. For example, the peak
expression at 10 minutes for gene I showed the most difference between measurements
ranging from ~300 to ~1700 copies of RNA per cell [Keller et al., in preparation].
However, the shape of the expression curves are consistent throughout infection. Thus,
while the absolute levels of mRNA may be affected by measurement location, the
observed reduction in relative mRNA levels is still significant.
Chapter 3.3.2. Molecular Model for T7 Gene Expression
I constructed a model for T7 gene expression using Tabasco. Tabasco tracks
individual molecules of phage DNA inside the cell and the polymerases transcribing the
DNA at single-base resolution [§2]. The initial model was parameterized using empirical
results combined with some prevailing assumptions of T7 biology [§3.6]. I did not adjust
parameters a priori to account for system level data.
I compared mRNA levels of our measurements to output from the simulations
based on our initial model [Figure 3-1]. Notably, given the available information prior to
the mRNA measurements, the initial model did not encode mechanisms for RNA
degradation. The computed mRNA values are, for the most part, overestimates of the
measured values and the average R2 (fraction of variance explained) is 0.2645 [§3.5.3].
However, the timings for the initial rise in measured mRNA levels did match the
simulation well [Figure 3], indicating the prevailing model for RNA polymerase mediated
genome entry is consistent with the mRNA observations [Zavriev & Shemyakin, 1982;
Garcia & Molineux, 1995]. In addition, the timing of transcription initiation and shutoff
agree with published results [Figure 3-2; Zhang & Studier, 2004].
Based on observed degradation of measured mRNA, I decided to incorporate
mRNA degradation into the model. I initially simulated a range of degradation rates
constant for all genes (data not shown). These simulations did not produce useful
improvements in the comparisons. At low degradation rates the simulations could not
account for the fast decline of class I and II mRNA, and at high degradation rates the
simulations could not produce high levels of class III mRNA. I next attempted to
estimate degradation rates by fitting a range of transcript-specific degradation rates to the
measured data (called Initial fit). Currently, an exhaustive search of degradation rates is
computationally unfeasible. Thus, I developed a fitting procedure that determines
degradation rates of genes from left to right across the genome [§3.5.3]. While not
exhaustive, comparisons between measured and fit mRNA levels were visually better and
the average R2 was 88% better (0.4641 versus 0.2645) [Figure 3-1, red; Figure 7-2a;
§3.5.3; §7.3.3]. The results for individual genes and estimated half-lives for transcripts
are described in Table 3-1. In general, class I genes were the quickest to be degraded,
followed by class II genes, and most class III genes showed very little degradation. There
are exceptions to this trend, the most apparent of which are genes 1.1, 8, and 18.5.
Finally, previous models and simulations, which did not account for mRNA degradation,
failed to recapitulate the experimentally observed drop in class I and II protein synthesis
rates [§ 1.2.3; Figure 1-2; Endy & Brent, 2001; Endy et al., 2000]. The simulations fit to
the mRNA measurements produced better correspondence to the observed protein
synthesis rates [Figure 3-3].
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Figure 3-2. Simulated transcriptional activity during T7 infection. Transcription initiations
over time (a) from strong (dark blue) and weak (light blue) E. coli promoters as well as the three
classes of T7 promoters (strong -- dark red; weak processivity -- magenta; weak processivity
and binding -- pink) show initial rise at expected timings followed by shutoff later in infection.
The attenuation of promoter activity is reflected in the RNA bases polymerized during infection
by each of the polymerases (b), and correspond with published results [Zhang & Studier, 2004].
Note the simulations do not account for transcription from the host genome.
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Figure 3-3. Simulated and Measured Protein Synthesis Rates. Simulations (blue)
match previous experimental results [Endy & Brent, 2001] showing shutdown of class I
and II mRNA much better than previous models (Figure 1-1) when the simulations are fit
to mRNA degradation rates. The simulations shown are from the Initial fit.
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Chapter 3.3.3. Constraining Models of T7 Gene Expression
I wanted to test the ability of the new RNA measurements to constrain areas of
uncertainty in the models. I tested different assumptions used in the model concerning
promoter strengths, RNA degradation, and polymerase interactions. Generally, I would
alter a particular assumption, and then test the ability of the new simulations to fit the
mRNA data shown. I hoped that altering the assumptions and looking at how the
comparisons were affected would eliminate some hypotheses.
I observed that simulated RNA polymerase initiation rates indicated that the
encoded high abortive initiation percentage was limiting the transcription initiation rate
(data not shown). The host and phage promoters on the T7 genome are among the
strongest known prokaryotic promoters [Lopez et al., 1994]. I suspected that the
measured in vitro rates of abortive initiation used in the simulation are higher than the
actual in vivo rates. I tested the effect of increasing promoter initiation rates of all the
promoters [§3.6.5]. I then refit individual degradation rates to the measured mRNA
levels [Table 3-1; Figure 7-1a; Figure 7-2b]. Overall, the simulations with increased
RNA polymerase initiation rates give an average R2 that is only 14% better than the
originally encoded rates. Most of this change was due to better fits for the class I genes,
which showed an average R2 that was 30% better.
I next tested different RNA degradation mechanisms in the simulations. The
Initial fit assumed the degradation machinery competes with ribosomes for the ability to
degrade mRNA [Yarchuk et al., 1991, 1992]. Thus, an mRNA with a bound ribosome
binding site is immune to degradation [Table 3-1; Figure 7-1b; Figure 7-2c]. I also tested
a scenario where mRNA degradation was independent of translation initiation. I found
that the simulations assuming competition for RNA showed moderately better fits for
class I genes (14%), but the class II and class III mRNA fits showed little change (4%
better each).
Finally, I simulated different outcomes resulting from RNA polymerase
interactions. Transcribing T7 RNA polymerases are expected to interact with E. coli
RNA polymerase during infection, because T7 RNA polymerase is measured to have a
five-fold higher synthesis rate [Garcia & Molineux, 1995]. I simulated, fit, and compared
four separate hypotheses of polymerase interactions. First, upon collision, the
downstream transcribing polymerase could terminate transcription, allowing the upstream
polymerase to pass (termed DSF for DownStream Falloff) [Table 3-1; Figure 7-lc; Figure
7-2d]. Incomplete mRNA being transcribed from the terminated polymerase are also
degraded, and ribosomes translating the nascent mRNA are freed. Second, the upstream
half life nodeg
0.3 0.11
0.7 0.18
1 0.19
1.1 0.17
1.2 0.05
1.3 0.04
1.4 0.06
1.7 0.48
2 0.50
2.5 0.18
3.5 0.43
5 0.15
6 0.17
8 0.01
9 0.47
10A 0.54
11 0.44
15 0.48
16 0.23
17.5 0.24
18.5 0.07
class I avg 0.0 3.9 3.5 4.8 4.1 1.4 2.3
class II avg 0.0 7.4 6.8 8.1 9.5 4.5 10.8
class III avg 0.0 12.2 10.0 13.1 15.5 6.2 53.9
class I R2  0.12 0.44 0.57 0.48 0.43 0.60 0.39
class II R2  0.28 0.46 0.52 0.50 0.44 0.50 0.36
class III R2  0.31 0.48 0.51 0.49 0.42 0.53 0.32
total R2  0.2465 0.4641 0.5295 0.4905 0.4299 0.542 0.3541
Table 3-1. Estimated half-lives for mRNA and R2 for each gene. T7 genes are listed
in the first column. The second column lists the R2. Columns 3-8 list the estimated half
lives for the initial fit (init), increased promoter strengths (prom), the alternative
degradation model (AltDeg), the downstream falloff model (DSF), the traffic jam
model (traffic), and the upstream falloff model (USF). Each half-life fit is shaded in
one of 5 levels of grey corresponding to R2 in 0.2 increments (darker indicates better
fit). Infrefers to no degradation rate, or an infinite half life. The bottom of the table
lists geometric mean for half-life and arithmetic mean of the R2 for each of the classes
of genes.
polymerase could also terminate transcription (USF), and incomplete mRNA are treated
as in the DSF case [Table 3-1; Figure 7-1d; Figure 7-2f]. Third, the upstream polymerase
could follow at the speed of the downstream polymerase (Traffic) [Table 3-1; Figure 3-1,
purple; Figure 7-2e]. Fourth, only an upstream T7 RNA polymerase can cause
termination of a downstream E. coli polymerase (same as increased promoter strength
model) [Table 3-1; Figure 7-1a; Figure 7-2b]. All other interactions in the Hybrid
simulations follow the Traffic simulation rules. I fit each of the models separately to the
measured mRNA data. The USF simulation was the worst at fitting the data with an
average R2 of 0.35, the DSF simulation was 21% better at fitting the data [Table 3-1].
The Hybrid and Traffic simulations both fit the model well, showing 49% and 53% better
fits than the USF model, respectively [Table 3-1]. I did not consider a model where
polymerases do not interact, i.e., they pass through one another unimpeded. The internal
data model of Tabasco cannot represent two polymerase occupying the same space on the
DNA.
Chapter 3.4. Discussion
In this study, the mismatch between previous models and experimental data led us
to quantitatively measure T7 mRNA as well as to construct more detailed models of gene
expression. Heather Keller measured absolute mRNA levels during T7 infection for 21
representative T7 genes. These measurements agreed with many known aspects
regarding the timing and levels of T7 gene expression. However, the observed systematic
mRNA degradation is in contrast to many previous studies [Summers, 1970; Mars &
Yanofsky, 1971; Yamada et al., 1974a; Yamada et al., 1974b; Yamada et al., 1975]. I
constructed a best-faith effort to construct a detailed, unfit, and biophysically realistic
model of T7 gene expression during infection. Initial comparisons between the model
and the measured mRNA levels showed significant discrepancies, primarily due to model
assuming mRNA levels were stable. I developed a procedure to fit degradation rates to
individual transcripts to fit the mRNA measurements. This procedure produced
estimates of the mRNA half-lives, and a much better overall fit to the data. The fit
simulations also corrected previous discrepancies between the simulated and measured
class I and II protein synthesis rates.
Measurement of absolute levels of mRNA provided stricter comparisons to our
simulations than relative levels could have provided. I used the mRNA measurements to
evaluate different hypotheses related to promoter strengths, RNA degradation, and
polymerase interactions. For example, when I tested four different possibilities on the
nature of expected polymerase interactions, two could not be optimized to fit the
measurements well. However, the large error associated with the absolute RNA levels
prevented confident discrimination of models concerning promoter strengths and
mechanisms for RNA degradation.
The measurements also question previous work indicating that transcription
ceases before DNA replication begins [Zhang & Studier, 2004]. The measurements show
transcription late in infection of a region upstream of the first rightward facing host
promoter Al. Transcription in this early region begins 10-12 minutes post-infection, at
least two minutes after transcription begins from all other measured regions [Keller et al.,
in preparation]. During DNA replication, T7 DNA forms concatemers connecting the
left end of the genome to the right end [Watson, 1972]. The late rise of mRNA levels
from this early region suggests that transcription from the right end of the genome is
continuing through the concatemer junction. The presence of concatemer junctions
during transcription indicates that DNA replication is initiated before RNA production is
complete. DNA replication during the course of transcription would augment the levels
of late gene expression predicted by the model. Further exploration of the timing and
extent of DNA replication during infection is needed to verify if the observations are
meaningful.
We chose to use real-time RT-PCR to measure RNA levels because of the
method's proven sensitivity, specificity, and dynamic range [Wong & Medrano, 2005;
Bustin, 2000]. However, we found that many aspects of real-time RT-PCR detract from
its usefulness in making absolute measurements for constraining a model. First, the
measurements show that the exponential nature of PCR leads to large error in absolute
measurements, making comparison to a model difficult. Second, we found that the
location of the measured region within a gene affects the observed RNA levels. We are
unable to distinguish between partial and complete transcripts using the standard
50-150bp regions. Therefore, our measurements are likely overestimates of the
functional mRNA levels. Longer amplification regions would decrease the detection of
partial transcripts, but also lead to problems with RT efficiency, increased PCR
optimization, and reduced throughput. Third, real-time RT-PCR is expensive and time-
consuming for large-scale studies. Ultimately, real-time RT-PCR is still one of the best
methods currently available for accurate and sensitive measurement of mRNA, but better
techniques are still needed [Wu & Schwartz, 2007].
Although our T7 gene expression model is more complete, there are still
mechanisms that need elucidation before we can confidently make model-based
predictions of perturbations such as genome rearrangements. For example, the models
often underestimate the RNA levels measured in some late genes such as 10 and 15.
Could this be explained by the concurrence of DNA replication and transcription we have
hypothesized? In addition, the simulator cannot match the sharp rise and subsequent fall
for some class II genes such as 1.7, 2, 2.5. Might this indicate our lack of understanding
of degradation mechanisms and/or promoter strengths? Also, we need a better
understanding of how the properties individual genetic elements change when placed in
different contexts in order to predict the effects of gene rearrangements. For example,
how do mRNA degradation rates change when moving a gene from one position to
another? Finally, for gene pairs that are expected to be on the same transcript, such as
1.1/1.2 and 15/16, the measurements often show that the downstream genes have
significantly lower mRNA levels. Are there processivity effects of the RNA polymerase
that I am not taking into account? Further understanding of such questions will bring us
closer to making accurate model-based predictions.
We can continue the process of increasing our measurement capabilities and study
T7 until we can make predictable changes to the genome. I have also started to work on
another approach. Rather than making our computational models more realistic
approximations of the natural organism, I am constructing new biological organisms that
are closer approximations of our models [§4]. Thus, I am constructing organisms that are
better optimized to be understood by insulating and standardizing the genetic elements, as
well as removing complicating elements.
Chapter 3.5. Methods
Chapter 3.5.1. Model Parameterization
I used mostly empirical data along with some assumptions of T7 biology to
constuct a first-pass model of T7 gene expression. Briefly, I derived canonical rates for
transcription and translation from previous empirical studies. I classified and
parameterized three classes of T7 promoters and two classes of E. coli promoters.
Polymerase processivity rates, translation rates, and termination efficiencies were taken
from literature values as well. Without better information, all translation initiation sites
were assumed to have the same strength. Complete details on the parameterization can
be found in §3.6.
Chapter 3.5.2. Simulation
Simulations were executed using the Tabasco simulator [§2.2]. All data shown
are for average of 25 runs of each simulation. Simulation of a single infection run takes
2-4 hours on a single processor (AMD Athalon). Input files and scripts are provided in
the appendix [§7].
Chapter 3.5.3. Fraction of Variance Explained (R2)
I used R2 as a metric for comparing our models and measurements. For each gene
and timepoint I summed the mean-squared distance (MSD) from the average normalized
simulator value to each of the individual normalized measurement values for that
timepoint. Both the simulations and measurements were normalized to the highest
measurement or simulation value recorded for each particular gene. I summed the MSD
for all the gene's timepoints from 0-25 minutes. I also found the minimal MSD
achievable by using the average measured value at each time-point instead of the
simulated value in the calculation. Then I divided the minimal MSD by the simulation
MSD across all the timepoints to give an R2 for a particular gene. The R2 will equal 1 if
the simulations produce the average experimental value for each timepoint. Many
comparisons use the average R2, which refers to the average R2 for all genes in a
particular simulation. The average R2 is not equivalent to calculating R2 for all the
timepoints in all the genes all at once.
Chapter 3.5.4. Fitting mRNA Degradation Rates
I optimized mRNA degradation rates to the measured mRNA levels through an
iterative process. I first found an average mRNA degradation rate for all class I genes by
fitting a range of degradation rates (from 0-15 minute half-lives in 1 minute increments)
and finding local maxima for the R2. I then set the class I average, and tested ranges for
the average class II mRNA degradation rates and then class III rates. After the averages
were set for all the classes, I tested ranges and fixed degradation rates for each of the
individual genes measured from left (gene 0.3) to right (gene 18.5). Upon inspection, the
R2 for almost all the genes and gene classes showed local maxima (or a maxima at one
end of the range) at only one location. Each fit was also inspected visually to make sure
that the procedure did not produce obviously unrealistic fits. Finally, I found that fitting
the later genes did not affect the fits of the earlier genes substantially as evidenced by the
lack of large R2 changes of the fits of upstream genes after fitting downstream genes.
Chapter 3.6. Model Parameterization
Chapter 3.6.1. Constants for Transcription
Chapter 3.6.1.1. RNA polymerase transcription rate and footprint
The rate of E. coli RNA polymerase transcription varies on the conditions and
templates of the measurements. For example, the transcription rate has been previously
measured in vitro to be 55 base pairs per second (bp/s) at 37*C [Bremer & Yuan, 1968],
but 43 or 25-28 bp/s at -30"C [Manor et al., 1969; Rose et al., 1970]. More recently, in
vivo studies have measured the rate to be 45 bp/s at 30"C and 24-62 bp/s at 37"C [Garcia
& Molineux, 1995; Epshtein & Nudler, 2003]. I use the 45 bp/s measurement in our
simulations because the mRNA measurements are done at 30"C. For the T7 RNA
polymerase transcription rate, I used previous in vitro and in vivo measurements to obtain
a value of 230 bp/s [Golumb & Chamberlin, 1974a; Garcia & Molineux, 1995].
In addition to the transcription rate, I parameterized the footprint of the
polymerase in order to account for when they do or do not block other proteins from
accessing the DNA. The T7 polymerase elongation complex keeps a transcription bubble
size of ~9 bp, and a potential footprint of ~13 bp [Liu & Martin, 2002]. I used the latter
value in the size of the footprint during T7 transcription. E. coli polymerase is protected
from cleavage by free radicals by ~25 bp [Zaychikov et al., 1995; Nudler et al., 1996;
Nudler et al., 1998; Korzheva et al., 2000; Greive & von Hippel, 2005]. I used 15 bp as
an estimate for the amount of DNA blocked by all the polymerases.
Chapter 3.6.1.2. Promoters Strengths
E. coli promoter parameterization
There are three major E. coli promoters, Al, A2, and A3 that are known to direct
most E. coli polymerase transcription during infection [Dunn and Studier, 1983]. In vitro
studies also identified several minor promoters named B, C, D (also known as AO), and E
[Minkley & Pribnow, 1973; Delius et al., 1973; Stahl & Chamberlin, 1977]. Due to its
leftward directionality, I did not include the D promoter in the simulation. In addition,
the E promoter was also ignored due to its location close to the right end of the T7
genome. Very little activity E. coli polymerase activity remains by the time the E
promoter has entered [Hesselbach and Nakada, 1977].
I used stopped-flow kinetic analysis data to parameterize the Al promoter
[Johnson & Chester, 1998]. Abortive initiation assays show that the minor promoters
have approximately a ten fold reduction in binding, which is reflected in our
parameterization by a 10-fold increase in koff [Dayton et al., 1984]. Figure 2-6 and Table
3-2 describe the exact parameters used in simulations.
T7 promoter parameterization
Traditionally, the T7 promoters
are classified into one of three groups:
the class II non-consensus promoters,
the class III consensus promoters, and
the replication promoters [Dunn and
Studier, 1983]. The class III promoters,
along with one of the replication
promoters, 00R, all share the same 23
base pair sequence from -17 to +6
relative to the transcription start site at
+1. The class II promoters and the
other replication promoter, OOL, have
mutations from this consensus sequence
that are described in Table 3-4. I could
not find a biophysical justification to
differentiate between the replication
promoters from the class II and class III
promoters, so I treated OOL as a class II,
and OOR as a class III T7 promoter.
Due to a lack of quantitative
data to parameterize each promoter
separately, I grouped the promoters into
classes that could be parameterized. All
the consensus promoters have the same
parameters. I classified the non-
consensus promoters by their deviations
from the consensus sequence into either
kon
koff
kiniton
runoff %
kelong
krecyc
Rate of RNA polymerase binding to
DNA to form an initiation complex
(M-Is-1).
Initiation complex releasing to form
RNA polymerase and free DNA (s-0).
Rate of transition from an initiation
complex to an elongation complex
(creation of first two nucleotides and
bubble formation) (s-1).
Percent of elongation complexes that
continue transcribing past the
promoter region instead of recycling
to an initiation complex
Rate of elongation complex clearing
promoter and leaving initiation phase
(s-1).
Rate of recycling by promoter fall
off and rebinding to initiation
complex (s-1).
Table 3-2. Description of promoter constants
used in model. See Figure 2-6 for the
corresponding visual depictions of the constants.
Kon 1.3ft /1.3t I as DeroreJ
koff 0.28 2.8 as before N/A
kiniton 0.19 0.19 as before N/A
runoff% 100 100 70 N/A
kelong 6 6 as before N/A
krecyc N/A N/A 0.19 N/A
Table 3-3. Constants for the E. coli RNA
polymerase promoter initiation. See Table
3-2 for an explanation of the constants.
I
weak processivity, or weak binding and processivity. It is known that the region from -
17 to -5 mostly contributes to the free energy of polymerase binding, the -3 to -1 region
is mostly important in initial double strand melting, and the +1 to +6 region is important
in the formation of a stable elongation complex [Bandwar & Patel, 2002]. Differences in
the -3 to +6 region affect the kinetic rate of polymerase initiation similarly by reducing
the rate of polymerase initiation [Ikeda, 1992]. Thus, differences from consensus in the
binding region (-17 to -5) places the promoter in the weak binding category, and
differences in the -4 to +6 region lead to weak processivity. The only exception is the
OOL promoter, where the -11 G to A difference was previously characterized as having
very little effect both in vivo and in vitro [Ikeda et al., 1992].
After a preliminary analysis of available kinetic data, I created a framework for
promoter initiation in Tabasco in order to reflect the mechanisms thought to control T7
RNA polymerase promoter initiation [Figure 3-2]. I then parameterized each class of T7
promoters above from interpretation of available data. For consensus promoter binding I
used a kon of 1.82E8 M-'s-1 and a koff of 0.2 seconds [Bandwar et al., 2002; Ujvari and
Martin, 1996]. For weaker binding, I used constants of 6.0E7 M-'s -1 and 18 s-1 for the
-11,1
-17,2,4
3,4,5
-5,5
-2,3,4,5
-2,3,4,5,6
-1,1,4,5
-13,-12,-11,-2
-17,-13,2
-2,3,4,5,6
-17,-16,-13,3,4,5,6
weak processivity
weak binding&processivity
weak processivity
weak binding&processivity
weak processivity
weak processivity
weak processivity
weak binding&processivity
weak binding&processivity
weak processivity
weak binding&processivity
Table 3-4. Non-consensus T7 promoters classification. The T7
weak promoters are split into two classes. The first class has
differences in the binding region (-17 to -5) and the processivity
region (-3 to 6). The second class has differences only in the
processivity region (see text).
#UL
01.1AOI.I
013.3
01.5
01.6
02.5
03.8
04c
04.3
04.7
kon and koff respectively [Bandwar et al., 2002]. Finally, I estimated promoter clearance
rates based on the work of Ikeda [Ikeda, 1992].
The constants for the initiation rate to form an elongation complex (kiniton), the
rate to clear the promoter if it is does not fall off (kelong), and the rate at which
terminated elongation complexes recycle to the promoter complex (krecyc) are all kept
constant across the different types of promoters. All these constants were derived from
the promoter initiation studies of Jia and Patel [Jia & Patel, 1996]. Kiniton was measured
directly at a rate of 1.82 M-Is-1. I inferred from the study that the the rate of addition of
bases +2 to +6 (kelong) is 30 s-lbp-1, plus the remaining 9 bases for the polymerase to
clear the promoter at ~230 bp/s, which gave a total of 5.8 s-1. Krecyc represents the
addition of 4 bases and then a 1 second falloff step, to give a total rate of 0.88 s-1
Chapter 3.6.1.3. Feedback inhibition on RNA polymerases
Interactions of the E. coli RNA polymerase with gp0.7 and gp2.
The phosphorylation of the B' subunit of the E. coli RNA polymerase by gp0.7 is
thought to cause a reduction in host transcriptional activity [Zillig et al., 1975].
Paradoxically, phosphorylation and host shutoff functions are distinct and separable by
Name of
constant
kon (IM s)
koff (Is)
kiniton (Is)
runoff %
kelong (Is)
krecyc (/s)
strong
1.82E8
0.2
3.5
70
5.8
0.88
wDp
6.0E7
18
3.5
30
5.8
0.88
wp
1.82E8
0.2
3.5
30
5.8
0.88
strong
1.82E8
0.2
0.875
42
1.45
0.22
wbp
6.0E7
18
0.875
18
1.45
0.22
wp
1.82E8
0.2
0.875
18
1.45
0.22
Table 3-5. Constants for T7 polymerase initiation for different
promoter classes. The parameterization of T7 promoters is split into 3
classes respresenting the T7 concensus promoters (strong), and two classes
of weak promoters; those with differences causing weak processivity (wp)
and those with both weak processivity and weak binding (wbp) [Table 3-4].
I,, ,I
i
mutation [Michalewicz & Nicholson, 1992; Simon & Studier, 1973]. For the purposes of
this model, I assumed a generalized catalytic model for reducing host polymerase activity
by gp0.7. I encoded the measured 70% reduction in activity [Hesselbach & Nakada,
1977a], by assuming gp0.7 modified host polymerase will abort initiation 30% of the
time. I assumed the rate at which phosphorylation occurs to be quick, with an kon
equivalent to the fast association rate measured in the gpl-gp3.5 interaction (see below).
More recent analysis, which was not accounted for in this study, shows that gp0.7
phosphorylation increases rho-dependent transcription termination [Severinova &
Severinov, 2006].
Gp2, the protein encoded by gene 2, strongly inhibits E. coli RNA polymerase
transcription [Hesselbach et al., 1974; Hesselbach & Nakada, 1975]. From interpretation
of data from Hesselbach and Nakada [1977b], the Kd Of the gene 2, host holoenzyme
interaction is between 2.8E-8 and 5.6E-8 M, which is ~2-3 times as strong that of the
gpl-gp3.5 interaction (92 nM, see below). I assumed that this difference is a reduction in
koff, to 1.1 s -1, because traditionally koff is the determinant in the strength of binding
interactions. I chose the higher end of strength because of data showing that the
disassociation rate of the complex is quite slow [Hesselbach & Nakada, 1977b]. The
transcriptional activity of the gene 2-host RNA polymerase complexes are assumed to be
zero.
Interactions of T7 polymerase with T7 lysozyme.
T7 lysozyme encoded by gene 3.5 inhibits transcription by the T7 RNA
polymerase by the formation of a 1:1 complex [Moffatt & Studier, 1987; Zhang &
Studier, 1997, 2004]. I use the association and dissociation rates for the T7 polymerase
and lysozyme of 3.8E7 M-is -1 and 3.5 s-1 respectively [Stano & Patel, 2004]. From
Kumar & Patel's study, I estimate that T7 lysozyme's effect on transcription are
approximately ~60%, thus reducing the runoff percentage for strong and weak promoters
to 42% and 18% respectively [Kumar & Patel, 1997]. In addition, attenuation of the rates
of initiation and initial elongation are also observed to be 25% of uninhibited polymerase
[Kumar & Patel, 1997]. The effect seems to occur for both class II and class III
promoters equally [Ikeda & Bailey, 1992]. A summary of parameter changes upon
lysozyme binding is presented in Table 3-5.
Chapter 3.6.1.4. Transcription Termination
There are three known functional terminators on the T7 genome. Starting from
the left end of the genome, terminator TE causes termination of RNAP quite efficiently in
vitro (>95%) with the addition of an unknown protein co-factor in E. coli called tau [Briat
& Chamberlin, 1984]. In vivo termination rates are also increased by modification of the
E. coli RNA polymerase by gp0.7 [Zillig et al., 1975; Nechaev & Severinov, 2003;
Severinova & Severinov, 2006]. However, T7 RNA polymerase efficiently transcribes
past TE [Dunn & Studier, 1980]. Currently, I set the termination rate of E. coli RNA
polymerase at TE to 100% for reasons discussed in the polymerase interaction section
(§3.2.1.5).
There are two specific terminators of T7 RNA polymerase. The first is called To
located between gene 10 and gene 11 and is about 80% efficient in vitro [Lyakhov, et al.,
1997]. The T7 lysozyme activity was shown to have no effect on the termination at To. I
used the in vitro termination efficiency for the simulations. The other is the CJ pause site
located near the left end of the genome [Golomb & Chamberlin, 1974a]. As this
terminator is located upstream of all known promoters, its role in gene expression is
probably minimal. Thus, the CJ terminator was ignored for the sake of these simulations.
Chapter 3.6.1.5. Inter-Polymerase Interactions
Several lines of circumstantial evidence points to interactions between host and
phage polymerase. First, upstream E. coli polymerases that collide with downstream
polymerase tend to rescue polymerases from small pauses in a cooperative manner
[Epshtein & Nudler, 2003]. In addition, expression of a gene from tandem E. coli
promoters causes interference of RNAP and attenuates gene expression [Adhya &
Gottesman, 1982; Horowitz & Platt, 1982; Nomura et al., 1985]. I assumed for the sake
of these simulations that an upstream polymerase, upon encountering a downstream
polymerase, will follow behind and be limited by the speed of the downstream
polymerase. This can lead to problems with genome entry however, if there is any read-
through by the E. coli polymerase at TE, which is why I approximated the termination
efficiency at 100%.
Chapter 3.6.2. mRNA Degradation
While there is some evidence of early class I T7 RNA being unstable [Yamada et
al., 1974a,b, 1975], it is generally thought that T7 mRNA is quite stable during infection.
To begin, I initially assumed for the sake of simplicity, that T7 mRNA does not degrade.
Chapter 3.6.3. Constants for Translation
There is little data available on translational strengths of T7 genes. Thus I
assumed that all proteins are transcribed with equal efficiency. I used a simple model for
translation initiation. I assumed diffusion limited binding of the ribosome to the RNA
with a rate of IE7 M-is-1 [de Smit & van Duin, 2003], followed by a slow initiation step
of 0.3 s-1 [Kennell & Riezman, 1977]. I assumed the rate of translation to be constant
across all mRNA at an average rate of 15 amino acids per second, taken from the analysis
of in vivo ribosomal elongation rate experiments [Dalbow & Young, 1975]. Estimates of
the physical and chemical footprints of the ribosome range between 30 and 40 bases
[Steitz, 1969; Hiittenhofer & Noller, 1994; Yusupova et al., 2001]. I used 40 bases to be
prudent.
Chapter 3.6.4. Host Parameters
I assumed the host cell to have an average volume of 8E-16 L [Donachie &
Robinson, 1987]. I assumed a value of 1800 molecules of active host RNA polymerases
in the cell at the time of infection [Bremer & Yuan, 1968]. I also overestimated the
number of ribosomes available for T7 infection in two ways. First, I assumed that no
host mRNA translation is occurring at the time of infection. Furthermore, I assumed that
10,000 ribosomes are available to the cell, which is on the high end for a cell with
doubling time of ~30 minutes [Bremer & Dennis, 1996].
Chapter 3.6.5. Model Refinements
I tested different models for phage gene expression based on their ability to fit the
mRNA profiles by fitting the models to the measured mRNA profiles [§3.5.4]. I first
increased promoter strengths of the encoded promoters in T7. Both the E. coli strong
promoters and T7 promoters are amongst the strongest known promoters known in vivo
in E. coli [Lopez et al., 1994]. The initial parameterization of the promoter strengths
were based on in vitro measurements, and the initiation rates were limited by the
initiation timings. I expected that these values were underestimates of the actual in vivo
rates, and thus I increased the initiation rates of these promoters to test the effects on the
overall fit. The initiation rate (kiniton) of the strong E. coli promoters was increased from
0.19 per second to 0.4 per second. I increased the T7 promoter strengths by increasing
the runoff percentage of uninhibited T7 polymerase to 50% and 100% (from 30% and
70%) for the class II and III promoters respectively. The refinements testing alternative
degradation model and the polymerase interaction models are described earlier in the text
[§3.3.3].
Chapter 4. Refactoring
This chapter is based on a manuscript I co-wrote and published with Leon Chan
and Drew Endy [Chan et al., 2005]. The planning, design, construction, and testing of
work done on this chapter was done in conjunction with Leon Chan.
Chapter 4.1. Introduction
In nature, the success of an individual organism depends directly on its ability to
continue to exist and replicate. Not surprisingly, natural biological systems appear to
have evolved, and continue to evolve, to meet these requirements [e.g., Block et al, 1982;
Aho et al, 1988]. However, should we also expect that the 'design' of an evolved
organism would be further optimized for the purposes of human understanding and
interaction? Evidence drawn from fields outside biology suggests that the answer is no.
For example, consider two different approaches to programming computers and
electronics: 'genetic programming' and 'structured design.' In genetic programming,
evolutionary algorithms are used to evolve computer software or electrical hardware for a
particular task [Koza et al, 2003]. The absolute performance of evolved systems often
meets, and sometimes exceeds, that produced by human-directed designs [Spector et al,
1999]. However, so-evolved systems are difficult to understand, fix, and modify for new
applications [Jacob, 1977]. By contrast, a structured design process produces systems
that, in addition to functioning, are designed to be easy to understand and extend
[Abelson et al, 1996]. Not surprisingly, an artifact produced via structured design may
not be optimal when evaluated only in terms of absolute algorithmic or physical
performance. However, a structured design process can bypass two limitations, direct-
descent and replication-with-error, which constrain the designs of evolved systems.
Thus, we might paradoxically expect that a structured design process will, when
practical, produce artifacts whose designs can 'evolve' more quickly.
Here, I, with Leon Chan, converted the genome of a natural biological system,
bacteriophage T7, to a more structured design. Our work was initially motivated by past
failures in modeling T7 development (below) and by a desire to better understand how
the parts that comprise bacteriophage T7 work together to encode a functioning whole
[Kirschner, 2005]. The design approach we used was inspired by the practice of
'refactoring,' a process that is typically used to improve the design of legacy computer
software [Fowler et al, 1999]. In general terms, the goal of refactoring is to improve the
internal structure of an existing system for future use, while simultaneously maintaining
external system function.
Bacteriophage T7 (T7) is an obligate lytic phage that infects Escherichia coli
[Molineux, 1999,2005]. Scientists isolated T7 and other phage to begin to study the
physical characteristics and components of biological systems [Demerec & Fano, 1945].
Genetics, and then biochemistry, enabled the discovery and characterization of some of
the individual elements that participate in T7 development. Sequencing of the T7
genome revealed additional elements [Dunn & Studier, 1983], not all of which have
obvious functions [§ 1.2.1; §4.4. 1].
Synthesis of the knowledge of individual parts and mechanisms produced
descriptive, system-level models for T7 development, from genome entry to phage
particle formation [Studier & Dunn, 1983]. Two features specific to T7 biology made the
construction of system-level models easier. First, compared to other phage, T7 is
relatively independent of complex host physiology [§ 1.2]. Second, RNA polymerase
pulls most of the T7 genome into the newly infected cell [Zavriev & Shemyakin, 1982;
Garcia & Molineux, 1995]. Polymerase mediated genome entry is a relatively slow
process that results in the direct physical coupling of gene expression dynamics to gene
position.
More recently, others and I have used computational models of T7 infection to
begin to explore questions related to the organization of genetic elements on the T7
genome and the timing and control of gene expression across uncertain physical
environments [Endy et al., 1997,2000; You & Yin, 2002a,b]. In using these computational
models, some predictions did not agree with experiments [Endy & Brent, 2001]. For
example, a mutant phage expected to grow faster than the wild type grew slower [Endy et
al., 2000].
Upon inspection, disagreements between model-based prediction and experiment
could have arisen for at least three reasons. First, our models could not meaningfully
include unknown functions. For example, disruption of an uncharacterized nonessential
gene, 1.7, appeared to impact DNA replication [Endy et al, 2000]. While differences
between expectation and observation can suggest follow-on science, a lack of complete
component-level understanding debased our system-level analyses. Second, the
boundaries of genetic elements on the T7 genome are more complex than our models of
the genome. For example, genes 2.8 and 3 are most easily modeled as separable genetic
elements even though the actual genes 2.8 and 3 overlap [Figure 4-1A; Figure 7-4].
Element overlap may also encode uncharacterized function(s) having to do with the
regulation of protein synthesis or the coupling of selective pressures during evolution.
For example, bioinformatic analysis of microbial genomes suggests that gene overlaps
are conserved across evolutionary distance [e.g., Johnson & Chisholm, 2004]. Element
overlap also prohibits independent element manipulation. For example, on the wild-type
genome, we cannot change the gene 3 ribosome binding site without at least changing the
codon usage of gene 2.8. Third, a computer model built with separable parts that encode
independent functions can be over-manipulated relative to the actual physical system.
A. Wild-type T7 2.8-3 elements
----------------2.8----------------->
acgcaaagqqggagcgacatggcaggttacggcgctaaaggaatccgaaa
<--3-RBS---><----------------3-------------..
B. T7.1 parts 28 and 29
acgcaaGggqggAcgacaCggcacggtta cggcc aaggagggaagga gacatggcaggttacgggctaaa
---------------- 2.8-----------------><D28RD29L><--3RBS------><---------------3----
Figure 4-1. Element decompression and part design. (A) The coding regions of genes 2.8 and 3
overlap in the wild-type T7 genome. The ribosome binding site of gene 3 (underlined) is encoded
within gene 2.8. (B) Distinct genetic parts make up the T7.1 genome. The natural ribosome
binding site and start codon (green) for gene 3 are disrupted by point mutations (capitals);
mutations do not change the amino acid sequence of the 2.8 protein. Parts 28 and 29 are separated
by bracketing restriction sites, BamHI (blue) and EagI (orange). Figure S2 lists all changes in the
DNA sequence of T7.1 relative to wild-type T7.
For example, while we could simulate the expected behavior of large sets of permuted
genomes, we could not easily move a single open reading frame to another arbitrary
position on the actual T7 genome [Endy et al, 2000].
Wild-type T7 is a superb organism for discovering the primary components of a
natural biological system [Studier, 1972]. However, is the original T7 isolate also best
suited for understanding how all parts of the phage are organized to encode a functioning
whole? Given our experiences, we decided to attempt to engineer a surrogate genome,
which we designated T7. 1.
Chapter 4.2.Results
Chapter 4.2.1. Design Goals
Six goals drove our design of the T7.1 genome. First, we wanted to define a set of
components that function during T7 development and, for each element, choose an exact
DNA sequence that we could use to encode element function. Second, we wanted the
DNA sequence encoding the function of any one element to not overlap with the DNA
sequence encoding any other element. Third, we wanted the DNA sequence of each
element to encode only the function assigned to that element and not any other functions.
Fourth, we wanted to enable the precise and independent manipulation of each element.
Fifth, we needed to be able to construct the T7.1 genome. Sixth, we needed the T7.1
genome to encode viable bacteriophage; at the start of this work, we were uncertain how
many simultaneous changes the wild-type genome could tolerate.
Chapter 4.2.2. Design Process
Briefly, we began design of the T7.1 genome by re-annotating the genome of
wild-type T7. The wild-type T7 genome is a 39,937 base pair linear double-stranded
DNA molecule [Dunn & Studier, 1983]. We annotated the genome by specifying the
boundaries of the following functional genetic elements: 57 open reading frames with 57
putative ribosome binding sites encoding 60 proteins, and 51 regulatory elements
controlling phage gene expression, DNA replication, and genome packaging. Our own
re-annotation can be found online at http://openwetware.org/wiki/T7. 1/Reannotation.
To specify the architecture of T7. 1, we organized the functional genetic elements
into 73 'parts.' Each part contains one or more elements. While the DNA sequence of
elements within parts may overlap, there is no overlap across part boundaries [Figure
4-1B]. Next, we organized contiguous parts into 'sections' with section boundaries
defined by restriction endonuclease sites found only once in the sequence of the wild-type
genome. Six sections, alpha through zeta, make up the T7.1 genome [Figure 4-2A;
Figure 7-4]. Sections were used to compartmentalize changes across the genome. In
addition, sections can be built, tested, and manipulated independently.
To specify the DNA sequence of T7. 1, we eliminated sequence overlap across part
boundaries. Overlaps were eliminated by exact duplication of the wild-type DNA
sequence; subsequent sequence editing produced a single instance of any duplicated
element [Figure 4-1 B; Figure 7-4]. All sequence edits within open reading frames were
silent and maintained the wild-type tRNA specification or, when necessary, specified a
higher abundance tRNA [Ikemura, 1981]. We also added bracketing restriction
endonuclease sites to insulate and enable the independent manipulation of each part
[Figure 4-2C, E; Figure 7-3]. Bracketing sites are not used elsewhere in the sequence of
any one section but are reused across sections. The DNA sequence of T7.1 changes or
adds 1,424 base pairs to the wild-type genome [Figure 7-4].
Chapter 4.2.3. Construction & Testing
The sections that comprise the T7.1 genome can be built and tested independently.
We constructed the first two sections, alpha and beta [§4.4.3]. Alpha and beta contain the
first 32 of 73 parts of the T7. 1 genome, replacing the left 11,515 base pairs of the wild-
type genome with 12,179 base pairs of redesigned DNA, and encoding the entire T7 early
region, the primary origins of DNA replication, most of the T7 middle genes, and the
control architecture that regulates T7 gene expression. Alpha and beta also contain the
highest density of elements across the genome. We combined alpha and beta with the
remainder of the wild-type (WT) genome to produce three chimeric phage: alpha-WT,
WT-beta-WT, and alpha-beta-WT.
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Figure 4-2. Genome design. (A) We split the wild-type T7 genome into six sections, alpha through
z ta, using five restriction sites unique across the natural sequence. (B) Wild-type section alpha genetic
elements: protein coding regions (blue), ribosome binding sites (purple), promoters (green), RNase III
recognition sites (pink), a transcription terminator (yellow), and others (gray). Elements are labeled by
convention [7]. Images are not to scale, but overlapping boundaries indicate elements with shared
sequence. The five useful natural restriction sites across section alpha are shown (black lines). (C) T7.1
section alpha parts. Parts are given integer numbers, 1 through 73, starting at the left end of the genome.
Unique restriction site pairs bracket each part (red/blue lines, labeled D[part #]L/R). Added unique
restriction sites (purple lines, U[part #]) and part length (# base pairs, open boxes) are shown. We do not
know if sequence changes in and around parts 6 and 7 destroy the minor E. coli promoter, B. (D) Wild-
type section beta genetic elements. (E) T7.1 section beta parts. Figure S2 depicts the six sections, alpha
through zeta, which make up the T7.1 genome.
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Figure 4-3. Cutting parts from T7.1 (A) Restriction enzymes specific to the sites that
bracket parts (P#.Enzyme) and added unique restriction sites (U#.Enzyme) were used to
cut section alpha (24). A subset of the digests is shown. As built, part 1 cannot be
removed. (B) Restriction digests cutting out all parts in section beta. As built, part 28
cannot be removed.
We tested and recovered viable chimeric phage by transfection and plating. All
three chimeric phage are viable. We isolated DNA and performed restriction digests
across alpha and beta to confirm that individual parts could be independently
manipulated. 30 of 32 parts in sections alpha and beta can be cut out as designed [Figure
4-3]. We also sequenced alpha and beta. Sequencing revealed differences between the
design of T7.1 and the actual 'as-built' sections. Relevant sequence differences in section
alpha include a single base deletion in gene 0.4 and in the E. coli terminator TE.
Differences in section beta include a single amino acid substitution in both genes 1.8 and
2, a single base deletion in gene 2.5, and an 82-base truncation in gene 2.8. All
differences were due to errors or limitations in construction [Table 7-1; Table 7-2].
Finally, we characterized some growth properties of the chimeric phage by liquid
culture lysis and plating. Phage-induced lysis of log-phase 300 C liquid cultures indicated
a 20, -1.4, and 22% increase in the half-lysis times of the alpha, beta, and alpha-beta
chimeras, respectively, relative to the wild type [Figure 4-4A]. Plaques were
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Figure 4-4. Characterization of T7.1 (a) Lysis of log-phase liquid cultures of E. coli BL21 (30'C) by
wild-type T7 (black), alpha-WT chimera (red), WT-beta-WT chimera (blue), alpha-beta-WT chimera(orange); absorbance of 0.275 is ~2E8 cells/ml. Vertical bars show standard deviation at each time point(based on four replicates) [Materials & Methods]. (b) T7 plaques on E. coli BL21 (24 hrs, 37°C, 10cm
Petri dish). Clockwise from top left: wild-type (WT) T7, alpha-WT chimera, WT-beta-WT chimera,
alpha-beta-WT chimera [Materials & Methods].
indistinguishable early during plaque growth and at 300 C (not shown). At 370 C the
chimeric phage plaques appeared to stop growing as the bacterial lawns developed; after
24h at 370C, plaque sizes relative to the wild type were smaller for each of the chimeric
phage, with the alpha-beta chimera being smallest [Figure 4-4B].
Chapter 4.3. Discussion
A system that is partially understood can continue to be studied in hope of exact
characterization [Davis, 1946]. Or, if enough is known about the system, a surrogate can
be specified to help study or extend the original. Here, we decided to redesign the
genome of a natural biological system, bacteriophage T7, in order to specify an
engineered biological system that is easier to study and manipulate. The new genome,
T7. 1, is based on our incomplete understanding of the information encoded in the wild-
type genome and our desire to insulate and independently manipulate known primary
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genetic elements. We constructed the first two sections of T7.1 and observed that the
resulting chimeric phage are viable.
Phage viability demonstrates the following for sections alpha and beta. First, our
parts as chosen can be separated by exogenous DNA sequence. Second, any functions
encoded by part overlap are non-essential. Third, our current understanding of T7 is not
insufficient to specify a viable bacteriophage. Viability does not demonstrate sufficiency
because (i) if the chimeric phage had not been viable then our current understanding
would have been demonstrably insufficient, and (ii) while T7.1 is based on our current
understanding, we do not have an exact understanding of all functions encoded in the
T7.1 genome (e.g., genes of unknown function). Finally, viability, combined with the
observed similarities in lysis times, suggest that T7. 1 preserves polymerase-mediated
genome entry and remains relatively independent of host cell physiology.
The T7.1 genome is easier to model and study. For example, by removing genetic
element overlap, the T7.1 genome better matches the understanding of T7 biology
encoded in our models, relative to the wild-type phage. However, more work is needed to
demonstrate that the dynamic behavior of the system encoded by the T7.1 genome is
easier to predict. Such work will benefit from the fact that the parts of T7.1 can be
independently manipulated.
We constructed sections alpha and beta manually. Concurrent advances in de
novo DNA synthesis technology have recently enabled the rapid automatic synthesis of
DNA fragments the size of the T7.1 genome sections [Stemmer et al, 1995; Yount et al,
2000; Smith et al, 2003; Kodumal et al, 2003; Tian et al, 2004]. As genome synthesis and
engineering technologies continue to improve [Carlson, 2003], the use of bracketing
restriction sites for manipulating each part should become less important, but the physical
separation of parts by the elimination of sequence overlap will remain useful. In general,
we expect that the ability to 'write' long fragments of synthetic DNA will directly
accelerate the engineering of biology, and impact the science of biology at least as much
as large-scale automated DNA sequencing technology.
The viability of T7.1 presents a choice. T7.1 is a 'physical model' that can be
used to continue to study the wild-type phage. Observed differences in the behavior of
T7. 1 relative to wild-type highlight relevant gaps in our understanding of the natural
system. Or, as T7.1 is simpler and easier to manipulate and appears to retain features that
make wild-type T7 an attractive system to study, we can define T7. 1 as our new model
system; successor phage based on T7. 1 can be constructed in order to answer questions of
genome organization, regulation, and evolution. More generally, other natural biological
systems could be redesigned and built anew in support of scientific discovery and human
intention.
Chapter 4.4.Methods
Chapter 4.4.1. Re-Annotation of the Wild-Type T7 Genome
Chapter 4.4.1.1. Summary:
We used past experiments and observations to define specific boundaries of
functional genetic elements on the bacteriophage T7 genome. We followed the standard
naming conventions developed by Studier and Dunn [Dunn & Studier, 1983; Studier &
Dunn, 1983]. The discovery of coding domains in T7 is discussed earlier [§1.2.1].
Chapter 4.4.1.2. Control Elements
4.4.1.2.A Ribosome Binding Sites
The definition of a ribosome binding site (RBS) that we used here is a contiguous
stretch of DNA that, when transcribed, produces a region of RNA that interacts with the
ribosome and allows for the initiation of protein synthesis. The T7 ribosome binding
sites were first postulated by analysis of the sequence data upstream of protein coding
domain start codons; DNA sequence complementary to the E. coli 16S rRNA suggested a
functioning RBS. Direct observation of proteins during T7 infection provides additional
support for the function of a subset of RBSs [Studier & Maizel, 1969].
4.4.1.2.B RNA Polymerase Promoters
The definition of a promoter that we used here is a contiguous stretch of DNA that
interacts with an RNA polymerase molecule and allows for the initiation of mRNA
synthesis. At least 22 RNA polymerase promoters help to coordinate transcription
dynamics during T7 infection. The discovery and mapping of the RNA polymerase
promoters is given earlier [§1.2.1]. The T7 RNA polymerase promoter was determined
by sequencing the 23 base pair region common to the late T7 promoters [Boothroyd &
Hayward, 1979]. Here, we used a 35 base pair region to define T7 promoters; our
broader definition of T7 promoter elements hoped to include conserved regions beyond
the initial 23 base pairs [Dunn & Studier, 1983]. The E. coli RNA polymerase promoter
is less well defined. Here, we used regions of at least 60 base pairs, ranging from the -50
to +10 positions, to define the major and minor E. coli promoters (AO, Al, A2, A3, B, C,
and E). Also, a boxA recognition site located between A3 and gene 0.3 is thought to be
involved with anti-termination of polymerases that initiate from the three strong early
promoters, Al, A2, and A3 [Olson et al, 1982]. Finally, The cloning of random sections
of the T7 genome into a plasmid that selected for transcription activity from the cloned
fragment identified other possible promoters [Studier & Rosenberg, 1981]. Sequence
analysis in regions containing these sections identified regions of homology to other
known promoters [Dunn & Studier, 1983]. Any contribution of these additional
promoters to wild-type T7 infection is not now defined. While we annotated these
additional promoters, we did not incorporate them as functional genetic elements of T7.1.
4.4.1.2.C RNA Polymerase Terminators
The definition of a terminator that we used here is a contiguous stretch of DNA
that, during transcription, produces a region of mRNA that stops the process of
transcription (at some efficiency). The first T7 transcription termination site was
identified by mapping the endpoints of mRNA starting from E. coli promoters [Studier,
1972]. Later it was shown that termination occurred at the same place in vivo and in vitro
[Dunn & Studier, 1973]. The termination site was later mapped precisely, sequenced, and
subsequently named 'TE' [Studier et al, 1979; Dunn & Studier, 1980]. A second
terminator specific to T7 RNA polymerase was suggested by in vitro transcription studies
on digested T7 DNA [Golomb & Chamberlin, 1974; Niles & Condit, 1975]. The
terminator, named 'TO,' was shown to function in situ [Dunn & Studier, 1980] and on
plasmids [McAllister et al, 1981]. Both TE and TO have stem loop structures that are
thought to set termination efficiency [Dunn & Studier, 1973]. The stem loop and flanking
sequence, which includes a poly-uridine tract, were taken together to define the element
we used here. While other terminators have been postulated, their precise location and
function, if any, during wild-type infection are tenuous [Dunn & Studier, 1983], and thus
we did not include them in our annotation.
4.4.1.2.D RNasellI Recognition Sites
The definition of an RNaseIII recognition site that we used here is a contiguous
stretch of DNA that, when transcribed, produces a region of mRNA that is recognized and
cleaved (at some efficiency) by RNaseIII. Sites for specific cleavage of T7 RNA by
RNaseIII were first shown in vitro and then correlated to in vivo data [Dunn & Studier,
1973]. In time, ten RNaseIII sites were mapped and their sites of cleavage identified
[Dunn & Studier, 1983]. The sites are thought to stabilize the 3' end of T7 transcripts by
providing a stem loop that prevents the binding of scanning single stranded RNA
degradation enzymes. A downstream gene often immediately follows an RNaseIII site.
Thus, we kept the RNaseIII recognition site elements as short as possible - with a
minimum boundary set by the probable stem loop structures [Dunn & Studier, 1983].
4.4.1.2.E DNA Replication Origins
The definition of a DNA replication origin that we used here is a stretch of DNA
that is used to initiate the copying of phage DNA during T7 infection. The primary
replication origin was mapped to the dual promoter region downstream of 01.1A and
01.1B by analysis of replication bubbles in electron micrographs [Dressler et al, 1972;
Wolfson et al, 1972] and subsequently sequenced [Saito et al, 1980]. The secondary
origin at OOL was identified using mutants that lacked the primary origin [Studier &
Rosenberg, 1981; Tamanoi et al, 1980]. Finally, plasmids containing cloned fragments of
T7 DNA were used to screen for regions that act as replication origins during T7
infection; these experiments revealed that OOR and 013 have origin activity [Dunn &
Studier, 1983]. While the precise boundaries of the replication origins are unknown, each
appears to be linked to a functioning RNA polymerase promoter [Zhang & Studier,
2004]. Here, we only annotate and define an element for the primary origin. While we
do not include other replication origins as elements, we do preserve the RNA polymerase
promoters that are associated with these secondary origins as elements, and thus possibly
the secondary origins as well.
4.4.1.2.F Terminal Repeats & Short-Repeats
The definition of a terminal repeat that we used here is a contiguous stretch of
DNA present at both ends of the T7 genome, and a short repeat is a series of direct
repeats of DNA near the end of the genome. Both the left and right ends of the T7
genome contain exact 160 base-pair direct repeats [Ritchie et al, 1967]. Also, adjacent to
the direct repeats on both ends of the genome are regions of DNA that contain 12
regularly arranged and highly conserved seven base pair sequences termed the short-
repeats left, SRL, and right, SRR [Dunn & Studier, 1981]. The terminal repeats and SRL/
R are thought to be involved in concatemer formation, DNA packaging, and particle
maturation [Kelly & Thomas, 1969]. However, the mechanisms by which the direct
repeats and the SRL/R act are unclear. Thus, we treated each end's direct repeat and
SRL/R as a monolithic element (the design of T7.1 does not make any changes to the
DNA sequence of these elements).
Chapter 4.4.2. Design of T7.1 Genome
Chapter 4.4.2.1. Design Goals & Overview
Three goals drove our design of T7.1. First, we wanted to insulate and enable
independent manipulation of all identified genetic elements [§4.2.2]. Second, we wanted
the T7.1 genome to encode a viable bacteriophage. Third, we wanted the behavior of
T7.1 to be as close to wild-type T7 as possible. The second and third goals acted as
constrains on the changes that we attempted in pursuit of the first.
The design of T7.1 genome uses six sections, alpha through z^ta. Each section is
made up of parts that contain one or more functional genetic elements [Figure 7-3]. In
our design, the modification of parts on the full T7.1 genome is a two-stage process.
First, parts are manipulated within a section. Second, sections are combined to assemble a
full genome. The design of sections beta through ze^ta were improved based on our
experience building section alpha.
Chapter 4.4.2.2. Definitions
#-Cutter: A restriction enzyme that cuts a particular DNA sequence # times
Functional Genetic Element: A promoter, protein coding domain, ribosome
binding site, etc., defined in the re-annotation of the T7 genome [§4.2.2].
Part: A piece of DNA that encodes one or more functional genetic elements and is
bracketed by a pair of identical restriction sites.
Construct: Any amalgamation of functional genetic elements or parts.
Section: A segment of the T7.1 genome who boundaries are 1-cutters on the wild-
type T7 genome.
Chapter 4.4.2.1. Sections
We used sections to limit the number of simultaneous changes to the wild-type T7
sequence and to make the construction process more manageable. Two practical
considerations drove our choice of section boundaries. First and foremost, the boundaries
of the sections had to be compatible with the sparse distribution of 1-cutter sites across
the wild-type genome. [The use of 1-cutter sites for section boundaries allows refactored
sections to be easily combined with other sections or with wild-type DNA.] Second, the
number of parts per section was limited by the number of "useful" 0-cutters across the
DNA sequence of each wild-type section. Useful 0-cutters are specific, free or smaller
recognition sites, dam/dcm insensitive, and leave sticky-end overhangs.
Chapter 4.4.2.2. From Functional Genetic Elements to Parts
Parts are made up of one or more functional genetic elements. Parts containing
more than one element were sometimes used to maintain the natural proximity of
elements known or likely to by physically or functionally coupled. For example, we
grouped most ribosome binding sites and downstream protein coding domains into two-
element parts. Also, some functional genetic elements overlap so severely as to prevent
efficient separation (e.g., the genes 4A, 4B, 4.1, and 4.2). Finally, some functional genetic
elements were very short (<150bp) such that variants containing deletions or separations
of the individual elements could be easily constructed (e.g., the E. coli promoter C and
RNase III site RI). In total, we combined the elements that make up T7.1 into 73 parts.
We numbered parts, one to seventy-three, starting from the genetic left end.
The arrangements of parts on the wild-type T7 DNA sequence sometimes resulted
in the overlapping of the DNA sequence specifying parts. To remove part-part overlap,
we duplicated the DNA sequence of the overlap, providing both parts with an
independent copy of the previously overlapping sequence. If, as a result of sequence
duplication, either of the parts encoded a function specific to an element in the other part,
we mutated the sequence to eliminate the duplicate function. All mutations to protein
coding domains were silent and result in either no change in the tRNA or, when
necessary, specify a higher abundance tRNA [Ikemura, 1981]. Parts separation is
detailed in Figure 7-4.
We surrounded each part with a restriction site pair that is not contained elsewhere
in that section. Typically, we added bracketing restriction sites to the DNA sequence of
each part but, when appropriate, we integrated the sites into the natural DNA sequence.
Also, to help reduce the length of T7.1 and were possible, we chose adjacent restriction
sites to have overlapping sequence with one another.
One of the most significant differences between the design of section alpha and
the other sections was in our choice of bracketing restriction sites. In section alpha, we
picked restriction enzymes that did not cut within section alpha only. However, as the
construction of alpha proceeded, and cloning directly into the phage became useful, it
was clearly advantageous to use restriction enzymes that did not cut within the entire
genome where possible.
Chapter 4.4.2.3. Design Features
4.4.2.3.A Deletion and Insertion
The design of the T7.1 genome allows for the simple deletions of parts.
Generally, the section containing the part is isolated and digested by the bracketing
restriction enzyme. The fragments can then be ligated to reform the section minus the
deleted part, and then joined to the rest of the genome.
Insertion of a new part can be more involved. Most simply, if there is a pre-
existing restriction site due to a deletion operation, then a new part can be inserted in its
place. If no such site exists, another method involves using two restriction enzymes,
NgoMIV and BspEI, that are 0-cutters across both the wild-type T7 and all refactored
sections. NgoMIV and BspEI have different recognition sequences but produce the same
overhang upon digestion. This allows for ligation of a product into these sites, while
simultaneously preventing the restriction sites from being reformed. Thus, a part
adjacent to the desired insertion site must be replaced with the same part that has an
NgoMIV site appended to it. Then the part to be inserted is amplified with bracketing
BspEI sites and inserted into the NgoMIV site. Since neither restriction site is reformed
upon insertion, this method can be reused to serially insert parts throughout the genome.
4.4.2.3.B Unstuffing Hooks
Since we didn't know how a phage made of separated parts would behave (e.g.,
would it form plaques?), we thought that it would be prudent to be able to easily revert to
the wild-type T7 sequence for purposes of comparison and debugging. Thus, we used
silent mutations to add additional 1-cutter restriction sites to section alpha. These new
restriction sites, labeled U1-4, can be used to replace refactored regions with wild-type
sequence. In sections beta through zeta, such extra sites were superfluous because we
used 0-cutters to bracket parts.
4.4.2.3.C Scaffolds
We used scaffolds to build sections alpha and beta. A scaffold is essentially the
sequence that remains when all parts are removed from the section. As such, the scaffold
contains all the restriction sites required to assemble the parts to form the section. In
addition, if a fully refactored phage was not viable, we could use the scaffold to
incrementally revert the sequence back to wild type in an attempt to restore function.
Chapter 4.4.2.4. T7.1 Annotation and Sequence
GenBank files for the annotation of T7.1 and the as-built section alpha and beta
are available upon request and are being deposited with NCBI. These three files plus a
GenBank file of our re-annotation of wild-type T7 are now available online:
http://web.mit.edu/endy/www/ncbi/
Chapter 4.4.3. Construction
Chapter 4.4.3.1. Alpha
The design of the scaffold for section alpha included all functional genetic
elements from the left end of T7 through RO.3, RO.5, parts 17,19, 21, plus the restriction
sites required to add all remaining parts (1334 bp total). The section alpha scaffold does
not contain any known protein coding domains. We sent the scaffold sequence to Blue
Heron Biotechnology for synthesis (http://www.blueheronbio.com/). The scaffold could
not be assembled onto the standard cloning plasmids then in use by Blue Heron and us.
Blue Heron agreed to instead ship the section alpha scaffold as four fragments with point
mutations in each fragment. The point mutations were:
Fragment 1: Single base changes at 89(G-T), 168(A-T), 169(C-A), 245(G-A) and
249(C-A) as well as single base deletions at 138 and 159
Fragment 2: A single base deletion in the -35 box of the Al promoter
Fragment 3: A four base deletion between the -35 and -10 boxes of the A3 promoter
Fragment 4: A single base deletion in the loop of TE
We decided to discard Fragment 1 but to correct and make use of Fragments 2, 3
and 4. We built a new vector, pREB, to facilitate the assembly of section alpha. pREB
(for rebuild) started as a chimera of the inducible copy control system of pSCANS-5 and
the insulated multi-cloning site (MCS) of pSB2K3-1 [§4.3.4]. We completed pREB by
adding a smaller MCS containing PstI, BstBI and BclI restriction endonuclease sites and
by removing nineteen other restriction sites from the plasmid backbone.
To build section alpha we first cloned parts 5, 6, 7, 8, 12, 13, 14, 15, 16, 18, 20,
22, and 24 into pSB 104. We cloned part 11 into pSB2K3. Each part was cloned with its
bracketing restriction sites surrounded by standard BioBricks restriction sites [Knight,
2002]. We used site directed mutagenesis on parts 6, 7, 14 and 20 to introduce the sites
Ul, U2, U3 and U4 respectively. Site directed mutagenesis on part 20 failed.
A single Eco01091 restriction site was removed by site directed mutagenesis from
the vector pUB 119BHB carrying scaffold Fragment 4. Part 15 was subsequently cloned
into this modified vector. Scaffold Fragment 4 was then transferred by cloning into
pREB. The following parts were serially cloned into this vector: 7, 8, 12, 13, 14, 16, 18,
20, 22 and 23. The now-populated scaffold Fragment 4 was digested with NheI and BclI
and purified.
Parts 5 and 6 were cloned into pUB 119BHB carrying scaffold Fragment 3. This
populated Fragment 3 was subsequently used for in vitro assembly of a construct
spanning from the left end of T7 to part 7. In vitro assembly of this construct began with
digestion of wild-type T7 genomic DNA with Asel and isolating the 388bp left end
fragment and ligating this to scaffold Fragment 2. The correct ligation product was
selected by PCR. The mutation in part 3 (Al) was then fixed by PCR ligation by a two-
step process. First primers with the corrected sequence for part 3 were used to amplify
the two halves of the construct to the left and right of part 3. A subsequent PCR ligation
was carried out to join these two constructs. Scaffold Fragment 3 was then added to the
above left-end construct once again by PCR ligation as described above. The mutation in
part 4 (A2, A3 and RO.3) was repaired similarly to the mutation in part 3. The right most
primer used to amplify the entire construct contained an MluI site on the tail that was
then used to ligate on a copy of part 7. The ligation product was again selected by PCR.
This populated left-end construct was then digested by NheI and purified.
The right arm of a BclI digestion of wild-type T7 genomic DNA was then isolated
and ligated to the populated left end construct and the populated Scaffold Fragment 4.
The three-way ligation product was then transfected into IJ1127 [Materials and
Methods]. Plaques were used to create lysates and DNA was purified and digested to
screen for desired clones [Materials and Methods].
Part 11 was then cloned into the rebuilt section using the same method of three-
way ligation followed by transfection. Cloning of part 9 required the in vitro assembly of
a construct that spanned part 6 through part 9 because RsrlI(D9L/R) cuts wild-type T7
elsewhere. The construct was created by amplifying the region spanning part 5 through
part 12 of the refactored genome by PCR. The PCR product was then digested with RsrII
and ligated to part 9. The correct ligation product was selected by PCR with a primer on
the right end that contained a SacII site in the tail. This PCR product was then digested
with SacI and SacII and cloned into the phage as described above. Lastly, the part 10 was
cloned into the SacII site of the phage.
Chapter 4.4.3.2. Beta
We constructed section beta using a process similar to that used with alpha. A
scaffold with all restriction sites as well as part 26 was made by Klenow extension of
overlapping primers. The product was digested with BstBI and cloned into pREB. The
following parts were then cloned into this vector: 23, 24, 27, 28, 30, 31 and 32. Part 32
(gene 3.8) had to be cloned as a truncation since we were unable to clone the full-length
part, probably due to the previously reported toxicity of gene 3.8 product [Molineux IJ,
personal communication]. The truncated version of part 32 still included the BglII site to
allow for assembly of section beta into a phage. Parts 25 and 29, which were also
previously reported to be toxic, were assembled in vitro. To insert part 25, we amplified a
region spanning part 23 through part 27 by PCR. This fragment was then digested with
BsiWI and part 25 was ligated to each of these fragments separately and selected for by
PCR. These two PCR products were then digested with DraIII, a restriction site internal
to part 25, ligated and then selected by PCR. The overall fragment was then digested
with BclI and MluI, purified, and ligated to wild-type fragments on the left and right.
The same method was used to insert part 29 by using the part 29 internal restriction site
EcoO109I and then digesting this overall fragment with MluI and BglII for cloning into a
phage. Lastly, these two phage genomes were digested with MluI and the left fragment
of the genome containing the refactored region spanning part 23 to 27 was ligated to the
right fragment of the genome containing the refactored region spanning from part 27 to
32.
Chapter 4.4.3.3. Synthesis & Construction Errors
Differences between the designed and constructed sections alpha and beta are
detailed in Tables 7-1 and 7-2.
Chapter 4.4.4. Materials and Methods
Chapter 4.4.4.1. Strains
E. coli
BL21: B hsdS Gal-
BR3: B rpoC-E2258K
D1210: HB101 laclq
DH5alpha: 4801acZAM15 A(lacZYA-argF) U169 endAl recAl hsdR17 (rk-, mk+) thi-1
gyrA96 relAl phoA
DH10B: mcrA A(mrr-hsdRMS-mcrBC) <80acZAM15 AlacX74 deoR recAl araD139 A
(ara leu)7697 galU galK rpsL endAl nupG
IJ1126: E. coli K-12 recB21 recC22 sbcA5 endA gal thi Su+ A(mcrC-mrr)102::TnlO
IJ1127: IJ1126 lacUV5 lacZ::T7 genel-Knr
Phage
T7+, wild-type bacteriophage T7, was a gift of Dr. Ian Molineux (UT Austin)
Chapter 4.4.4.2. Media Recipes
L-broth or LB Medium (Luria-Bertani Medium) [Sambrook & Russell, 2001]
10 g Bacto-tryptone
5 g yeast extract
10 g NaCI
distilled water up to 1 L
1.5% T-agar [Garcia, 1996]
10 g Bacto-Tryptone
5 g NaCI
15 g Bacto-agar
distilled water up to 1 L
0.7% T-agar [Garcia, 1996]
10 g Bacto-Tryptone
5 g NaCl
7 g Bacto-agar
distilled water up to 1 L
50X TAE Electrophoresis Buffer [Sambrook & Russell, 2001]
242 g Tris base
57.1 ml glacial acetic acid
100 ml 0.5 EDTA pH 8.0
distilled water up to 1 L
T7 Buffer [Garcia, 1996]
0.1 M Tris-HCI pH 7.5
1 M NaCl
1 mM EDTA pH 7.5
TES Buffer [Garcia, 1996]
50 mM NaCl
50 mM Tris-HC1 pH 7.5
5mM EDTA pH 7.5
Q=1.4 3 cesium chloride [Garcia, 1996]
33 g cesium chloride
50 ml 10 mM Tris-HCL pH 7.5,
Q=1.53 cesium chloride [Garcia, 1996]
41 g cesium chloride
50 ml 10 mM Tris-HCL pH 7.5,
Q=1.6 2 cesium chloride [Garcia, 1996]
50 g cesium chloride
50 ml 10 mM Tris-HCL pH 7.5,
TE [Sambrook & Russell, 2001]
10mM Tris-Cl pH 8.0
1mM EDTA pH 8.0
10mM MgCl2
10mM MgCI2
10mM MgC12
Chapter 4.4.4.3. General Protocols
4.4.4.3.A Plating of T7
T7 was plated by adding various dilutions of a phage stock to 200uL of saturated BL21
culture and 3mL of molten (460 C) 0.7% T-agar and pouring the mixed contents onto
1.5% T-agar plates. Plaques appeared after 3-5 hours of incubation at 370C.
4.4.4.3.B Isolation of 77 Genomic DNA From Crude Cell Lysates
T7 genomic DNA was isolated according to the protocol described in Rene Garcia's
dissertation [Garcia, 1996], reproduced here:
1. Grow 40 ml of permissive cells to a density of 108-109 cells/ml at 370 C in
a rotary shaking water bath. Inoculate the cells with a drop from a master
phage stock. Continue to shake cells in the water bath at 370C until the
culture clarifies.
2. Add NaCI to a final concentration of 1 molar. Centrifuge the lysate at
10,000 rpm for 10 min. Discard the cellular debris, and centrifuge the
lysate at 24,000 rpm for 90 min in a SW28 rotor (Beckman).
3. Discard the supernatant, and add 1 ml of T7 buffer or TES buffer to the
phage pellet.
4. Let the pellet site at 40C for at least 5 hours. Resuspend the pellet, and
quickly spin down the cellular debris. Discard the pellet.
5. To the supernatant, add 0.5 ml of 50 mM Tris-HCl, pH 8 saturated phenol
and gently mix the sample until an emulsion forms. Quickly microfuge
the sample to separate the layers. Carefully remove the aqueous layer
without disturbing the organic layer. Phenol extract with 0.5 ml 50 mM
Tris-HCl, pH 8 saturated phenol one more time.
6. To the aqueous layer, add 0.5 ml of 50mM Tris-HC1, pH 8 saturated
phenol: chloroform: isoamyl alcohol (25:34:1 by volume) mixture, and
gently mix the sample until an emulsion forms. Quickly microfuge the
sample to separate layers. Carefully remove the aqueous layer without
disturbing the organic layer. Phenol: chloroform: isoamyl alcohol and
extract the aqueous layer one more time.
7. Add 3 times volume of 95% ethanol alcohol to the sample. A fibrous
precipitate should form. Spin down the precipitate, remove the
supernatant, and wash the pellet with ethanol. Dry the pellet. Dissolve the
pellet in 500 uL of water or TES buffer. There should be about 109
molecules of phage DNA/uL. Store the DNA at -200C.
4.4.4.3.C Purification of T7 Particles via CsCl-gradient Centrifugation
T7 particles were purified by cesium chloride gradient centrifugation according to
Garcia's protocol [Garcia, 1996]. The protocol is reproduced here:
1. Grow 100ml of permissive cells to a density of 108 to 109 cells/ml at 370C
in a rotary shaking water bath. Inoculate the cells with a drop from a
master phage stock. Continue to shake cells in the water bath at 370C
until culture clarifies. [NOTE - As a standard laboratory protocol, T7
stocks have always been propagated at 300 C; however, at this temperature
cultures infected with (A1, A2, A3)- T7 mutants take longer to clarify that
those infected with (Al, A2, A3)+ phages or with mutants that eject their
DNA faster. At 370 C the differences in lysis periods are not as
pronounced. Stocks of (A 1, A2, A3)- T7 mutants are propagated at 370C
to decrease the growth disadvantage of spontaneous arising mutants that
eject their DNA faster. For constancy (Al, A2, A3)+ phages are also
grown at this higher temperature.]
2. Add NaCl to the lysate to make the final concentration 1 molar.
Centrifuge the lysate at 10,000 rpm for 10 min, Discard the cellular debris,
and add 10 grams polyethylene glycol (PEG) m.w. 8000 (10% w/v) to the
supernatant. Gently stir the mixture until the PEG has totally dissolved.
Keep lysate on ice for 1 hour.
3. Pellet the phage at 5,000 rpm for 15 min. Decant the supernatant, and
very gently resuspend the pellet in 3.5 ml of T7 buffer. Centrifuge the
lysate at 5,000 rpm for 10 min, and keep the supernatant.
4. Pour a cesium chloride step gradient: ass .5 ml of cesium chloride with a
density of 1.6 to the bottom of a centrifuge tube that fits in a SW 40.1
rotor. Gently layer 0.5 ml of cesium chloride p=1.5 onto the p=1.6 layer.
Finally ass 0.5 ml of cesium chloride p=1.4 onto the p=1. 5 layer.
5. Gently layer the phage supernatant onto the cesium chloride step gradient.
Centrifuge the phage in a SW 50.1 rotor at 30,000 rpm for 2 to 3 hours.
The phage will band at the p=1. 5 layer.
6. Remove the phage band from the side of the tube with a syringe.
7. Remove the cesium chloride by dialysis against 0.5 to 1 liter of T7 buffer
at 40C.
4.4.4.3.D Purification of T7 Genomic DNA From CsCl-gradient Purified Phage Particles
T7 particles were purified by cesium chloride gradient centrifugation (above).
The DNA was then purified by subsequent rounds of phenol and phenol:chloroform
extraction as follows: pH7.8 phenol [Sambrook & Russell, 2001] was added in a 1:1
volume ratio to the sample and the tube was inverted to mix the aqueous and organic
phases. The mixture was centrifuged for 10 minutes at 13,000g. The aqueous layer was
removed and subjected to an additional round of phenol extraction. This resulting
aqueous layer was added in a 1:1 volume ratio to pH7.8 phenol:chloroform:isoamyl
alcohol (25:24:1) [Sambrook & Russell. 2001], mixed and centrifuged for 5 minutes.
This extraction step was repeated again. The DNA was precipitated by adding a 10%
sample volume of 3M sodium acetate and 2-5 sample volumes of cold (4°C) absolute
ethanol. The samples were mixed and incubated at -800C for 1 hour. The DNA was then
pelleted by centrifugation for 30 minutes at 13,000g and at 40C. The DNA pellet was
washed once with 80% ethanol, dried and resuspended in TE buffer.
4.4.4.3.E Purification of Restriction Enzyme Digested Fragments
All restriction enzyme digestions were carried out according to the manufacturer's
directions. All fragments smaller than 10kb were purified using Qiaquick gel extraction
kit (Qiagen). All fragments larger than 10kb were purified by electro-elution as follows:
20ug of digested product was preincubated with luL of a 1000X solution of SYBR Gold
(Molecular probes) for 15 minutes. 200ng of DNA was loaded into each well of a 0.5%
TAE agarose gel and electrophoreised at 1-1.5V/cm and at 40C for 16-20 hours. Agarose
blocks containing desired restriction fragments were excised under UV transillumination
and loaded into a dialysis bag (3500 MWCO Snakeskin dialysis tubing, Pierce)
containing 1X TAE. Fragments were electro-eluted from the agarose blocks for 1-5
hours at 5V/cm. After the completion of electro-elution was confirmed by UV
visualization, the electric field was reversed for 1 minute to aid in elution. The liquid
contents of the bag were then subjected to one round of phenol extraction to remove trace
amounts of agarose and the DNA was ethanol precipitated and resuspended in TE buffer.
4.4.4.3.F Plating of Phage for Comparative Plaque Analysis
Stocks of cesium chloride purified phage were serially diluted to an appropriate
titer. 50, 100 or 200uL of that dilution was mixed with 200uL of saturated BL21 culture,
added to 12mL of molten (500C) 0.7% T-agar and plated directly on Petri dishes. Plaques
were allowed to grow for 5-48 hours at 300 C or 370 C.
4.4.4.3.G Measuring Phage Lysis Curves
lmL containing 2x108 cells of BL21 was infected at a MOI of 5 and 200uL of the
resulting mixture was loaded per well into a 96 well ViewPlate (Packard) at 300C.
Mineral oil was layered into each well and the OD was monitored at 300C with agitation
by a Wallac Victor3 plate reader (Perkin-Elmer).
4.4.4.3.H Sequencing of DNA
All sequencing of phage DNA was performed using the dideoxy terminator
method. All sequencing was performed by the MIT Biopolymers Laboratory using a
Perkin Elmer Applied Biosystems Division model 377 DNA sequencer. When long
regions of DNA were sequenced, primers were designed at 500-800bp intervals to both
sense and antisense strands. All reported sequence represents at least two separate
sequence runs with no intervening ambiguities.
4.4.4.3.1 Template preparation ofphage genomic DNA for sequencing
For phage sequencing, only full length packaged genomic DNA (described above)
was used as template.
4.4.4.3.J Template preparation of cloned parts for sequencing
The preparation of sequencing template for cloned parts was done using Qiaprep
spin Miniprep Kit (Qiagen). When the quantity of purified plasmid was insufficient for
sequencing, a subsequent Templiphi (Amersham) reaction was used to amplify the
sequencing template.
4.4.4.3.K Template preparation of in-vitro constructs for sequencing
In-vitro constructs were amplified using PCR, gel purified and used as template in
a sequencing reaction.
Chapter 4.4.4.4. Genome Design and Sequence Analysis Tools
Restriction Site Distribution
All design and annotation of DNA constructs was done using Vector NTI
(InforMax). All restriction analyses were performed with Vector NTI (InforMax),
NEBcutter [Vincze et al, 2003], and REBASE [Roberts et al, 2005]. A perl script was
written to search for sites within coding regions where restriction sites could be
introduced by silent mutation [http://web.mit.edu/endy/www/software/cuts/1.
Sequencing Analysis and Contig Assembly
Sequence analysis and contig assembly was done with AlignX and Contig
Express (InforMax).
Chapter 4.4.4.5. Genome Construction Protocols
4.4.4.5.A Oligonucleotide Synthesis
All oligonucleotides were synthesized by MWG, Invitrogen or using an ABI
Model 394 DNA synthesizer (Tom Knight).
4.4.4.5.B Part Amplification
All parts were amplified by PCR using the following reaction mixture: 5uL 10X
Thermo Pol Buffer (NEB), 20pM primerl, 20pM primer2, 3-30ng T7 genomic DNA,
lunit Vent polymerase (NEB), 10uM each dNTP and water to 50uL. The mixture was
thermocycled (MJ Research PTC-200) as follows: 950C for 2 minutes, 25-35 cycles of
950C for 30 seconds, 500C-600 C for 30 seconds, 720 C for 1-5 minutes, 72 0C for 10
minutes.
4.4.4.5.C Part Cloning
All parts and vectors (0.1 - 50pmoles) were restriction enzyme digested according
to the manufacturers' directions (NEB, Fermentas). Parts and vectors were then purified
by gel electrophoresis (0.5 - 2% TAE agarose gel, 3 - 8 V/cm) and extracted with
Qiaquick gel extraction kit (Qiagen). Ligation reactions using T4 DNA ligase (NEB)
were carried out in a 3:1 part:vector molar ratio according to the manufacturer's
directions. Ligation products were dialyzed on nitrocellulose membranes (Millipore)
against 1000X volume of water for 30 minutes. Ligation products were transformed by
electroporation using 1800V across a 1mm gap (Bio-Rad Gene Pulser Xcell) and plated
on the appropriate medium. Screening for clones was performed by colony PCR with the
following protocol: Colonies were picked and diluted in 100uL of water. luL of that cell
suspension was added to luL 10X Thermo Pol Buffer (NEB), 4pM primerl, 4pM
primer2, 0.5U Taq Polymerase (NEB), 2uM each dNTP and water to 10uL. This mixture
was thermocycled as follows: 950 C for 6 minutes, 25-35 cycles of 950C for 30 seconds,
540C for 30 seconds, 720 C for 1-5 minutes, 720 C for 10 minutes.
4.4.4.5.D Site Directed Mutagenesis of Parts
Site specific changes were performed on the cloned parts using QuickChange
Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer's directions.
Primers were 5' phosphorylated using Polynucleotide Kinase (NEB) according to the
manufacturer's directions.
4.4.4.5.E Construction of pREB Plasmid
pREB was constructed from pSB2K3-1 [http://parts.mit.edu], a chimera of
pSCANS-5 (gift of John Dunn, Brookhaven National Laboratory) and pSB1A3-1 [http://
parts.mit.edu]. The multiple cloning site of pSB2K3-1 was replaced by a PstI-BstBI-BclI
multiple cloning site by primer annealing and cloning. Primer duplexes were prepared
using the following steps: the reaction mixture, 100pM each primer, 2uL restriction
buffer (NEB) and distilled water to 20uL was incubated as follows: 950C for 4 minutes,
0.1 0C/s ramp to 800 C, 800 C for 4 minutes, 0.1 C/s ramp to 700 C, 700 C for 4 minutes,
0.1 0 C/s ramp to 600 C, 600 C for 4 minutes, 0.1 0 C/s ramp to 500 C, 500 C for 4 minutes,
0.1 C/s ramp to 220C, 220 C for 10 minutes. The annealed duplexes were 5'
phosphorylated using Polynucleotide Kinase (NEB). pREB was then cleaned of
restriction sites using QuickChange Multi Site-Directed Mutagenesis Kit (Stratagene) and
screened by digestion.
4.4.4.5.F Construction and Cloning of the Beta Scaffold
The beta scaffold was constructed by annealing two partially overlapping primers
as described above. The overhangs were then filled in using Klenow fragment (NEB)
extension according to the manufacturer's directions. The extension product was
digested with BstBI and cloned into pREB.
4.4.4.5.G Assembly of Section Fragments in E. coli:
Parts were cloned into the scaffold using the same cloning method as above with
the addition of treating the purified cut vector with Antarctic Phosphatase (NEB)
according to the manufacturer's directions and using a molar ratio of 6-10:1 insert:vector
in the ligation reaction. Screening was again performed by colony PCR but included a
second PCR to verify directionality via an internal primer.
4.4.4.5.H Assembly of Section Fragments in vitro
Fragments were assembled in vitro using both PCR ligation and traditional T4
DNA ligation. T4 DNA ligation products were subsequently selected by PCR. All
amplification was carried out as described above using either Taq polymerase, Vent
Polymerase or a 99:1 Taq:PfuTurbo (Stratagene) enzyme mixture. Selection of ligation
products was carried out using various serial dilutions of the ligation products as
template.
4.4.4.5.1 Ligation of 2 or 3 DNA Fragments for Phage Transfection
4x10 9 molecules of each DNA fragment was ligated using T4 DNA ligase (NEB)
and incubated at 160C overnight. In certain cases, up to 4x1010 molecules of a particular
DNA fragment was added to drive the reaction towards the desired outcome.
4.4.4.5.J Preparation of Competent Cells for Phage Transfection
Competent cells were prepared according to Garcia's protocol [Garcia, 1996] and
allowed to rest at 40C for 20-24 hours prior to transfection. Garcia's protocol is
reproduced here:
1. Grow 20 ml of cells to a density of 5 x 108 cells/ml in L broth at the
desired temperature.
2. Pellet the cells in a centrifuge at 5,000 rpm for 5 min. Remove the
supernatant.
3. Resuspend the cell pellet in 10 ml of ice-cold 50mM CaCl2 (half volume
of starting culture).
4. Incubate the cells on ice for 30 min.
5. Pellet the cells in a centrifuge at 5,000 rpm for 5 min. Remove the
supernatant.
6. Resuspend the cell pellet in 2 ml of ice-cold 50 mM CaCl2 (one-tenth
volume of the starting culture). The cells are ready to take up DNA.
4.4.4.5.K Transfection of the Ligation Products
All pipette tips were pre-chilled at -200 C, molten 0.7% T-agar was kept at 460C
and 1.5% T-agar plates were equilibrated to room temperature. The ligation mixture was
added to 200uL of cold (40C) competent cells and incubated in an ice bath for 30
minutes. The mixture was then added to 2.5mL of molten (460 C) 0.7% T-agar, gently
mixed for 10 seconds by manual agitation and poured onto a 1.5% T-agar plate. The
plates were then incubated at 370 C for 3-5 hours.
Chapter 5. Future & Conclusions
Chapter 5.1. Simulation
I have built a new simulator called Tabasco that allows simulation of gene
expression at a single-molecule, single base-pair resolution by encoding logical rules of
gene expression directly into the simulator. Using these rules, Tabasco does not have to
track or encode every possible state, just those states that are accessed during the course
of a simulation. Efforts for building simulators similar to Tabasco will continue to be
useful for systems where the number of possible states is much larger than the number of
molecules that transition between those states. For example, the biosynthesis of the large
polysaccharide chains (glycosaminoglycans) on proteoglycans is a multi-step pathway
leading to proteins with large structural diversity [Esko, 1999]. The production of
glycosaminoglycans (GAGs) is difficult to explore using traditional simulation methods
because the number of possible species that may arise during sugar production are large.
Using logical rules of how enzymes recognize, modify, and extend GAGs in vivo, we can
simulate the evolution of individual GAGs in order to explore the mechanisms of
proteoglycan formation. In collaboration with Jonathan Behr and Tarak Upadhyaya, we
are constructing a simulator based on Tabasco to simulate GAG formation.
Chapter 5.2. Modeling
I constructed a best-faith model for gene expression during the infection of
bacteriophage T7 using the Tabasco simulator. Together with Heather Keller, we found
that the previous discrepancies between simulations and measurements of class I and II
protein synthesis rates are accounted for by the previously uncharacterized degradation of
mRNA. The new models of T7 gene expression are better and more detailed, but we still
need to address several points of uncertainty before we can expect accurate model-based
predictions.
First, we need to understand mechanisms that lead to the newly characterized
mRNA degradation. While we have characterized degradation rates on the natural
genome, the question remains as to what factors determine the stability of a particular
message. If we move a gene from one position to the next, can we reasonably predict the
stability of the gene's mRNA? Second, our understanding of RNA polymerase
processivity and interactions on the genome is limited. Recent studies have explored
such processes in greater detail, and may help to improve future models [Zhou & Martin,
2006; Epshtein & Nudler, 2003]. Third, more work on the functioning of individual
components in the context of a larger genome is needed in order for new genome
architectures to reliably work according to expectation. Fourth, we must reevaluate our
assumptions that gene expression and DNA replication are independent processes. In the
process of measurements of mRNA levels during infection, we observed transcription late
in infection of a region of DNA that most likely was due to genome concatemer
formation during DNA replication. If transcription and replication are concurrent, the
expected increase of transcription rates of class III mRNA could lead to better
correspondence between the measurements and simulations [§4]. Finally, the model
would benefit from system-wide absolute measurements of protein levels and relative
measurements of the strengths of the ribosome binding sites, the latter of which are
currently being made by Heather Keller.
Construction of a better model will allow exploration of how genome designs are
(or are not) optimized to solve challenges T7 is faced with. For example, an individual
T7 particle, suspended in solution, lacks information detailing the size, growth state, and
genotype of its future host cell. At the time of infection, the number of other T7 particles
that are simultaneously infecting the host is uncertain. However, we know that wild-type
T7 can produce near-identical growth curves at multiplicities of infection (MOI) from 1
to -20 [Endy, personal communication]. We also know that wild-type T7 plaques
continue to grow as host cells begin to enter stationary phase and that T7 can infect
-~1/10th volume minicells [Ponta et al., 1977; Libby et al., 1984; Shepherd et al., 2001].
While other phage (e.g., lambda) use variation in host cell state and multiplicity of
infection to trigger developmental decisions (e.g., lysis or lysogeny) [Ptashne, 2004], T7
appears able to maintain its consistent lifestyle in spite of environmental uncertainty.
One mechanism for controlling
system response to uncertainty in MOI
and cell volume would be to use negative
feedback [Becskei & Serrano, 2000;
Rosenfeld et al., 2002] to regulate the
activity of the E. coli and T7 RNA
polymerases, wherein the rates of
polymerase inhibition would depend on
the rates of synthesis for the early and
middle T7 proteins. A cell infected at a
high MOI would inactivate the host RNA
polymerase faster, producing less phage
protein on a per-phage-infecting basis.
Similarly, a phage that infected a large cell
would be able to synthesize more of the
early proteins needed to take advantage of
increased host resources.
Both early and middle T7 proteins
are known to inhibit the E. coli and T7 RNA
--class I
--class II
--class Ill
0 200 400 oo0 800
time (9)
1000 1200 1400
Figure 5-1. Simulated effects of the loss of
negative feedback regulation on phage
resource allocation during infection. The
amino acid incorporation rate for the class I
(blue), class II (red), and class III (green)
proteins are plotted as a function of infection
time with (dark) and without (light)
transcriptional feedback mechanisms encoded in
the simulation. Class I and class II proteins
show sustained expression at the expense of
class III protein production when the
transcriptional feedback mechanisms are not
present.
polymerases [§3.2.3]. The standard model
for T7 infection is that gp0.7, gp2 and gp3.5 are used to control transitions in T7 gene
expression, from early to middle to late classes, and to help initiate DNA replication
[Figure 5-1; Studier & Dunn, 1983]. The relative positioning of these genes on the
genome play an important role in determining the extent of the feedback inhibition
because the timing and level of gene expression is in essence controlled by the gene
location. An accurate model for T7 gene expression would allow us to explore the extent
that the natural T7 genome is optimized to handle such uncertainty.
Chapter 5.3. Refactoring and T7.2
''~
,·
,,·
i
The design and synthesis of T7.1 afforded us a first experience at design and
construction of an engineered T7 genome. For example, the design of section alpha took
six person-months to complete. We were not entirely confident that section alpha, with
-400 base pairs changed or added, would be viable. So, during the design phase, we
were careful to try to exclude every possible change that might impact phage
development. We did this by minimizing changes of variables that we were aware of,
from genetic element secondary structure to untranslated mRNA regions. When we
discovered that section alpha was viable, we began design of section beta, which took
two-person weeks. We then subsequently designed the rest of the T7.1 genome in three-
person days. Some of the reduction in design times arose via simple optimization of
techniques, but another change was due to our knowledge of the types and extent of
changes that could be made.
However, the resulting T7.1 genome is more constrained by our initial uncertainty
than driven by our primary design goal - to construct a genetic system that is a physical
instance of our understanding of a biological system that we believe, to first
approximation, to understand. I have designed and planned construction of a second-
generation synthetic T7 genome, which I designate T7.2, in order to improve our
understanding of the functional genetic elements that contribute to phage gene
expression. The design of T7.2 makes good use of our initial experience with designing
and building T7.1 [§2]. For example, we now know that the wild-type T7 genome can
tolerate many simultaneous engineered changes without gross impact to phage viability.
Five goals drove the design of T7.2; the first four goals revisited or extended
those used in the design of T7. 1. First, the T7.2 genome only includes elements that are
thought to contribute to phage gene expression. Moving beyond our design of T7. 1, I
actively erased or deleted elements of unknown function. Second, the T7.2 genome
design does not include any functions that might be encoded via the physical coupling of
multiple genetic elements. Third, the design of T7.2 enables unique and selection-
independent manipulation of each genetic element via restriction enzymes. Fourth, for
practical reasons, the design of T7.2 is designed to encode a viable bacteriophage. Fifth,
to attempt to make our modeling of gene expression easier, I used standard synthetic
elements in place of the natural elements that regulate transcription and translation.
Taken together, the design of T7.2 should specify a genome that is simpler to model and
manipulate, in which we have a putative function for each base pair of DNA involved in
phage gene expression. Thus, I hypothesize that T7.2 will also encode a dynamic system
that is easier to model and interact with, relative to the wild type.
Chapter 5.3.1. T7.2 Design Specification
The design of the T7.2 genome is a component-based design. I defined and
specified each component, added them to the Registry of Standard Biology Parts (http://
parts.mit.edu), and compiled the individual components to construct a design draft of the
genome. Part numbers indexed in the Registry take the form BBaZOXXX. After the
initial draft, I did global optimizations such as restriction site additions, RBS-CDS
secondary structure removal, and addition of elements to aid in measurement of system
function to construct a draft sequence of the T7.2 genome (BBaZ0506). The following
sections describe the considerations made for each step of the process.
Chapter 5.3.1.1. Coding Domains
There are 57 annotated genes on the T7 genome encoding 60 proteins. Many of
the natural T7 genes are not known to contribute to phage development in the set of
conditions in which I wish to assay them, and they confound systems-level analysis. The
Figure 5-2. T7.2 Design (next page). In the T7.2 design, I defined and concatenated
individual parts to arrive at the design. The labeled genetic elements include protein coding
regions (light blue & green lozenges), strong and medium strength ribosome binding sites
(orange & red arcs before coding domains), the three major E. coli promoters (blue arrows),
two standardized classes of T7 weak promoters (orange & pink arrows), standardized T7
strong promoters (red arrows), standardized RNase III recognition sites (pink diamonds),
transcription terminators (red circles), a fluorescent reporter construct (purple stars), and other
regions of importance (gray). Sites where I removed RNA secondary structure across the
RBS-gene interface are labeled by verticle blue lozenges. The genome will be constructed in
sections to make hybrid phage at labeled natural T7 single cut sites (red lines). Additional
single-cut restriction sites were used throughout the design to aid in further manipulations
(black lines).
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following genes are not conserved across other T7 relatives and encode no known
function during T7 development: 0.4, 0.5, 0.6AIB, 1.4, 1.5, 1.6, 1.8, 2.8, 3.8, 4.1, 4.2, 4.7,
5.3, 6.3, 7, 7.7. I did not include these genes in the design of T7.2. I also included many
genes that will eventually be removed, but am including to be cautious. These genes
mostly show evolutionary conservation or anecdotal evidence for important functions. I
included the genes in the design, but have made them easier to remove in the future.
These genes are 0.3, 1.1, 4.3, 4.5, 5.5-5.7, 5.7, 5.9, 6.5, 18.5, 18.7, 19.2, 19.3, 19.5.
Chapter 5.3.1.2. Ribosome Binding Sites
Each gene has a corresponding putative ribosome binding sites (RBS) that
controls translation initiation. I standardized the RBS of these genes to reduce the
parameters necessary to represent the system, and possibly to reduce any unknown
functions of translation coupling. I chose three RBS to standardize from that were
measured by Heather Keller to have a varied range of expression rates. I assigned one of
these RBS to each coding domain based on both knowledge of the amounts of total
protein production necessary for phage function, as well as computational analysis of the
strength of existing ribosome binding sites. The computational analysis assigned
predicted strengths [Table 6-3] of the RBS based on their sequence through a published
algorithm [Barrick et al., 1994]. I standardized the natural sites to three ribosome binding
sites (strong, medium, and weak) that were characterized experimentally by Heather
Keller. After the design was completed, I found the weak RBS only mapped to genes that
were not included in the T7.2 design. Thus I use only two standardized RBS - the strong
RBS based on the gene 5 (BBaZ0261), and an exogenous RBS (BBaZ0262; Weiss,
2001). The assignments of the RBS are shown in Figure 5-2.
Chapter 5.3.1.3. Host Promoters
I encoded only the three strong host promoters (Al, A2, A3). I removed the other
annotated promoters by virtue of not including genes they were contained in, or by point
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mutations intended to obliterate function. The edits are annotated at http://parts.mit.edu.
The following is the listing of promoters that were removed:
B: Located mostly in gene 0.5, which is not encoded
C: Only -35 region is included within coding domain of gene 0.7; -10 region and
start are not included in T7.2 design.
E: Strong -10 region mutated, -35 region not included
Sl: -35 and -10 regions edited to remove promoter
S2: -35 region edited, -10 region already not optimal
S3: -35 and -10 regions edited to remove promoter
S4: -35 and -10 regions edited to remove promoter
S5: Located within gene 5.3 which is not included
S6: -35 and -10 regions edited to remove promoter
Fl: Only -35 region is included within coding domain of gene 6.5; n 10 region
and start are not included in T7.2 design.
F2: -35 region mutated, -10 region already not optimal
Chapter 5.3.1.4. Phage Promoters
I standardized the phage promoters that I encoded into the genome. In our models,
I split the promoters into three class; weak binding and processivity, weak processivity, or
strong promoters [§3.6.1.2]. The natural T7 promoters on the T7 genome are listed in
Table 3-4, along with their classification. I used the 02.5, 03.8, and 010 promoters as the
standard for the weak processivity (BBaZ0253), weak processivity and binding
(BBaZ0252), and the strong promoters (BBaZ0251), respectively. I chose these three
promoters they were used in past detailed kinetic studies. Applying a conservative
approach, each promoter occupies 35 bp, more than the necessary and sufficient 23 bp.
Finally, as a consequence of removing genes, sometimes two T7 promoters would
become directly adjacent. In those cases, I removed one of the two T7 promoters. The
final distribution of T7 promoters is shown in the final design diagram [Figure 5-2].
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Chapter 5.3.1.5. Miscellaneous elements
I treated the primary origin of replication, and the promoters that are contained
within it (01.1A and 01.1B), as a separate part in order to prevent disturbances
(BBaZO291). In addition, I treated the left end (BBaZ0292; 377 bp) and right end
(BBaZ0293; 399 bp) of the genome as individual parts due to their large repeats and
importance in DNA replication and packaging. Also, I kept the definitions for the
transcriptional terminators as they were in T7.1. TE (BBaZ0271) and TO (BBaZO272),
while the CJ terminator remained unaltered in the right end part. Finally, I specified
addition of a fluorescent reporter, Venus YFP, into the genome [Nagai et al., 2002].
Chapter 5.3.1.6. RBS - CDS Interface
To avoid possible effects of introduced secondary structure at the interface
between the standardized RBS and the coding domains that could interfere with
expression, Alex Mallet and I analyzed and minimized secondary structure for many
genes. Alex designed software to evaluate secondary structure effects, and developed a
minimization procedure to reduce the secondary structure across the part interface
[Mallet, 2006]. Briefly, we used the RNAfold algorithm [Hofacker et al., 1994] to
evaluate free energy of the possible secondary structures of the 20 RBS with the first 13
codons of the CDS. Structures that had significant secondary structure across the
interface (>-9 kCal/mol) were marked to be modified. Those structures that were
changed are labeled on Figure 5-2. For each of the genes to be altered, we chose three
alternative codons for each amino acid residue, and calculated secondary structures of all
possible combinations of the codons. The search reduced secondary structure pairing
significantly. I used the minimum free energy structure for the coding domains in the
T7.2 design.
Chapter 5.3.1.7. Restriction Enzyme Cut Sites.
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In the T7.1 design, I flanked each part with restriction enzyme recognition sites to
allow easy part manipulation. However, I was limited by the number of independent
recognition sites, and thus many of the restriction sites cut more than once in different
sections of the T7.1 genome. We had expected to be able to clone substantial portions of
each genome, but the sections proved to be fairly toxic. I found that having single cut
sites spaced farther apart would be better for future manipulations. After the draft initial
T7.2 design was complete, I added restriction cut sites that cut only once on the genome
approximately every 1000 bp [Figure 5-2].
Chapter 5.3.2. T7.2 Construction Plans
The manual construction of T7.1 proved to be very tedious. Thus, I explored
automated ways to construct T7 sections. Commercial synthesis companies have become
somewhat adept at building DNA the size of T7 sections. However, most companies rely
on cloning in E. coli in order to produce their DNA. I worked with Codon Devices on in
vitro methods to construct the genomes. Codon Devices constructed the first 8000 bp of
the T7.2 genome in 9 ~1000 bp fragments. Efforts on combining these fragments
together is still ongoing, and is now beyond the scope of this thesis.
Chapter 5.4. Conclusions
In this thesis, I worked to construct accurate and biophysically realistic models of
gene expression for a natural biological system, bacteriophage T7. I constructed more
detailed simulation tools [§2], and used them to make new, more detailed models of
bacteriophage T7 gene expression [§3]. Heather Keller then made system-wide
measurements of T7 mRNA levels, and I showed that the inability of the previous models
to account for class I and II protein synthesis attenuation late in infection can be
accounted for by mRNA degradation. However, the models still lack sufficient
information to provide predictable gene expression in T7 variants containing arbitrary
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genetic rearrangements. For example, if we move a gene from one position to another,
we would not have a mechanistic model for how the rate of mRNA degradation would
change.
We can continue to improve computational models by better characterizing
individual components, and compare them to system-wide measurements to analyze the
validity of models. Differences between the models and measurements can lead to
further understanding, and point towards future work. We can hope that in the future, our
models will progress to a point where they are realistic representations of the natural
phage, and that model-based predictions of arbitrary perturbations can be trusted.
I also embarked on a complementary approach to the process of trying to
understand natural systems. Rather than making models of T7 evermore detailed, I
decided to construct synthetic phage that are closer physical representations of our
models. Leon Chan and I began, by designing and constructing a portion of a new phage,
T7. 1, where we define and insulate genetic elements eliminating genetic overlaps that we
assigned no function to in our models [§4]. The resulting phage had similar gross
characteristics to T7 and the genome of T7.1 is now easier to model.
I have also designed a new phage, T7.2, that goes beyond simply specifying a
genome that is easier to model, to a phage where infection is easier to model [§5.3]. For
example, in our models, I assume the measured kinetics of one T7 strong promoter are
the same for all the strong T7 promoters. We could further study the phage promoters in
their individual contexts to test the validity of the assumption. Alternatively, we can
standardize the relevant sequences to match the model more accurately. Thus, we don't
necessarily care about the natural T7 genome per se, we care about how individual
elements in a genome can interact to produce the dynamic system that leads to
development of a replicating and productive phage.
Construction of synthetic biological systems in support of understanding and
analyzing natural biological systems can serve a number of purposes. First,
recapitulation of observable functions provides a powerful test of our understanding of
how system components interact to form a functioning whole [Sprinzak & Elowitz,
2005]. Differences between models used to design synthetic systems and the synthetic
systems themselves point to gaps in our understanding of the governing components and
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interactions [Chan et al., 2005]. Likewise, differences between synthetic and natural
systems can lead to insight into what other functions the natural biological systems might
serve. Second, evolving surrogate synthetic systems can act as a tool to understand how
the individual parts of the natural system contribute to system fitness, as well as provide a
platform to understand how evolutionary processes can optimize system performance.
Third, constructing more defined, measurable, and manipulable developmental systems
provides a foundation for the rational engineering of novel self-replicating, self-
assembling systems [Knight, 2005].
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Chapter 7. Appendices
Chapter 7.1. T7 Modeling Appendix
Chapter 7.1.1. Simulation and Measurements Comparisons
Figure 7-1 (following 4 pages). Real time measurements and simulation results
showing absolute, gene-specific mRNA levels per cell during T7 infection. Each plot
shows the measured (green) and computed (red;blue;purple) number of T7 mRNA per
cell throughout infection. Measurements were made using real-time RT-PCR. For all
graphs, the solid lines show the average all of all replicates (2-4 extractions per gene,
each extraction measured in triplicate). Shaded regions represent the range of the
measurements, with the standard deviation show by error bars. Simulation data plotted
are the unfit (blue) and the best fit model (purple; traffic jam model with increased
promoter strength). The red plots represent the final fitting of the other models tested:
(a) Increased promoter strength; (b) Alternative degradation model; (c) DownStream
Falloff model; (d) Upstream Falloff model. The width of the computed curves shows
the variation (± standard deviation) from the average of 25 simulations.
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Chapter 7.1.2. Fitting Procedure Charts.
Figure 7-2. Fitting simulations of T7 mRNA levels to measured data (next 3
pages). Each table shows the optimization procedure to fit the RT-PCR mRNA
measurements for the initial fit (a), the altered promoter model (b), the alternative
degradation model (c), the DownStream Falloff polymerase interaction model (d),
the Traffic Jam polymerase interaction model (e), and the UpStream Falloff model
(f). Each row shows the simulations run to fix the mRNA levels for one particular
gene, or class average. The columns represent mRNA half-lives tested in
minutes. The values shown in each entry are R2 for the particular gene and half-
life being tested. A shaded box means the half-life was not tested. To begin, in
row 1, an average mRNA half-life was tested for all the class I genes. The highest
R2 found (highlighted) was fixed, and I then tested and fixed the class II average
half-life (row 2). After the average class III values were set, each gene was then
optimized against the mRNA measurement profiles for different half-lives. After
this process was complete, I show the final the final R2 found after the last
simulation in the last column. As can be seen, the R2 were not significantly
changed from the original value, meaning optimization of downstream genes did
not significantly affect the fit of the upstream genes. Finally, the last row shows
the average R2 for all the individual fits.
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Chapter 7.2. Refactoring Supplemental Information
Figure 7-3. Genome design. We split the wild-type T7 genome into six sections, alpha through
z ta, using five restriction sites unique across the natural sequence. Each section shown here has a
wild-type section with representations of the genetic elements: protein coding regions (blue),
ribosome binding sites (purple), promoters (green), RNase III recognition sites (pink), transcription
terminators (yellow), and others (gray). Elements are labeled by convention [7]. Images are not to
scale, but overlapping boundaries indicate elements with shared sequence. The useful natural
restriction sites across each section are shown (black lines). T7.1 sections are shown below the wild-
type sections. Parts are given integer numbers, 1 through 73, starting at the left end of the genome.
Unique restriction site pairs bracket each part (red/blue lines, labeled D[part #]L/R). Added unique
restriction sites (purple lines, U[part #]) and part length (# base pairs, open boxes) are shown.
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Figure 7-4. Differences between wild-type T7 and T7.1. A listing from left to right on
the T7 genome of the changes made during design of T7.1. Changes are shown by
comparison of the annotated wild-type T7 (above) and T7.1 (below) sequences. Point
mutations are capitalized. The natural ribosome binding sites are underlined. The
bracketing restriction sites surrounding parts are orange (left cutter) and blue (right
cutter), with overlaps of neighboring bracketing restriction sites in light green. Other
features include start codons (green), stop codons (red), and overlaps of start and stop
codons (purple).
Changes in Section Alpha
LeftEnd-Partl: TR-SRL/A0
T7: gagtgtctctctgtgtccctatctgttacagtctcctaaagtatcctcct
------ TR----------> <-------SRL -----
T7.1: gagtgtctctctgtgtccctatcGgttacCgtctcctaaagtatcctcct
------ TR----------> <-DIL-> <-------SRL-----
Partl-Part2: SRL/AO-oOL
T7: acctaaagacgccttgttgttagccataaagtgataacctttaatcattgtctttattaa
-- SRL--> < ----- oOL----
T7.1: acctaaagGTTaccgcatgcttgttgttagccataaagtgataacctttaatcattgtctttattaa
-- SRL--> <D2L-> <-----00L----
<-DIR->
Part2-Part3: 00L-A1
T7: aaggagagacaacttaaagagacttaaaagattaatttaaaatttatcaaaaag
---00L--> <---Al---
T7.1: aaggagagacaacttaaagagCAtgcttaaaagattaatcgattaaaatttatcaaaaag
---oOL--> <D2R-> <D3L-> <---Al---
Part3-Part4: A1-A2/A3/BoxA/RO.3
T7: gagagggacacggcgaatagccatcccaatcgacaccggggtcaaccggataagtagacagcctgataagtcgcacgaaaaacagg
----Al----> <----A2----
T7.1: gagagggacacggcgaatagccatcccaatcgaTaccggggtcaaccggataagtagaAagcTtgataagtcgcacgaaaaacagg
----Al----> <D3R-> <D4L-> <----A2----
Part4-Part5: A2/A3/BoxA/RO.3-0.3
T7: gatattcactaataactgcacgAggtaacacaagatggctatgtctaaca
--- R0.3---> <-0.3RBS-> <------0.3------
T7.1: gatattcactaagcttgcgcgctgcacgag"aacacaagatggctatgtctaaca
---R0.3---> <D5L-> <-0.3RBS-> <------0.3 ------
<D4R->
Part5-Part6: 0.3-0.4
T7: cgaggagtacgAaggigatgaagagtaatgtctactacc
------------- 0.3----------->
<-0.4RBS-> <----0.4----
T7.1: cgaggagtacgaggaggaCgaagagtaagcgcgcaccaggtcgaggagtacgaggAggatgaagagtaatgtctactacc
------------- 0.3 ----------- ><D5R-><-D6L-> <-0.4RBS-> <----0.4----
U1-RO.5: U1/0.4-RO.5
T7: caaagaactgtacgaaaacaacaaggcaatagctttagaatctgctgagtgatagactcaaggtc
--------------------------------------------0.4---->
< ------- RO.5-------
T7.1: caaacaG :tCtacgaaaacaacaaggcaatagctttagaatctgctgagtgaaccaggtgagtgatagactcaaggtc
-------------------------------------------- 0.4----><-D6R-><-------RO.5-------
<-Ul->
RO.5-Part7: RO.5-0.5
T7: gcctttatgattatcactttacttatgAggg•gtaatgtatatgctt
------- RO.5-------> <-0.5RBS-><---- 0.5----
T7.1: gcctttatgattatcacttacgcgtcttatgAgggsgtaatgtatatgctt
------- RO.5-------><D7L-> <-0.5RBS-><---- 0.5----
U2
T7: gctctaggtctagctgtaggtgcatcc
--------------- 0.5---------
T7.1: gctctagg•' : t ag tgtaggtgcatcc
--------------- 0.5---------
<-U2->
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Part7-Part8: 0.5-0.6A/B
T7: catca&&ggggcactacgcaaatgatgaagcac
--------- 0.5------------>
<-0.6RBS-> <----0.6----
T7.1: catcaA•g~CgcactacgcaaatAaacgi:cgtacgcaAAggggcactacgcaaatgatgaagcac
--------- 0.5------------><D7R-> <-0.6RBS-> <----0.6----
<D8L->
Part8-Part9: 0.6A/B-0.7
T7:
aacaggcactagccaacacactgaacgctatctcataacgaacata.aggacacaatgcaatgaacattacc
---- 0.6----> <-0.7RBS-> <----0.7----
T7.1:
aacaggcactagcgtac-gtccgcgaacataaaggacacaatgcaatgaacattacc
---- 0.6----><DR-> <-0.7RBS-> <----0.7----
<-D9L->
Part9-PartlO: 0.7-C/R1
T7: caacattgataagcaacttgacgcaatgttaatgggctgatagtcttatct
------------------- 0.7-----------------> <---- R---
<----------------------C----------------------
T7.1: caacattgataagcaacttgacgcaatgttaatgggctgacggtccgccgcggattgataagcaacttgacgcaatgttaatgggctgatagtcttatct
------------------- 0.7-----------------><-D9R-><DOL><---------------------------------------------
<----R1---
PartlO-Partll: C/R1-1
T7: ataggtacgatttactaactggaag••Lgcactaaatgaacacgatt
----R1-----> <-1RBS-> <-----1-----
T7.1: ataggtacgatttactaacccg gg ccgctggaag•ggcactaaatgaacacgatt
----R1-----> <DIOR> <-1RBS-> <-----1-----
<D11L>
Partll-Partl2: 1-01.1A/R1.1/01.1B
T7: gcgttcgcgtaacgccaaatcaatacgactcactatagagggacaaac
----- 1---- > <---R1.1----
<---------------01.1A---------------->
T7.1: gcgttcgcgtaacggccgttaattaaaacgccaaatcaatacgactcactatagagggacaaac
-- 1----- ><D11R><-D12L-><---------------1.1A---------------- >
<---R1.1----
Partl2-Partl3: 01.1A/R1.1/01.1B-1.1
T7: tataggagaaccttaaggtttaactttaagacccttaagtgttaattagagatttaaattaaagaattactaagagAgactttaagtatgcgtaacttc
---01.IB---> <-1.IRBS-> <----1.1----
T7.1: tataggagaaccttaaggtttaactttaagacccttaagtgttaattaAagatttaaattaaagaattCctaagagaggactttaagtatgcgtaacttc
--- 1.1B---> <-D12R-> <D13L> <-1.1RBS-> <----1.1----
Partl3-Partl4: 1.1-1.2
T7: ctgggAgggtcagtaagatgggacgttta
------ 1.. ------ > <----1.2----
<-1.2RBS->
T7.1: ctgggagggtcagtaagaattccaggactgggaýggtcagtaagatgggacgttta
------ 1.1 ------ ><D13R> <-1.2RBS-> <----1.2----
<D14L->
U3
T7: gacgaggacgttctgttcaatatgtgtactgattggttgaaccat
---------- 1.2--------------------------------
T7.1: gacgaggacgttctgttcaatatqtgCactgattggttgaaccat
---------- 1.2--------------------------------
<-U3->
Partl4-Partl5: 1.2-01.3/R1.3
T7: gttgaaggactggaagtaatacgactcagtatagggacaa
-------- 1.2-------> <---R1.3---
<--------------01.3---------------
T7.1: gttgaaggactggaagtaatccaggacccggactggaagtaatacgactcagtatagggacaa
-------- 1.2-------><D14R-> <--------------01.3---------------
<D15L-> <---R1.3---
Partl5-Partl6: 01.3/R1.3-1.3
T7: atttaaccaatagg.gataaacattatgatgaacatt
----R1.3---> <----1.3----
<-1.3RBS->
T7.1: atttaaccaataggaggac (cgggccaatAgg• ataaaacattatgatgaacatt
----R1.3---> <D16L> <-1.3RBS-> <----1.3----
<Dl5L->
Partl6-Partl7: 1.3-TE
T7: agagaaaatgtaatcacactggctcaccttcgggtgggcctt
----- 1.3----> <----------TE------------
T7.1: agagaaaatgtaacccgggcccaaaatgtaatcacactggctcaccttcgggtgggcctt
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----- 1.3----><D16R> <----------TE------------
<D17L>
Partl7-Partl8: TE-1.4
T7: gcctttctgcgtttat.iAgAgacactttatgtttaagaag
-TE--> <1.4RBS > <----1.4----
T7.1: gcctttcagggaaaacgggccc atggttataggagacactttatgtttaagaag
-TE--> <D17R> <1.4RBS > <----1.4----
<D18L>
Partl8-Partl9: 1.4-01.5
T7: cgtgtggagtatagttaactggtaatacgactcactaaagg
----------- 1.4---------->
<---------01.5------------
T7.1: cgtgtggagtatagttaactggtaatccatggcgccgttaactggtaatacgactcactaaagg
----------- 1.4 ---------- > <D18R> <--------- 01.5--------------
<D19L>
Partl9-Part20: ol.5-1.5
T7: taaaogaaatacacaccatgatgtactta
---- 0 1.5---> <---- 1.5----
<-1.SRBS->
T7.1: taaaggaggtacggcgcc taggcactaaaGggatacaacccatgatgtactta
---- 01.5---><D19R> <-1.5RBS-> <----1.5----
<D20L>
U4
T7: gtcattgtaggatgccttgcgctccactgtagcgatgat
------- 1.5-----------------------------
T7.1 gtcattgtaggatgccttgqTct.:cactgtagcgatgat
-------1.5-----------------------------
<-U4-->
Part20-Part21: 1.5-ol.6
T7: tgccagatggtcacgcttaatacgactcact
-------- 1.5-------->
<-------- •.6-----------
T7.1: tgccagatggtcacgcttaacctaggjacgtctggtcacgcttaatacgactcact
-------- 1.5--------><D20L> <--------01.6-----------
<D21L>
Part21-Part22: ol.6-1.6
T7: taA•gg•Aacactatatgtttcgactt
---- 1.6---> <----1.6----
<-1.6RBS->
T7.1: taaaggagacacgacgtctagacactaAAgggAacactatatgtttcgactt
----ol.6---><D21R> <-1.6RBS-> <----1.6----
<D22L>
Par22-Part23: 1.6-1.7
T7: tcaaaaagggtttctgatgggactgtta
------- 1.6------>
<--1.7RBS--> <----1.7----
T7.1: tcAaAgAAgt~ttctgatctagaaccggttcaagaaagtgttctgatgggactgtta
------- 1. 6------><D22R><D23L> <--1.7RBS--> <----1.7----
Changes in Section Beta
Part23-Part24: 1.7-1.8
T7: gaactctttgagaaacaAjggAtaaatgttatgcataacttcaagtca
----------------- 1.7------------------>
<-1.8RBS-> <------1.8 --------
T7.1: gaactctttgagaaacaZaAAgAtaaatgttaCgcataaccggtgacctctttgagaaacat•aggAtaaatgttatgcataacttcaagtca
----------------- 1.7 ------------------ > <D24L-> <-1.8RBS-> <-----1.8---------
<D23R>
Part24-Part25: 1.8-2
T7: gaactttggaaatcgagAggacaatgactatgtcaaacgta
------------ 1.8-----------> <-----2-----
<--RBS-->
T7.1: gaactttggaaatcgagaggtcaatgaggtcaccgtacgttggaaatcgagAgg~caatgactatgtcaaacgta
------------ 1.8 ----------- ><D24R> <--2RBS--> <-----2-----
<D25L>
Part25-Part26: 2-02.5
T7: ttgtgtagcaccgaagtaatacgactcactat
--------- 2-------->
<-----------02.5----------
T7.1: ttgtgtagcaccgaagtaacgtacgaattcagcaccgaagtaatacgactcactat
--------- 2--------><D25R> <------------02.5 ---------
<D26L>
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Part26-Part27: 02.5-2.5
T7: cactattagggaagactccctctgagaaaccaaacgaaacctaAgggagattaacattatggctaagaag
----- 02.5 ----- > <-2.5RBS-> <----2.5----
T7.1: cactattagggaagagaatt ccgggcgaaacctaAggl.gattaacattatggctaagaag
----- 02.5-----><D26R> <-2.5RBS-> <----2.5----
<D27L>
Part27-Part28: 2.5-2.8
T7: gcagacgaagacggLgacttctaagtggaactgcgg
--------- 2.5-----------><----2.8----
<-2.8RBS->
T7.1: gcagacgaagacggGgacttctaacccgggatccgaagacgg•gacttctaagtggaactgcgg
--------- 2.5-----------><D27R> <-2.8RBS-> <----2.8----
<D28L>
Part28-Part29: 2.8-3
T7: acgcaaaggaggcgacatggcaggttacggcgctaaaggaatccgaaa
---------------- 2.8 ----------------- >
<--3RBS--> <----------------3--------------
T7.1: acgcaaGgggAcgacaCggcaggttacggcgctaaggatccggccgcaaAgggAgcagacatggcaggttacggcgctaaaggaatccgaaa
---------------- 2.8 ----------------- ><D28R> <--3RBS--> <---------------3---------------
<D29L>
Part29-Part30: 3-3.5
T7: gattaaaaagga gg•ggaaagaaataatggctcgtgta
------------ 3 --------------- >
<-3.5RBS-> <----3.5----
T7.1: gattaaaaCgCaAGggGggGaagaaataacggccgccgcggaaaggaAgggAggaaagaaataatggctcgtgta
--------- 3 --------------- ><D29R><D30L> <-3.5RBS-> <----3.5----
Part30-Part31: 3.5-03.8/R3.8
T7: tctgaccgtggataattaattgaactcactaaag
------ 3.5----->
<------------3.8-----------
T7.1: tctgaccgtggataaccgcggacatgtcgtggataattaattgaactcactaaag
------ 3.5 ----- ><D30R><D31R><------------ o3.8-----------
Part31-Part32: 03.8/R3.8-3.8
T7: tttccctttgttcgcattggAggrcaaataatgcgcaagtct
------- R3.8------> <----3.8----
<-3.8RBS->
T7.1: tttccctttgttcgcattggaggtcaaataatacatgtcgacaggotcaaataatgcgcaagtct
------- R3. 8------> <D31R> <-3.8RBS-> <----3.8----
<D32L>
Changes in Section Gamma
Part32-Part33: 3.8-4A/4B/4.1/4.2
T7: tagaactAggAgggaattgcatggacaattcgcacgattccgatagtgt
-------------------- 3.8---------------------->
<-4ARBS-> <-----------4A-------------
T7.1: tagaactagA&AgaattgcaCggacaattcgcacgattccgataggtcgacgtacgctaggAgggaattgcatggacaattcgcacgattccgatagtgt
-------------------- 3.8 ---------------------- ><D32R> <-4ARBS-> <----------4A--------------
<D33L>
Part33-Part34: 4A/4B/4.1/4.2-o4.3
T7: ggagagtcccattctaatacgactcactaaa
------- 4.2------>
<------------4.3 ----------
T7.1: ggagagtcccattctaacgtacggccgagtcccattctaatacgactcactaaa
------- 4.2 ------><D33R> <------------ 4.3 ----------
<D34L>
Part34-Part35: 04.3-4.3
T7: ctai~.gggacacaccatgttcaaactg
---- 04.3 ---- > <---- 4.3----
<-4.3RBS->
T7.1: ctaaaggagacacaccggccggtggcgcgcctagagacacacaccatgttcaaactg
---- 04.3----> <D34R> <D35L> <-4.3RBS-> <----4.3----
Part35-Part36: 4.3-4.5
T7: ttctttgagtaatcaaacALgSgaaaccattatgtctaacgta
---- 4.3----> <-4.5RBS-> <----4.5----
T7.1: ttctttgagtaatggcgcgccaccggcgaaacAggAgaaaccattatgtctaacgta
---- 4.3----> <D35R><-D36L-> <-4.5RBS-> <----4.5----
Part36-Part37: 4.5-R4.7/04.7
T7: attgataactaagagtggtatcct
----4.5----><----R4.7---
T7.1: attgataactaacaccggcgaagcttaagagtggtatcct
----4.5----><-D36R-><D37L> <----R4.7---
Part37-Part38: R4.7/o4.7-4.7
T7: ctataggA• atattaccatgcgtgaccct
---- 04.7 ---- > <----4.7----
<-4.7RBS->
T7.1: ctataggagatattaccaagctt cctggactatlggbaAatattaccatgcgtgaccct
---- 04.7 ---- > <D37R> <-4.7RBS-> <----4.7----
<D38L->
Part38-Part39: 4.7-5
T7: aagtcacgataatcaatAggA• aaatcaatatgatcgtttct
---- 4.7 ---- > <-5RBS-> <-----5-----
T7.1: aagtcacgataatcctggagctagcatcaatAgg•.aaatcaatatgatcgtttct
---- 4.7 ---- ><D38R-><D39L> <-5RBS-> <-----5-----
Part39-Part40: 5-5.3
T7: atttgccactgatacagga ctactcatgaacgaaaga
----- 5 ----- > <-5.3RBS-> <----5.3----
T7.1: atttgccactgagctagcatgctacSggaggctactcatgaacgaaaga
----- 5-----><D39R> <-5.3RBS-> <----5.3----
<D40L>
Part40-Part41: 5.3-5.5
T7: ataaaactatAggagaaattattatggctatgaca
---- 5.3----> <----5.5----
<-5.5RBS->
T7.1: ataaaactatagcatgccatggtataggagaaattattatggctatgaca
---- 5.3----> <D41L> <-5.5RBS-> <----5.5----
<D40 R>
Part41-Part42: 5.5-5.7
T7: acagaggatattctgatgtctgactac
------ 5.5------ >
<-5.7RBS-> <----5.7----
T7.1: acgCgAggtgttctgaccatggatccaggAggtgttctgatgtctgactac
------ 5.5 ------ ><41R> <-5.7RBS-> <----5.7----
<42L>
Part42-Part43: 5.7-5.9
T7: tgggAggatgtgtctaatgtcgt gtgac
------- 5.7 ------ >
<-5.9RBS-> <----5.9----
T7.1: tgggCggGtgtgtctaaggatccgcggcgaatgggAggatgtgtctatgtctcgtgac
------- 5.7 ------><D42R> <-5.9RBS-> <----5.9----
<D43L>
Part43-Part44: 5.9-6
T7: ctagAggagaaacttaatggcacttcttgacc
--------------- 5.9----------->
<-6RBS-> <--------6------
T7.1: ctAgaAgaAaaacttaaCggcacttcttgaccgcgggcccggaactagaggagaaacttaatggcacttcttgacc
--------------- 5.9 ----------- ><D43R> <-6RBS-> <--------6------
<D44L>
Part44-Part45: 6-6.3
T7: gacaAggagatttacctgtggagaccgtagcgt
-------------- 6 -------------- >
<-6.3RBS-> <------6.3 ------
T7.1: gacAgAuSAatttacctCtggagaccgtagggcccgggc aagagatttacctgtggagaccgtagcgt
------------- 6 -------------- > <D45L><-6.3-RBS-> <------ 6.3 ------
<D44R>
Part45-Part46: 6.3-R6.5/06.5
T7: gacactaagtgataaact
---- 6.3---->
<---R6.5----
T7.1: gacactaaAtAacccgggagctcactaagtgataaact
---- 6.3 ---- ><D45R> <---R6.5----
<D46L>
Part46-Part47: R6.5/06.5-6.5
T7: cgattattactttaagatttaactctaagAggaatctttattatgttaacacct
---- R6.5 ---- > <-6.5RBS-> <----6.5----
T7.1: cgattattactttaagatttaagagct cgagtaagaggaatctttattatgttaacacct
---- R6.5----> <D46R> <-6.5RBS-> <----6.5----
<D47L>
Part47-Part48: 6.5-6.7
T7: tgatSggggagattgacactatgtgtttctca
------ 6.5----- > <----6.7----
<-6.7RBS->
T7.1: tgaggCaAgattgactcgagaattctgatgagaggattgacactatgtgtttctca
------ 6.5------><D47R> <-6.7RBS-> <----6.7----
<D48L>
Part48-Part49: 6.7-7
T7: tttggaggjaagaagtgatgtctgagttc
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------ 6.7 -------- >
<-7RBS-> <----- 7-----
T7.1: tttggaggtaagaagtgagaattcgatcgcatttg••ggaagaagtgatgtctgagttc
------ 6.7--------><D48R> <-7RBS-> <-----7-----
<D49L>
Part49-Part50: 7-7.3
T7: tttaaggaggtataagttatgggtaagaaa
------- 7------> <----7.3----
<-7.3RBS->
T7.1: tttaaggaggtataacgatcggtccgctttaaggaaggataagttatgggtaagaaa
------- 7------><D49L> <-7.3RBS-> <----7.3----
<D50R->
Part50-Part51: 7.3-7.7
T7: atcaacatttaatcAggAggttatcgtggaagactgc
---- 7.3----> <-7.7RBS-> <----7.7----
T7.1: atcaacatttaacggtccgctgcagtcAjgAgggtatcgtggaagactgc
---- 7. 3----><D50R-><D51L> <-7. 7RBS-> <---- 7. 7----
Changes in Section Delta
Part51-Part52: 7. 7-8
T7: gacatgggacacatttaatggctgagaaa
------- 7.7 -------- >
<-8RBS-> <-----8-----
T7.1: gacatggagacacatttaactgcagcgtacgagacatgg.gacacatttaatggctgagaaa
------- 7. 7--------><D51R><D52L> <-8RBS-> <-----8-----
Part52-Part53: 8-09
T7: cagccgggaatttaatacgactcactatag
------- 8----- >
<------------09-------------
T7.1: cagccgggaatttaacgtacgatcgccgggaatttaatacgactcactatag
------- 8------><D52L> <------------09-------------
<D53L>
Part53-Part54: 09-9
T7: tagggagacctcatctttgaaatgagcgatgacaagaggttggagtcctcggtcttcctgtagttcaactttA&gAgacaataataatggctgaat
---- 09---> <-9RBS-> <----9----
T7.1: tagggagacctcatctttgaaatgagcgatcgacaagaggttggagtcctcggtcttcctgtagaattcaactttdAgqAgacaataataatggctgaat
---- 09---> <D53R> <D54L> <-9RBS-> <----9----
Part54-Part55: 9-o10
T7: tcgaacttctgatagacttcgaaatta
----- 9-----> <----010----
T7.1: tcgaacttctgatagaattccgcggacttcgaaatta
S-----9-----> <D54R> <----010----
<D55L>
Part55-Part56: 10O-10A/B
T7: tatagggagaccacaacggtttccctctagaaataattttgtttaactttaagAAggagatatacatatggctagcatg
---- 01 0----> <-10RBS-> <----10-----
T7.1: tatagggagaccacaaccgcggatccctctagaaataattttgtttaactttaagaAggAgatatacatatggctagcatg
---- 010 ---- > <D55R> <-10RBS-> <----10-----
<D56L>
Part56-Part57: 10A/B-To
T7: gctgagcaataactagcataaccccttggggcct
---- 10-----> <------- T-------
T7.1: gctgagcaataaggatcccgggctagcataaccccttggggcct
---- 10-----><D56R> <------- T-------
<D57L>
Part57-Part58: To-11
T7: gttttttgctgaAgg0Aggaactatatgcgctcata
--To--> <-IIRBS-> <---- 11----
T7.1: gttttttgctgacccqggccctgaA&ggaggaactatatgcgctcata
--TO--> <D57R> <-11RBS-> <----11----
<D58L>
Part58-Part59: 11-12
T7: tgactcgctaacattaataaataaggAggctctaatggcactcat
---- 11 ---- > <-12RBS-> <----12----
T7.1 tgactcgctaagggcccaagcttaataaataaggAggctctaatggcactcat
----11----><D58R><D59L> <-12RBS-> <----12----
Changes in Section Epsilon
Part59-Part60: 12-R13/013
T7: ccggtatttaataaatattctccctgtgg
---- 12----> <----R13----
T7.1: ccggtatttaattaaagcttcccggattctccctgtgg
---- 12----> <D59L> <----R13----
<D60R->
Part60-Part61: R13/013-13
T7: tatagggagaacaatacgactacaggAgggttttcttatgatgactat
---- 0 13----> <-13RBS-> <----13----
---- R13--->
T7.1: tatagggagaacaatactcccggaattctacgggAgggttttcttatgatgactat
----013----> <D60R-> <-13RBS-> <----13----
---- R13---> <D61L>
Part61-Part62: 13-14
T7: acgaA~AgAggataaccatatgtgttgggc
------ 13------> <----14----
<-14RBS->
T7.1: acgaaiggCggCtaagaattcgtacgcacgaaaggaaataaccatatgtgttgggc
------ 13------><D61R> <-14RBS-> <----14----
<D62L>
Part62-Part63: 14-15
T7: gacgagZUA k=aatgagctatgagtaaaat
----- 14---- > <----15----
<-15RBS->
T7.1: gacCggCAggkaacgtacgatcgccaagacggggAggaaatgagctatgagtaaaat
----- 14-----><D62R> <-15RBS-> <----15----
<D63L>
Part63-Part64: 15-16
T7: gtaaggagtaactaaaggctaca.aaggAggccctaaatggataagta
---- 15----> <-16RBS-> <----16----
T7.1: gtaaggagtaacgatcggccgtaaaggctacatAAggAggccctaaatggataagta
---- 15---- ><D63R> <-16RBS-> <----16----
<D64L>
Changes in Section Zdta
Part64-Part65: 16-017
T7: gggagcgtaggaaataatacgactcactatag
------- 16------ >
<--------------0 o17----------
T7.1: gggagcgtaggaaataacggccgcggcgtaggaaataatacgactcactatag
------- 16-------><D64R> <--------------17 ----------
<D65L>
Part65-Part66: 017-17
T7: gggagaggcgaaataatcttt tgtagt cccttag ttagatttactttaa ggtcaaatggctaacgt
--017--> <-17RBS-> <----17----
T7.1: gggagaggcgaaataatcttctcccgcggtgtaagcttcttagatttactttaaggaggtcaaatggctaacgt
--017--> <D65R> <D66L> <-17RBS-> <----17----
Part66-Part67: 17-17.5
T7: aacgagtaattggtaaatcacaaggaaagacgtgtagtccacggatggactctcaaggaggtacaaggtgctatca
---17---> <-17.5RBS-> <--17.5--
T7.1: aacgagtaattggtaaatcacaagcttgaaagacgtgtagtccacggatccggactctcaaggaggtacaaggtgctatca
---17---> <D66R> <D67L> <-17.4RBS-> <--17.5--
Part67-Part68: 17.5-18
T7: caaf;iagg=tgatatgtatggaaaagga
---- 17.5----> <----18----
<-18RBS->
T7.1: caalAAAgatgaggatccc(gggaa~8gagotgatatgtatggaaaagga
---- 17.5----><D67R> <-18RBS-> <----18----
<D68L>
Part68-Part69: 18-R18.5
T7: cattacagtgatatactcaa
---- 18---->
<-----R18.5-----
T7.1: cattacaatagcccggqgcccacattacagtgatatactcaa
---- 18---- ><D68R> <-----R18.5-----
<D69L>
Part69-Part7O: R18.5-E/18.5/18.7
T7: gtcattgtctatacgagatgctcctacgtgaaatctgaaagttaacgggaggcattatgctagaatt
-R18.5-> <-------------------E------------------
<-18.5RBS-> <---18.5---
T7.1: gtcattgtctatacgagatgctgggccctacgtgaattctgaaagttaacgggAggcattatgctagaatt
-R18.5-> <D69R> <D70L> <-18.5RBS-> <---18.5---
Part70-Part71: E/18.5/18.7-19/19.2/19.3
T7: aacgtaagtaggaaatcaagtAaggaggcaatgtgtctactca
---18.5---> <-19RBS-> < ---- 19----
T7.1: aacgtaagtaggaattcgtacgaagtgaggaggcaatgtgtctactca
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---18.5---><D70R>
<D71L>
<-19RBS-> <----19----
Part71-Part72: 19/19.2/19.3-00R
T7: ggtgatttatgcattaggactgcatagggatgcactatagaccacggatggtcagttctttaagttactgaaaagacacgat
-19-> <-oOR-
T7.1: ggtgatttatgcattaggactgcatagggatgcactatagaccacgtacgatggtcagttctttaagttactgcagaaaagacacgat
-19-> <D71R> <D72L> <-oOR-
Part72-Part73: 00R-19.5
T7: gagagga... 94nt... gattatattgtattagtatcaccttaacttaaggaccaacataaAgggAggagactcatgttcc
-0OR-> <-19.5RBS-> <-19.5-
T7.1: gagagga... 94nt... gattatattgtattagtatcaccttaactgcaqtcgaccaacataaAgaggagactcatgttcc
-oOR-> <D72R> <-19.5RBS-> <-19.5-
<D73L>
Part73-SRR/TR: 19.5-SRR/TR
T7: cgattagggtcttcctgaccgactgatggctcaccgagggattcagcggtatgattgcatcacaccacttcatccctata
-19.5-> <-SRR-
T7.1: cgattagggtcgacttcctgaccgactgatggctcaccgagggattcagcggtatgattgcatcacaccacttcatccctata
-19.5-> <D73R> <-SRR-
Table 7-1. Errors in synthesis & construction of section alpha.
D1L (164-170), D1R
& D2L (338-350)
gene 0.4 (1418)
D6L (1304-1310)
D6R (1494-1500)
gene 0.6B
D11 L (3302-3307)
gene 1 (4877)
gene 1 (5159)
gene 1 (5399)
D14R (6591-6597)
TE (7827)
D20L (8082-8086)
U4 (8153-8159)
D22L (8247-8253)
Restriction sites were
not added in
construction
Single base deletion
Restriction sites appear
twice.
Single base addition
Restriction site appears
twice
Single base mutation
Single base mutation
Single base mutation
Restriction site appears
twice
Single base deletion
Restriction site appears
twice
Restriction site was not
added in construction
Restriction site appears
twice
Difficulties in
manipulating left end of
genome resulted in using
wild-type
Unknown
Inefficiency of digestion
of scaffold
Error is known to be in
stock of wild-type
genome
Inefficiency of digestion
of scaffold
Error in PCR or within
wild-type genome
Error in PCR or within
wild-type genome
Error in PCR or within
wild-type genome
Inefficiency of digestion
of scaffold
Primer synthesis error
Inefficiency of digestion
of scaffold
Failure in site-directed
mutagenesis
Inefficiency of digestion
of scaffold
Loss of manipulability in
part 1 (containing AO)
Frameshift after 27th
amino acid followed by
early termination of gene
0.4
No expected change
Dependent upon nature
of putative translational
slippage in formation of
gene 0.6B
No expected change
Silent mutation, no
expected change
Silent mutation, no
expected change
Silent mutation, no
expected change
No expected change
Possible loss of function
of transcriptional
terminator.
No expected change
Loss of manipulability of
overlap in parts 18 and
19
No expected change
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Table 7-2. Errors in synthesis & construction of section beta.
gene 1.7 (8794)
gene 1.8 (9245)
gene 2.0 (9447)
gene 2.5 (10351)
gene 2.8 (10627)
gene 2.8
(10717-10803)
gene 3.0 (10926)
Single base silent
mutation
Single base mutation
Single base mutation
Singe base deletion
Single base mutation
82 base deletion
Single base silent
mutation
Error during PCR or
within wild-type genome
Error during PCR or
within wild-type genome
Error during PCR or
within wild-type genome
Error during primer
design
Error during PCR
Error in cloning of part
Error during PCR or
within wild-type genome
No expected change
Amino acid change in
gene 1.8 from Asp to
Gly
Amino acid change in
gene 2.0 from Glu to Val
deletion in stop codon;
read-through adding on
8AA
Amino acid change in
gene 2.8 from Asp to
Gly
Loss of function in gene
2.8 in addition to
unknown effect on
translation of 3.0 due to
read-through
No expected change
7.28
5.89
8.32
6.79
6.35
7.91
7.31
8.33
7.34
8.57
6.61
8.47
6.18
6.69
7.34
5.64
5.28
4.94
5.59
6.48
7.84
7.61
6.85
7
7.13
6.18
7.56
7.94
6.86
7
7.3
7.7
8
9
11
12
13
14
15
16
17
17.5
Table 7-3. Calculated ribosome binding site strength for T7 genes. I used the computational
algorithm from the Barrick et al., 1994 study to predict RBS strength of all the T7 genes and 4
BioBrick RBS (B0030-B0033).
3
3.5
3.8
4.1
4.2
4.3
4.5
4.7
5
5.3
5.5
5.7
5.9
6
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0.4
0.5
0.7
1.2
1.3
1.4
1.5
1.6
1.7
1.8
2
2.5
6.61
6.88
5.51
4.99
6.65
7.8
6.69
6.21
6.86
6.37
6.55
5.87
5.92
18.7
19
19.2
19.3
19.5
OAAA
IOA
4A
4B
B0030
B0031
B0032
B0033
7.64
4.87
5.33
5.24
7.01
5.62
7.37
6.76
6.8
6.13
3.84
6.31
5.87
0.3 2.8 4.3 6.7 7.64 18.5i 6.9
Chapter 7.3. Input Files
Chapter 7.3.1. Input Files for Simple Gene Expression Models
Tabasco Input File for Single-molecule Simple Gene Expression model
<REQUEST>
<EXECUTE-SIMULATION runs="500" random_seed="34143" simulation_name="test-1" time_step="50" time_end="25000"
min_num_for_init_oputput=" 1">
<CELL volume=" 1 E- 15" growth_rate="O" polymerase_interaction_model="TRAFFIC_JAM">
<RIBOSOME initialnumber="10000" speed="40" footprint="35" />
<POLYMERASE n="700" speed="40" id="2" organism_id="2" footprint=" 15" name="coli Pol" />
<SPECIES name="test" n="O" ID="3" organism="l" />
<REACTIONS>
<REACTION>
3>0;7E-4
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phagel" genome_length="3800" copynumber-" 1" entry_rate_constant="50000" entry_offsite="3800">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism_id="l">
<POLYMERASE polymeraselD="2" aon="4e7" aoff="4" ainiton="1.2" runoff_percent="O" aelong="0.23" arecyc="0" />
</PROMOTER>
<TERMINATOR start="3600" stop="3610" stopsite="3610" name="TE" organism="2">
<POLYMERASE ID="2" efficiency="0.99" />
</TERMINATOR>
<RBS start="495" stop="500" startsite="500" initstepsize="20" strength="1.15e4" stopsite="522" protid="3"
initRateConstant="0. 14" mrnadeg="2.5e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
Tabasco Input File for Species-level Simple Gene Expression model
<REQUEST>
<EXECUTE-SIMULATION runs="1000" randomseed="34143" simulationname="test-l"
time_step="50" time end="25000" min_num_forinit_output="1">
<CELL volume="1E-15" growth_rate="0" polymerase interaction_model="TRAFFIC_JAM">
<RIBOSOME initial_number="10000" speed="40" footprint="35" />
<POLYMERASE n="700" speed="40" id="2" organism_id="2" footprint="15" name="coli Pol" />
<SPECIES name="rib" n="10000" ID="3" organism="1" />
<SPECIES name="pol" n="700" ID="4" organism="1" />
<SPECIES name="promoter" n="l1" ID="5" organism=" " />
<SPECIES name="pol-promoter " n="0O" ID="6" organism="1" />
<SPECIES name="pol-promoter-init" n="O" ID="7" organism="1" />
<SPECIES name="pol-dna-elong" n="0" ID="8" organism="1" />
<SPECIES name="rbs" n="O" ID="9" organism="l" />
<SPECIES name="rib-rbs" n="0" ID="10" organism="1" />
<SPECIES name="rib-elong" n="0O" ID="11" organism="1" />
<SPECIES name="cust_prot" n=" 0" ID="12" organism="1" />
<REACTIONS>
<REACTION>
4+5>6;4e7
</REACTION>
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<REACTION>
6>4+5;4
</REACTION>
<REACTION>
6>7;1.2
</REACTION>
<REACTION>
7>5+8;0.23
</REACTION>
<REACTION>
8>4+9; 0.645
</REACTION>
<REACTION>
3+9>10; 1.15e4
</REACTION>
<REACTION>
10>9+11; 0.1308
</REACTION>
<REACTION>
11>3+12; 20
</REACTION>
<REACTION>
12>0; 7e-4
</REACTION>
<REACTION>
9>0;2.5e-3
</REACTION>
<REACTION>
10>3;2.5e-3
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phagel" genome_length=" 3800" copy_number=" 1" entry_rate_constant=" 50"
entry off site=" 850">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism id=" 1">
<POLYMERASE polymeraseID=" 2" aon=" 0" aoff="4" ainiton="1.2" runoff percent=" 35"
aelong="5" arecyc="0.7" />
</PROMOTER>
<TERMINATOR start="3600" stop="3610" stopsite="3610" name="TE" organism="2">
<POLYMERASE ID="2" efficiency="0.99" />
</TERMINATOR>
<RBS start="485" stop="500" startsite="500" initstepsize="50" strength="0"
stopsite="3500" protid="3" initRateConstant="0.14" mrnadeg="2.5e-3" />
</DNA SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
Chapter 7.3.2. Input Files for Polymerase Interaction Simulations
Tabasco Input File for Downstream Falloff
<REQUEST>
<EXECUTE-SIMULATION runs=" 100" random_seed="34206" simulation_name="test-1" time_step="50" time_end="25000"
min_num_for_iniLoutput=" 1 ">
<CELL volume=" 1E- 15" growthrate="0" polymerase_interaction_model="DOWNSTREAM_FALL_OFF">
<RIBOSOME initial_number-"10000" speed="40" footprint-"35" />
<POLYMERASE n="700" speed="300" id="2" organismid="l" footprint=" 15" name="T7 pol" />
<POLYMERASE n="700" speed="40" id="3" organismid="2" footprint="15" name="Coli pol" />
<SPECIES name="test-1" n="O" ID="4" organism=" 1" />
<SPECIES name="test-2" n="O" ID="5" organism="" 1/>
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<REACTIONS>
<REACTION>
4>0;7E-4
</REACTION>
<REACTION>
5>0;7E-4
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phagel" genomelength="4000" copy_number=" 1" entry_rateconstant="5000" entry_offsite="3950">
<PROMOTER start-"405" stop="428" startsite="423" name="Al" organism_id="2">
<POLYMERASE polymeraseID="3" aon="1.5e7" aoff="0.28" ainiton="0.2" runoffpercent=" 100" aelong="6"
arecyc="0" />
<IPROMOTER>
<PROMOTER start="1505" stop="1528" startsite="1523" name="phil0" organism_id="l">
<POLYMERASE polymeraselD="2" aon="1.26e8" aoff="0.2" ainiton="1.2" runoff_percent="70" aelong="5"
arecyc="0.7" />
</PROMOTER>
<TERMINATOR start-"3900" stop="3910" stopsite="3910" name="TE" organism="2">
<POLYMERASE ID="2" efficiency="0.99" />
<POLYMERASE ID="3" efficiency="0.99" />
</TERMINATOR>
<RBS start="485" stop="500" startsite="500" initstepsize="50" strength="1. 15e4" stopsite="1499" protid="4"
initRateConstant="0.14" mmadeg="2.5e-3" />
<RBS start=" 1585" stop="1600" startsite="1600" initstepsize="50" strength="1.15e4" stopsite="3600" protid="5"
initRateConstant="0. 14" mrnadeg="2.5e-3" />
</DNA_SYSTEM>
</CELI>
</EXECUTE-SIMULATION>
</REQUEST>
Tabasco Input File for Upstream Falloff
<REQUEST>
<EXECUTE-SIMULATION runs=" 100" random_seed="34206" simulation_name="test- 1" time_step="50" time_end="25000"
min_num_for_init_output-" 1">
<CELL volume=" 1E- 15" growth_rate="0" polymerase_interaction_model="UPSTREAMFALL_OFF">
<RIBOSOME initial_number=-"10000" speed="40" footprint="35" />
<POLYMERASE n="700" speed="300" id="2" organismid="l" footprint=" 15" name="T7 pol" />
<POLYMERASE n="700" speed="40" id="3" organism_id="2" footprint=" 15" name="Coli pol" />
<SPECIES name="test-1" n="0" ID="4" organism="l" />
<SPECIES name="test-2" n="O0" ID="5" organism=" " />
<REACTIONS>
<REACTION>
4>0;7E-4
</REACTION>
<REACTION>
5>0;7E-4
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phagel" genome_jength="4000" copynumber=-" 1" entry_rate_constant="5000" entry_offsite="3950">
<PROMOTER start-"405" stop="428" startsite="423" name="Al" organism_id="2">
<POLYMERASE polymeraselD="3" aon="1.5e7" aoff="0.28" ainiton="0.2" runoff_percent="100" aelong="6"
arecyc="0" />
</PROMOTER>
<PROMOTER start="1505" stop="1528" startsite="1523" name="phi 10" organismid=" ">
<POLYMERASE polymeraselD="2" aon=" 1.26e8" aoff="0.2" ainiton=" 1.2" runoff.percent="70" aelong="5"
arecyc="0.7" />
</PROMOTER>
<TERMINATOR start="3900" stop="3910" stopsite="3910" name="TE" organism="2">
<POLYMERASE ID="2" efficiency="0.99" />
<POLYMERASE ID="3" efficiency="0.99" />
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<TrERMINATOR>
<RBS start="485" stop="500" startsite="500" initstepsize="50" strength="1.15e4" stopsite="1499" protid="4"
initRateConstant="0.14" mrnadeg="2.5e-3"/>
<RBS start="1585" stop="1600" startsite="1600" initstepsize="50" strength="1.15e4" stopsite="3600" protid="5"
initRateConstant"0. 14" mrnadeg="2.5e-3" />
</DNA.SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
Tabasco Input File for Traffic Jam
<REQUEST>
<EXECUTE-SIMULATION runs=" 00" random_seed="34206" simulation_name="test-l" time_step="50" timeend="25000"
minnumjor_init_output=" 1 ">
<CELL volume=" E-15" growth_rate="0" polymeraseinteractionmodel="TRAFFIC_JAM">
<RIBOSOME initial_number=" 10000" speed="40" footprint="35" />
<POLYMERASE n="700" speed="300" id="2" organismid="l" footprint=" 15" name="T7 pol" />
<POLYMERASE n="700" speed="40" id="3" organismid="2" footprint=" 15" name="Coli pol" />
<SPECIES name="test- " n="O" ID="4" organism="l" />
<SPECIES name="test-2" n="O0" ID="5" organism=" " />
<REACTIONS>
<REACTION>
4>0;7E-4
</REACTION>
<REACTION>
5>0;7E-4
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phagel" genome_length="4000" copynumber=-" 1" entry_rateconstant="5000" entry_offsite="3950">
<PROMOTER start="405" stop="428" startsite="423" name="Al" organism_id="2">
<POLYMERASE polymeraselD="3" aon="1.5e7" aoff="0.28" ainiton="0.2" runoff_percent="100" aelong="6"
arecyc="0" />
</PROMOTER>
<PROMOTER start-" 1505" stop=" 1528" startsite=" 1523" name="phi 10" organism_id=" 1">
<POLYMERASE polymeraselD="2" aon="1.26e8" aoff="0.2" ainiton="1.2" runoff_percent="70" aelong="5"
arecyc="0.7" />
</PROMOTER>
<TERMINATOR start="3900" stop="3910" stopsite="3910" name="TE" organism="2">
<POLYMERASE ID="2" efficiency="0.99" />
<POLYMERASE ID="3" efficiency="0.99" />
</TERMINATOR>
<RBS start-"485" stop="500" startsite="500" initstepsize="50" strength=" .15e4" stopsite="1499" protid="4"
initRateConstant="0. 14" mrnadeg="2.5e-3" />
<RBS start=" 1585" stop=" 1600" startsite=" 1600" initstepsize="50" strength="1. 15e4" stopsite="3600" protid="5"
initRateConstant-"0. 14" mrnadeg="2.5e-3" />
</DNASYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
Tabasco Input File for Traffic Jam with No T7 RNA Polymerase
<REQUEST>
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<EXECUTE-SIMULATION runs=" 100" random_seed="34206" simulation_name="test-l" time_step="50" time_end="25000"
min_num_for_initoutput-" 1">
<CELL volume=" lE-15" growth_rate="0" polymerase_interaction_model="TRAFFIC_JAM">
<RIBOSOME initial_number="10000" speed="40" footprint="35" />
<POLYMERASE n="O" speed="300" id="2" organismid="l" footprint="15" name="T7 pol" />
<POLYMERASE n="700" speed="40" id="3" organismjd="2" footprint="15" name="Coli pol" />
<SPECIES name="test- " n="O" ID="4" organism="1" />
<SPECIES name="test-2" n="O" ID="5" organism="l" />
<REACTIONS>
<REACTION>
4>0;7E-4
</REACTION>
<REACTION>
5>0;7E-4
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phage I" genome_length="4000" copynumber=" 1" entry_rate_constant="5000" entry_offsite="3950">
<PROMOTER start="405" stop="428" startsite="423" name="Al" organism_id="2">
<POLYMERASE polymeraseID="3" aon="1.5e7" aoff="0.28" ainiton="0.2" runoff_percent="100" aelong="6"
arecyc="0" />
</PROMOTER>
<PROMOTER start="1505" stop="1528" startsite=" 1523" name="phil0" organismid=" ">
<POLYMERASE polymeraselD="2" aon=" .26e8" aoff="0.2" ainiton="1.2" runoff_percent="70" aelong="5"
arecyc="0.7" />
</PROMOTER>
<TERMINATOR start="3900" stop="3910" stopsite="3910" name="TE" organism="2">
<POLYMERASE ID="2" efficiency="0.99" />
<POLYMERASE ID="3" efficiency="0.99" />
</TERMINATOR>
<RBS start-"485" stop="500" startsite="500" initstepsize="50" strength="1.15e4" stopsite="1499" protid="4"
initRateConstant="0.14" mrnadeg="2.5e-3" />
<RBS start="1585" stop="1600" startsite="1600" initstepsize="50" strength="1.15e4" stopsite="3600" protid="5"
initRateConstant-"0.. 14" mrnadeg="2.5e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
Tabasco Input File for Traffic Jam with No E. coli RNA polymerase
<REQUEST>
<EXECUTE-SIMULATION runs="100" random_seed="34206" simulation_name="test-1" time_step="50" time_end="25000"
min_num_for_init_output=" 1">
<CELL volume=" 1E- 15" growthrate="0" polymerase_interaction_model="TRAFFICJAM">
<RIBOSOME initial_number=-"10000" speed="40" footprint="35" />
<POLYMERASE n="700" speed="300" id="2" organismjid=" " footprint=" 15" name="T7 pol" />
<POLYMERASE n="0" speed="40" id="3" organismid="2" footprint="15" name="Coli pol" />
<SPECIES name="test- " n="O" ID="4" organism=" 1" />
<SPECIES name="test-2" n="O" ID="5" organism="l" />
<REACTIONS>
<REACTION>
4>0;7E-4
</REACTION>
<REACTION>
5>0;7E-4
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phagel" genome_length="4000" copy_number="l" entryrateconstant="5000" entry_offsite="3950">
<PROMOTER start="405" stop="428" startsite="423" name="A 1" organism_id="2">
<POLYMERASE polymeraselD="3" aon="1.5e7" aoff="0.28" ainiton="0.2" runoff_percent=" 100" aelong="6"
arecyc="0" />
</PROMOTER>
<PROMOTER start=" 1505" stop="1528" startsite="1523" name="phil 10" organismjd="l">
<POLYMERASE polymeraseID="2" aon=" 1.26e8" aoff="0.2" ainiton=" 1.2" runoff_percent="70" aelong="5"
arecyc="0.7" />
</PROMOTER>
<TERMINATOR start="3900" stop="3910" stopsite="3910" name="TE" organism="2">
<POLYMERASE ID="2" efficiency="0.99"/>
<POLYMERASE ID="3" efficiency="0.99" />
<TfERMINATOR>
<RBS start="485" stop="500" startsite="500" initstepsize="50" strength="1.15e4" stopsite="1499" protid="4"
initRateConstant="0.14" mrnadeg="2.5e-3" />
<RBS start="1585" stop="1600" startsite="1600" initstepsize="50" strength="1.15e4" stopsite="3600" protid="5"
initRateConstant="0. 14" mrnadeg="2.5e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
Chapter 7.3.3. Simulation Optimizations for Different Models
Tabasco Input File for Unfit Simulations
<REQUEST>
<EXECUTE-SIMULATION runs="l" random_seed="34145" simulation_name="test-l" time_step="5" timeend="1500"
write_DNA="no" writeJnitRNA="yes" write_Energy="yes" compDeg="no">
<CELL volume="8e-16" polymerase_interaction_model="CUSTOM">
<RIBOSOME initial_number=-"10000" speed="45" footprint="40" />
<POLYMERASE n=" 1800" speed="45" id="2" organism_id="2" footprint=" 15" name="coli Pol" />
<POLYMERASE n=:"O" speed="45" id="3" organismid="2" footprint="15" name="coli Pol-P" />
<POLYMERASE n=:"O" speed="45" id="4" organism id="2" footprint=" 15" name="coli Pol-2.0" />
<POLYMERASE n=:"O" speed="45" id="5" organism_id="2" footprint="15" name="coli Pol-P-2.0" />
<POLYMERASE n="O" speed="230" id="6" organism id="l" footprint=-"15" name="gpl" />
<POLYMERASE n="O" speed="230" id="7" organismid=" " footprint=" 15" name="gpl-3.5" />
<SPECIES name="gp0.3" n="O0" ID="8" organism="1" />
<SPECIES name="gp0.4" n="O" ID="9" organism="l" />
<SPECIES name="gp0.5" n="O0" ID=" 10" organism="1" />
<SPECIES name="gp0.6A" n="O" ID="11" organism="l" />
<SPECIES name="gp0.7" n="0" ID="12" organism="1" />
<SPECIES name="gpl.1" n="O" ID=-"13" organism="1" />
<SPECIES name="gpl.2" n="O" ID="14" organism="1" />
<SPECIES name="gpl.3" n="0" ID="15" organism=" " />
<SPECIES name="gpl.4" n="O" ID="16" organism=" 1" />
<SPECIES name="gpl.5" n="0" ID="17" organism="l" />
<SPECIES name="gpl.6" n="0" ID="18" organism="1" />
<SPECIES name="gpl.7" n="0" ID="19" organism="l" />
<SPECIES name="gpl.8" n="O" ID="20" organism=" " />
<SPECIES name="gp2.0" n="O0" ID="21" organism="l" />
<SPECIES name="gp2.5" n="O" ID="22" organism="l" />
<SPECIES name="gp2.8" n="O" ID="23" organism="" />
<SPECIES name="gp3.0" n="O" ID="24" organism="l" />
<SPECIES name="gp3.5" n="0" ID="25" organism="l" />
<SPECIES name="gp3.8" n="O" ID="26" organism=" " />
<SPECIES name="gp4A" n="O" ID="27" organism="l" />
<SPECIES name="gl4.2" n="O" ID="28" organism="l" />
<SPECIES name="gp4.3" n="O0" ID="29" organism="l" />
<SPECIES name="gp4.5" n="0" ID="30" organism="l" />
<SPECIES name="gp4.7" n="O" ID="31" organism="l" />
<SPECIES name="gp5.0" n="O0" ID="32" organism="l" />
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<SPECIES name="gp5.3" n="O" ID="33" organism="l" />
<SPECIES name="gp5.5" n="O" ID="34" organism="l" />
<SPECIES name="gp5.7" n="O" ID="35" organism="l" />
<SPECIES name="gp5.9" n="O" ID="36" organism=" "/>
<SPECIES name='gp6.0" n="O" ID="37" organism="l" />
<SPECIES name="gp6.3" n="O" ID="38" organism="l" />
<SPECIES name="gp6.5" n="O" ID="39" organism="l" />
<SPECIES name="gp6.7" n="O" ID="40" organism="l" />
<SPECIES name="gp7" n="O" ID="41" organism="l" />
<SPECIES name="gp7.3" n="O" ID="42" organism="l" I/>
<SPECIES name="gp7.7" n="O" ID="43" organism=" />
<SPECIES name="gp8" n="O" ID="44" organism="l" />
<SPECIES name="gp9" n="O" ID="45" organism="" 1/>
<SPECIES name="gpl0A" n="O" ID="46" organism="l" />
<SPECIES name="gpll" n="O" ID="47" organism="l" />
<SPECIES name="gpl2" n="O" ID="48" organism="l" />
<SPECIES name="gpl3" n="O" ID="49" organism="l" />
<SPECIES name="gpl4" n="O" ID="50" organism="l" />
<SPECIES name="gpl5" n="O" ID="51" organism="l" />
<SPECIES name="gpl6" n="O" ID="52" organism="l" 1"/>
<SPECIES name="gpl7" n="O" ID="53" organism="l" />
<SPECIES name="gpl7.5" n="O" ID="54" organism=" 1"/>
<SPECIES name=" gpl8" n="O" ID="55" organism=" I/>
<SPECIES name="gpl8.5" n="O" ID="56" organism="l" />
<SPECIES name="gpl9" n="O" ID="57" organism="I" />
<SPECIES name="gpl9.5" n="O" ID="58" organism="l" />
<REACTIONS>
<REACTION>
12+2>3+11 ;3.8E7
</REACTION>
<REACTION>
12+4>5+11 ;3.8E7
</REACTION>
<REACTION>
21+2>4;3.8E7
</REACTION>
<REACTION>
21+3>5;3.8E7
</REACTION>
<REACTION>
4>21+2;1.1
</REACTION>
<REACTION>
5>21+3;1.1
</REACTION>
<REACTION>
25+6>7;3.8E7
</REACTION>
<REACTION>
7>6+25;3.5
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phagel" genomejlength="39937" copynumber="3" entry_rate_constant="70" entry_offsite="850">
<PROMOTER start=:"405" stop="428" startsite="423" name="phi0L" organism_id=" ">
<POLYMERASE polymeraselD="6" aon="l.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent="18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="498" stop="548" startsite="542" name="Al" organismid="2">
<POLYMERASE polymeraselD="2" aon="1.5e7" aoff=".28" ainiton="0. 19" runoffpercent="100" aelong="6"
arecyc="O"/>
<POLYMERASE polymeraselD="3" aon="1.5e7" aoff=".28" ainiton="0.19" runoff_percent="70" aelong="6"
arecyc="0. 19"/>
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<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoffpercent-"O" aelong="0" arecyc="0"I>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="O" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="626" stop="676" startsite="670" name="A2" organismid="2">
<POLYMERASE polymeraselD="2" aon=" 1.5e7" aoff=".28" ainiton="0.19" runoff_percent=" 100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraselD="3" aon=" 1.5e7" aoff=".28" ainiton="0. 19" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start-"750" stop="800" startsite="794" name="A3" organism_id="2">
<POLYMERASE polymeraseID="2" aon=" 1.5e7" aoff=".28" ainiton="0.19" runoff_percent=" 100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraselD="3" aon=" 1.5e7" aoff=".28" ainiton="0. 19" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoffpercent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="O" arecyc="0"/>
</PROMOTER>
<PROMOTER start=" 1514" stop=" 1564" startsite="1558" name="B" organism_id="2">
<POLYMERASE polymeraselD="2" aon=" 1.5e7" aoff="2.8" ainiton="0.19" runoff_percent=" 100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraselD="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoffpercent-"0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="3113" stop="3163" startsite="3157" name="C" organismid="2">
<POLYMERASE polymeraselD="2" aon=" 1.5e7" aoff="2.8" ainiton="0.19" runoffpercent="100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraselD="3" aon=" 1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoffpercent-"0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="5848" stop="5871" startsite="5866" name="phil. IA" organismid=" l ">
<POLYMERASE polymeraselD="6" aon="6E7" aoff=" 18" ainiton="3.5" runoff_percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff=" 18" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start-="5923" stop="5946" startsite="5941" name="phil.IB" organism_id="1">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff-percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="l.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start-="6409" stop="6432" startsite="6427" name="phil.3" organismid=" 1">
<POLYMERASE polymeraselD="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7778" stop="7801" startsite="7796" name="phi1.5" organism id="1 ">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start-"7895" stop="7918" startsite="7913" name="phil.6" organismid="l">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
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</PROMOTER>
<PROMOTER start="9107" stop="9130" startsite="9125" name="phi2.5" organismid=" 1">
<POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start=" 1180" stop="11203" startsite=" 11198" name="phi3.8" organismid="l">
<POLYMERASE polymeraselD="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff=" 18" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="12671" stop="12694" startsite="12689" name="phi4c" organismid="1 ">
<POLYMERASE polymeraselD="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff=" 18" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start=" 13341" stop="13364" startsite=" 13359" name="phi4.3" organismid="1 ">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start=" 13915" stop=" 13938" startsite=" 13933" name="phi4.7" organismid=" ">
<POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="18545" stop="18568" startsite="18563" name="phi6.5" organism_id="1 ">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="70" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="21865" stop="21888" startsite="21883" name="phi9" organism_id="1">
<POLYMERASE polymeraseID="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoffpercent="42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start-="22904" stop="22927" startsite="22922" name="phil0" organism_id="l">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong=" 1.45"
arecyc="0.22" />
4PROMOTER>
<PROMOTER start="27274" stop="27297" startsite="27292" name="phi13" organismjd="l ">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="70" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start=:"34566" stop="34589" startsite="34584" name="phi 17" organism_id=" 1">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="39229" stop="39252" startsite="39247" name="phiOR" organismjid="l ">
<POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="70" aelong="5.8"
arecyc="0.88" />
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<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoffpercent-"42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<TERMINATOR start="7546" stop="7610" stopsite="7588" name="TE" organism="2">
<POLYMERASE ID="2" efficiency=" 1"/>
<POLYMERASE ID=-"3" efficiency="l" />
<POLYMERASE ID="4" efficiency="l" />
<POLYMERASE ID="5" efficiency="l" />
<POLYMERASE ID="6" efficiency="0" />
<POLYMERASE ID="7" efficiency="O" />
</TERMINATOR>
<TERMINATOR start="24158" stop="24230" stopsite="24209" name="Tphi" organism="1 ">
<POLYMERASE ID="2" efficiency="0" />
<POLYMERASE ID="3" efficiency="O" />
<POLYMERASE ID="4" efficiency="0" />
<POLYMERASE ID="5" efficiency="0" />
<POLYMERASE ID="6" efficiency="0.8" />
<POLYMERASE ID="7" efficiency="0.8" />
</TERMINATOR>
<RBS start="910" stop="925" startsite="925" initstepsize="50" elongstepsize="" strength="le7" stopsite="1278" protid="8"
initRateConstant-"0.3" mrnadeg="0" />
<RBS start=" 1262" stop="1277" startsite="1277" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="1433" protid="9"
initRateConstant="0.3" mmrnadeg="0" />
<RBS start="1454" stop="1469" startsite="1469" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="1639" protid="10"
initRateConstant="0.3" mmadeg="0" />
<RBS start-" 1621" stop=" 1636" startsite=" 1636" initstepsize="50" elongstepsize="" strength=" le7" stopsite-" 1797" protid=" ll"
initRateConstant="0.3" mmadeg="0" />
<RBS start="2006" stop="2021" startsite="2021" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="3100" protid="12"
initRateConstant="0.3" mmadeg="0" />
<RBS start-"3156" stop="3171" startsite="3171" initstepsize="50" elongstepsize="" strength=" I e7" stopsite="5822" protid="6"
initRateConstant="C0.3" mrnadeg="O" />
<RBS start-"5992" stop="6007" startsite="6007" initstepsize="50" elongstepsize="" strength="le7" stopsite="6135" protid="13"
initRateConstant-"0.3" mmadeg="0" />
<RBS start="6119" stop="6134" startsite="6134" initstepsize="50" elongstepsize="" strength=" le7" stopsite="6394" protid="14"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="6460" stop="6475" startsite="6475" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7554" protid="15"
initRateConstant="0.3" mmadeg="0" />
<RBS start="7593" stop="7608" startsite="7608" initstepsize="50" elongstepsize="" strength=" le7" stopsite="7763" protid="16"
initRateConstant="0.3" mmadeg="0" />
<RBS start="7776" stop="7791" startsite="7791" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7880" protid="17"
initRateConstant="0.3" mmadeg="0" />
<RBS start="7891" stop="7906" startsite="7906" initstepsize="50" elongstepsize="" strength=" le7" stopsite="8166" protid="18"
initRateConstant="0.3" mmadeg="0" />
<RBS start="8150" stop="8165" startsite="8165" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="8756" protid="19"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="8734" stop="8749" startsite="8749" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8895" protid="20"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="8879" stop="8894" startsite="8894" initstepsize="50" elongstepsize="" strength=" le7" stopsite="9092" protid="21"
initRateConstant="0.3" mmadeg="0" />
<RBS start="9136" stop="9152" startsite="9158" initstepsize="50" elongstepsize="" strength=" e7" stopsite="9856" protid="22"
initRateConstant="0.3" mrnadeg="0" />
<RBS start-"9840" stop="9855" startsite="9855" initstepsize="50" elongstepsize="" strength=" l1e7" stopsite=" 10276" protid="23"
initRateConstant="0.3" mmadeg="0" />
<RBS start="10242" stop="10257" startsite="10257" initstepsize="50" elongstepsize="" strength=" I e7" stopsite="10706" protid="24"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="10690" stop="10705" startsite=" 10705" initstepsize="50" elongstepsize="" strength="1e7" stopsite=" 11161" protid="25"
initRateConstant="0.3" mmadeg="0" />
<RBS start="11210" stop="11225" startsite="11225" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11590" protid="26"
initRateConstant="0.3" mmadeg="0" />
<RBS start-" 11550" stop="11565" startsite="11565" initstepsize="50" elongstepsize="" strength="le7" stopsite="13265" protid="27"
initRateConstant="0.3" mmadeg="0" />
<RBS start=" 12973" stop="12988" startsite="12988" initstepsize="50" elongstepsize="" strength=" le7" stopsite="13326" protid="28"
initRateConstant="0.3" mmadeg="O" />
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<RBS start-"13337" stop="13352" startsite="13352" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="13564" protid="29"
initRateConstant="0.3" mmadeg="0" />
<RBS start=" 13575" stop=" 13584" startsite="13584" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13853" protid="30"
initRateConstant="0.3" mrnadeg="0" />
<RBS start=" 13912" stop="13927" startsite="13927" initstepsize="50" elongstepsize="" strength="1e7" stopsite="14334" protid="31"
initRateConstant="0.3" mrnadeg="0" />
<RBS start=" 14338" stop="14353" startsite="14353" initstepsize="50" elongstepsize="" strength="le7" stopsite="16467" protid="32"
initRateConstant="0.3" mmadeg="O" />
<RBS start="16468" stop="16483" startsite="16483" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16838" protid="33"
initRateConstant="0.3" mmrnadeg="0" />
<RBS start=" 16839" stop="16851" startsite="16851" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="17159" protid="34"
initRateConstant="0.3" mrnadeg="0" />
<RBS start=" 17124" stop=" 17149" startsite=" 17149" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite=" 17359" protid="35"
initRateConstant="0.3" mmadeg="0" />
<RBS start=" 17343" stop="17358" startsite="17358" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="17517" protid="36"
initRateConstant="0.3" mmrnadeg="0" />
<RBS start="17489" stop="17504" startsite="17504" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="18406" protid="37"
initRateConstant="0.3" mmadeg="O" />
<RBS start-" 18379" stop="18394" startsite="18394" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="18507" protid="38"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="18590" stop="18605" startsite="18605" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="18859" protid="39"
initRateConstant="0.3" mmadeg="0" />
<RBS start-" 18860" stop="18864" startsite="18864" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="19131" protid="40"
initRateConstant="0.3" mrnadeg="0" />
<RBS start=" 19114" stop="19129" startsite=" 19130" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite=" 19531" protid="41"
initRateConstant="0.3" mrnadeg="0" />
<RBS start-" 19515" stop="19530" startsite="19530" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="19834" protid="42"
initRateConstant="0.3" mmadeg="0" />
<RBS start:="19835" stop="19848" startsite="19848" initstepsize="50" elongstepsize="" strength="1e7" stopsite="20240" protid="43"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="20224" stop="20239" startsite="20239" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="21850" protid="44"
initRateConstant="0.3" mmadeg="0" />
<RBS start="21935" stop="21950" startsite-"21950" initstepsize="50" elongstepsize="" strength="1e7" stopsite="22873" protid="45"
initRateConstant="0.3" mmrnadeg="0"/>
<RBS start="22942" stop="22967" startsite="22967" initstepsize="50" elongstepsize="" strength=" e7" stopsite="24004" protid="46"
initRateConstant="0.3" mmadeg="0" />
<RBS start="24213" stop="24228" startsite="24228" initstepsize="50" elongstepsize="" strength="le7" stopsite="24818" protid="47"
initRateConstant="0.3" mmadeg="O" />
<RBS start="24827" stop="24842" startsite="24842" initstepsize="50" elongstepsize="" strength=" e7" stopsite="27226" protid="48"
initRateConstant="0.3" mmadeg="0" />
<RBS start="27292" stop="27307" startsite="27307" initstepsize="50" elongstepsize="" strength="le7" stopsite="27723" protid="49"
initRateConstant="0.3" mrnadeg="O" />
<RBS start-"27707" stop="27722" startsite="27728" initstepsize="50" elongstepsize="" strength="le7" stopsite="28318" protid="50"
initRateConstant="0.3" mrnadeg="0" />
<RBS start-"28302" stop="28317" startsite="28325" initstepsize="50" elongstepsize="" strength="le7" stopsite="30568" protid="51"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="30580" stop="30595" startsite="30595" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="34551" protid="52"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="34609" stop="34624" startsite="34624" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36285" protid="53"
initRateConstant="0.3" mmadeg="0" />
<RBS start="36329" stop="36344" startsite="36344" initstepsize="50" elongstepsize="" strength="le7" stopsite="36547" protid="54"
initRateConstant="0.3" mmrnadeg="0" />
<RBS start="36531" stop="36546" startsite="36553" initstepsize="50" elongstepsize="" strength=" le7" stopsite="36822" protid="55"
initRateConstant="0.3" mmadeg="0" />
<RBS start="36902" stop="36917" startsite="36917" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="37348" protid="56"
initRateConstant="0.3" mmadeg="0" />
<RBS start="37355" stop="37370" startsite="37370" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39130" protid="57"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="39374" stop="39389" startsite="39389" initstepsize="50" elongstepsize="" strength=" le7" stopsite="39538" protid="58"
initRateConstant="0.3" mmadeg="0" />
</DNASYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
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Tabasco Input File for Initial Fit
<REQUEST>
<EXECUTE-SIMIJLATION runs=" 1" random_seed="34145" simulation_name="test-1" time_step="5" time_end="1500"
writeDNA="no" write_InitRNA="yes" write_Energy="yes" compDeg="yes">
<CELL volume="8e-16" polymerase_interaction_model="CUSTOM">
<RIBOSOME initialnumber-"10000" speed="45" footprint="40" />
<POLYMERASE n=" 1800" speed="45" id="2" organismid="2" footprint=" 15" name="coli Pol" />
<POLYMERASE n="0" speed="45" id="3" organism_id="2" footprint=" 15" name="coli Pol-P" />
<POLYMERASE n="O" speed="45" id="4" organism_id="2" footprint="15" name="coli Pol-2.0" />
<POLYMERASE n="0" speed="45" id="5" organismid="2" footprint="15" name="coli Pol-P-2.0" />
<POLYMERASE n="0" speed="230" id="6" organism_id=" 1" footprint=" 15" name="gp 1" />
<POLYMERASE n="O" speed="230" id="7" organismid="1" footprint=" 15" name="gpl-3.5" />
<SPECIES name="gp0.3" n="O" ID="8" organism=" " />
<SPECIES name=" gp0.4" n="O" ID="9" organism="l" 1"/>
<SPECIES name="gp0.5" n="O" ID="10" organism="l" />
<SPECIES name="gp0.6A" n="O" ID="11" organism="l" />
<SPECIES name="gp0.7" n="O" ID="12" organism="l" />
<SPECIES name="gpl.1" n="O" ID=" 13" organism="l" />
<SPECIES name="gpl.2" n="O" ID="14" organism="l" 1"/>
<SPECIES name="gpl.3" n="O" ID="15" organism="l" />
<SPECIES name="gpl.4" n="O" ID="16" organism="l" />
<SPECIES name="gpl.5" n="O" ID="17" organism="1" />
<SPECIES name="gpl.6" n="O" ID="18" organism="l" />
<SPECIES name="gpl.7" n="O" ID="19" organism=" " />
<SPECIES name="gpl.8" n="O" ID="20" organism="l" />
<SPECIES name="gp2.0" n="0" ID="21" organism="l" />
<SPECIES name="gp2.5" n="O" ID="22" organism="l" I/>
<SPECIES name="gp2.8" n="O" ID="23" organism=" " />
<SPECIES name="gp3.0" n="O" ID="24" organism="l" 1"/>
<SPECIES name="gp3.5" n="O" ID="25" organism=" "/>
<SPECIES name="gp3.8" n="O" ID="26" organism="l" />
<SPECIES name="gp4A" n="O" ID="27" organism="l" />
<SPECIES name="gp4.2" n="O" ID="28" organism="l" />
<SPECIES name="gp4.3" n="O" ID="29" organism="l" />
<SPECIES name="gp4.5" n="O" ID="30" organism="1" />
<SPECIES name="gp4.7" n="O" ID="31" organism=" " />
<SPECIES name="gp5.0" n="O" ID="32" organism="l" />
<SPECIES name="gp5.3" n="O" ID="33" organism="l" />
<SPECIES name="gp5.5" n="0" ID="34" organism="" />
<SPECIES name="gp5.7" n="O" ID="35" organism="l" />
<SPECIES name="g;p5.9" n="O" ID="36" organism="l" />
<SPECIES name="gp6.0" n="O" ID=-"37" organism="1" />
<SPECIES name="gp6.3" n="0" ID="38" organism=" 1" />
<SPECIES name="gp6.5" n="0" ID="39" organism="l" />
<SPECIES name="gp6.7" n="O" ID="40" organism="l" />
<SPECIES name="gp7" n="O" ID="41" organism="l" />
<SPECIES name="gp7.3" n="0" ID="42" organism="l" />
<SPECIES name="gp7.7" n="O" ID="43" organism="l" />
<SPECIES name="gp8" n="0" ID="44" organism="l" />
<SPECIES name="gp9" n="O" ID="45" organism=" " />
<SPECIES name="gpl0A" n="O" ID="46" organism="l" />
<SPECIES name="gpll" n="0" ID="47" organism=" 1" />
<SPECIES name="gpl2" n="O" ID="48" organism="l" />
<SPECIES name="gpl3" n="O" ID="49" organism="l" />
<SPECIES name="gpl4" n="O" ID="50" organism="l" I/>
<SPECIES name="gpl5" n="O" ID="51" organism=" " />
<SPECIES name="gpl6" n="O" ID="52" organism="1" />
<SPECIES name="gp17" n="O" ID="53" organism=" " />
<SPECIES name="gpl7.5" n="0" ID="54" organism="l" />
<SPECIES name="gpl8" n="O" ID="55" organism="l" />
<SPECIES name="gpl8.5" n="O" ID="56" organism="1" />
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<SPECIES name="'gpl9" n="O" ID="57" organism="l" />
<SPECIES name="gpl9.5" n="O" ID="58" organism="l" />
<REACTIONS>
<REACTION>
12+2>3+11 ;3.8E7
</REACTION>
<REACTION>
12+4>5+11;3.8E7
</REACTION>
<REACTION>
21+2>4;3.8E7
</REACTION>
<REACTION>
21+3>5;3.8E7
</REACTION>
<REACTION>
4>21+2;1.1
</REACTION>
<REACTION>
5>21+3;1.1
</REACTION>
<REACTION>
25+6>7;3.8E7
</REACTION>
<REACTION>
7>6+25;3.5
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phagel" genome_length="39937" copynumber=-"3" entry_rate_constant="70" entry_offsite="850">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organismid="l ">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="498" stop="548" startsite="542" name="Al" organism_id="2">
<POLYMERASE polymeraseID="2" aon= "l1.5e7" aoff=".28" ainiton="0.19" runoff_percent=" 100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.19" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent-"0" aelong="O" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoffpercent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="626" stop="676" startsite="670" name="A2" organism_id="2">
<POLYMERASE polymeraselD="2" aon="l.5e7" aoff=".28" ainiton="0.19" runoff_percent=" 100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraselD="3" aon="l.5e7" aoff=".28" ainiton="0.19" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="750" stop="800" startsite="794" name="A3" organism_id="2">
<POLYMERASE polymeraselD="2" aon=" 1.5e7" aoff=".28" ainiton="0.19" runoff_percent=" 100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraselD="3" aon="1.5e7" aoff=".28" ainiton="0. 19" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start-="1514" stop=" 1564" startsite="1558" name="B" organism_id="2">
<POLYMERASE polymeraseID="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoffpercent="100" aelong="6"
arecyc="0"/>
<POLYMIERASE polymeraselD="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoffpercent="70" aelong="6"
arecyc="0.19"/>
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<POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent-"0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="O" arecyc="0"/>
</PROMOTER>
<PROMOTER start="3113" stop="3163" startsite="3157" name="C" organism_id="2">
<POLYMERASE polymeraseD=-"2" aon=" 1.5e7" aoff="2.8" ainiton="0.19" runoffpercent=" 100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraselD="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="5848" stop="5871" startsite="5866" name="phi 1.1A" organismid="1">
<POLYMERASE polymeraseID="6" aon="6E7" aoff=" 18" ainiton="3.5" runoff_percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoffpercent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="5923" stop="5946" startsite="5941" name="phil.1B" organism_id="l">
<POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start--"6409" stop="6432" startsite="6427" name="phil.3" organismid=" 1">
<POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff=" 18" ainiton="0.875" runoff_percent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7778" stop="7801" startsite="7796" name="phi 1.5" organismid="1 ">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent"l18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7895" stop="7918" startsite="7913" name="phi1.6" organismid="1 ">
<POLYMERASE polymeraselD="6" aon=" .82e8" aoff="0.2" ainiton="3.5" runoffpercent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="9107" stop="9130" startsite="9125" name="phi2.5" organismid="l ">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff.percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff.percent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start=" 11180" stop="11203" startsite="11198" name="phi3.8" organismid="1">
<POLYMIvERASE polymeraselD="6" aon="6e7" aoff="18" ainiton="3.5" runoffpercent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="12671" stop="12694" startsite=" 12689" name="phi4c" organism_id="1">
<POLYMERASE polymeraselD="6" aon="6e7" aoff="18" ainiton="3.5" runoffpercent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff=" 18" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start=" 13341" stop="13364" startsite="13359" name="phi4.3" organismid="1 ">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent=" 18" aelong="l.45"
arecyc="0.22" />
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</PROMOTER>
<PROMOTER start-=" 13915" stop="13938" startsite=" 13933" name="phi4.7" organismid=" ">
<POLYMERASE polymeraselD="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff=" 18" ainiton="0.875" runoffpercent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="18545" stop="18568" startsite="18563" name="phi6.5" organism-id="l ">
<POLYMERASE polymeraseID="6" aon="l.82e8" aoff="0.2" ainiton="3.5" runoffpercent="70" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent-"42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="21865" stop="21888" startsite="21883" name="phi9" organismid="1 ">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong=" 1.45"
arecyc="0.22" 1/>
</PROMOTER>
<PROMOTER starl="22904" stop="22927" startsite="22922" name="phil0" organism_id="1 ">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent="42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="27274" stop="27297" startsite="27292" name="phil3" organismid="1">
<POLYMERASE polymeraselD="6" aon="l.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="34566" stop="34589" startsite="34584" name="phil7" organism_id=" ">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="70" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="39229" stop="39252" startsite="39247" name="phiOR" organismid="l">
<POLYMERASE polymeraseID="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8"
arecyc="0.88" />
<POLYMIERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent-"42" aelong="1.45"
arecyc="0.22" />
4<PROMOTER>
<TERMINATOR start="7546" stop="7610" stopsite="7588" name="TE" organism="2">
<POLYMERASE ID="2" efficiency=" I"/>
<POLYMERASE ID="3" efficiency="l" />
<POLYMERASE ID="4" efficiency="l" />
<POLYMERASE ID="5" efficiency="1" />
<POLYMERASE IDI"6" efficiency="0"/>
<POLYMERASE ID="7" efficiency="O" />
</TERMINATOR>
<TERMINATOR start="24158" stop="24230" stopsite="24209" name="Tphi" organism="l ">
<POLYMERASE ID="2" efficiency="O"/>
<POLYMERASE ID="3" efficiency="0" />
<POLYMERASE ID="4" efficiency="O" />
<POLYMERASE ID="5" efficiency="O" />
<POLYMERASE ID="6" efficiency="0.8" />
<POLYMERASE ID="7" efficiency="0.8" />
</TERMINATOR>
<RBS start="910" stop="925" startsite="925" initstepsize="50" elongstepsize="" strength=" e7" stopsite="1278" protid="8"
initRateConstant="0.:3" mrnadeg="4.17e-3" />
<RBS start="1262" stop="1277" startsite="1277" initstepsize="50" elongstepsize="" strength="1e7" stopsite-"1433" protid="9"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=" 1454" stop="1469" startsite="1469" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1639" protid=" 0"
initRateConstant="0.3" mrnadeg="4.17e-3"/>
<RBS start=-"1621" stop="1636" startsite="1636" initstepsize="50" elongstepsize="" strength=" I e7" stopsite="1797" protid=" l"
initRateConstant="0.3" mmrnadeg="4.17e-3" />
<RBS start="2006" stop="2021" startsite="2021" initstepsize="50" elongstepsize="" strength="1e7" stopsite="3100" protid="12"
initRateConstant-"0.3" mmadeg="8.33e-3" />
<RBS start="3156" stop="3171" startsite="3171" initstepsize="50" elongstepsize="" strength="1e7" stopsite="5822" protid="6"
initRateConstant="0.3" mmadeg="4.17e-3" />
<RBS start-"5992" stop="6007" startsite="6007" initstepsize="50" elongstepsize="" strength="le7" stopsite="6135" protid="13"
initRateConstant="0.3" mrnadeg=" 1.11 e-3" />
<RBS start="6119" stop="6134" startsite="6134" initstepsize="50" elongstepsize="" strength=" e7" stopsite="6394" protid="14"
initRateConstant="0.3" mmrnadeg="2.38e-3" />
<RBS start="6460" stop="6475" startsite="6475" initstepsize="50" elongstepsize="" strength=" le7" stopsite="7554" protid="15"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="7593" stop="7608" startsite="7608" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="7763" protid="16"
initRateConstant="0.3" mmadeg="5.56e-3" />
<RBS start="7776" stop="7791" startsite="7791" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="7880" protid="17"
initRateConstant="0.3" mrnadeg="4.17e-3" >
<RBS start="7891" stop="7906" startsite="7906" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8166" protid="18"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start-"8150" stop="8165" startsite="8165" initstepsize="50" elongstepsize="" strength=" Ie7" stopsite="8756" protid="19"
initRateConstant="0.3" mmadeg="2.08e-3" />
<RBS start="8734" stop="8749" startsite="8749" initstepsize="50" elongstepsize="" strength=" e7" stopsite="8895" protid="20"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="8879" stop="8894" startsite="8894" initstepsize="50" elongstepsize="" strength="le7" stopsite="9092" protid="21"
initRateConstant="0.3" mmadeg="0" I>
<RBS start="9136" stop="9152" startsite="9158" initstepsize="50" elongstepsize="" strength="le7" stopsite="9856" protid="22"
initRateConstant="0.3" mrnadeg=" 1.19e-3" >
<RBS start="9840" stop="9855" startsite="9855" initstepsize="50" elongstepsize="" strength="le7" stopsite="10276" protid="23"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="10242" stop="10257" startsite="10257" initstepsize="50" elongstepsize="" strength=" e7" stopsite="10706" protid="24"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=" 10690" stop="10705" startsite="10705" initstepsize="50" elongstepsize="" strength=" Ie7" stopsite="11161" protid="25"
initRateConstant="0.3" mrnadeg=" 1.19e-3" />
<RBS start="11210" stop="11225" startsite=" 11225" initstepsize="50" elongstepsize="" strength=" e7" stopsite="11590" protid="26"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start-" 11550" stop=" 11565" startsite=" 11565" initstepsize="50" elongstepsize="" strength=" le7" stopsite=" 13265" protid="27"
initRateConstant="0.3" mrnadeg="4.17e-3" I/>
<RBS start="12973" stop="12988" startsite="12988" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="13326" protid="28"
initRateConstant-"0.3" mrnadeg="4.17e-3" />
<RBS start="13337" stop="13352" startsite="13352" initstepsize="50" elongstepsize="" strength=" e7" stopsite="13564" protid="29"
initRateConstant="0.3" mrnadeg="4.17e-3"/>
<RBS start=" 13575" stop="13584" startsite="13584" initstepsize="50" elongstepsize="" strength="le7" stopsite="13853" protid="30"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="13912" stop="13927" startsite="13927" initstepsize="50" elongstepsize="" strength=" e7" stopsite="14334" protid="31"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=" 14338"' stop="14353" startsite="14353" initstepsize="50" elongstepsize="" strength=" e7" stopsite="16467" protid="32"
initRateConstant="0.3" mrnadeg="3.33e-3" />
<RBS start=" 16468" stop="16483" startsite="16483" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="16838" protid="33"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="16839" stop="16851" startsite="16851" initstepsize="50" elongstepsize="" strength=" e7" stopsite="17159" protid="34"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start-="17124" stop="17149" startsite="17149" initstepsize="50" elongstepsize="" strength=" e7" stopsite="17359" protid="35"
initRateConstant"0..3" mrnadeg="4.17e-3" />
<RBS start="17343" stop="17358" startsite="17358" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="17517" protid="36"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="17489" stop="17504" startsite="17504" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18406" protid="37"
initRateConstant="0.3" mmadeg="2.38e-3" />
<RBS start="18379" stop="18394" startsite="18394" initstepsize="50" elongstepsize="" strength=" e7" stopsite="18507" protid="38"
initRateConstant-"0.3" mrnadeg="4.17e-3" />
<RBS start="18590" stop="18605" startsite="18605" initstepsize="50" elongstepsize="" strength=" e7" stopsite="18859" protid="39"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=" 18860" stop="18864" startsite="18864" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="19131" protid="40"
initRateConstant="0.3" mmrnadeg="5.56e-3" />
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<RBS start=" 19114" stop="19129" startsite="19130" initstepsize="50" elongstepsize="" strength="le7" stopsite="19531" protid="41"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start=" 19515" stop="19530" startsite="19530" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="19834" protid="42"
initRateConstant="0.3" mmadeg="5.56e-3" />
<RBS start="19835" stop="19848" startsite-"19848" initstepsize="50" elongstepsize="" strength="le7" stopsite="20240" protid="43"
initRateConstant-"0.3" mrnadeg="5.56e-3"/>
<RBS start-"20224" stop="20239" startsite="20239" initstepsize="50" elongstepsize="" strength="le7" stopsite="21850" protid="44"
initRateConstant="0.3" mmrnadeg="5.56e-3" />
<RBS start="21935" stop="21950" startsite="21950" initstepsize="50" elongstepsize="" strength="le7" stopsite="22873" protid="45"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="22942" stop="22967" startsite="22967" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="24004" protid="46"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24213" stop="24228" startsite="24228" initstepsize="50" elongstepsize="" strength="le7" stopsite="24818" protid="47"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24827" stop="24842" startsite="24842" initstepsize="50" elongstepsize="" strength="le7" stopsite="27226" protid="48"
initRateConstant="0.3" mmadeg="5.56e-3" />
<RBS start="27292" stop="27307" startsite="27307" initstepsize="50" elongstepsize="" strength=" e7" stopsite="27723" protid="49"
initRateConstant="0.3" mrnadeg="5.56e-3" 1>
<RBS start="27707" stop="27722" startsite="27728" initstepsize="50" elongstepsize="" strength="1e7" stopsite-"28318" protid="50"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="28302" stop="28317" startsite="28325" initstepsize="50" elongstepsize="" strength="1e7" stopsite="30568" protid="51"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="30580" stop="30595" startsite="30595" initstepsize="50" elongstepsize="" strength="1e7" stopsite="34551" protid="52"
initRateConstant-"0.3" mmadeg="1.19e-3" />
<RBS start="34609" stop="34624" startsite="34624" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="36285" protid="53"
initRateConstant="0.3" mmadeg="5.56e-3" />
<RBS start-"36329" stop="36344" startsite="36344" initstepsize="50" elongstepsize="" strength="le7" stopsite="36547" protid="54"
initRateConstant="0.3" mrnadeg="0" />
<RBS start-"36531"' stop="36546" startsite="36553" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="36822" protid="55"
initRateConstant-="C.3" mrnadeg="5.56e-3" />
<RBS start-"36902" stop="36917" startsite="36917" initstepsize="50" elongstepsize="" strength="1e7" stopsite="37348" protid="56"
initRateConstant="C'.3" mrnadeg="4.17e-3" />
<RBS start="37355" stop="37370" startsite="37370" initstepsize="50" elongstepsize="" strength="le7" stopsite="39130" protid="57"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="39374" stop="39389" startsite="39389" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39538" protid="58"
initRateConstant="0.3" mmadeg="5.56e-3" />
</IDNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
Tabasco Input File for Increased Promoter Strength Fits
<REQUEST>
<EXECUTE-SIMUIATION runs="1" random_seed="34145" simulation_name="test-1" time_step="5" time_end="1500"
write_DNA="no" write_InitRNA="yes" writeEnergy="yes" compDeg="yes">
<CELL volume="8e-16" polymerase_interaction..model="CUSTOM">
<RIBOSOME initial_number=-"10000" speed="45" footprint="40" />
<POLYMERASE n=" 1800" speed="45" id="2" organismid="2" footprint=" 15" name="coli Pol" />
<POLYMERASE n="O" speed="45" id="3" organismid="2" footprint="15" name="coli Pol-P" />
<POLYMERASE n="O" speed="45" id="4" organismid="2" footprint=" 15" name="coli Pol-2.0" />
<POLYMERASE n="O" speed="45" id="5" organism_id="2" footprint=" 15" name="coli Pol-P-2.0" />
<POLYMERASE n="O" speed="230" id="6" organismid="l" footprint="15" name="gpl" />
<POLYMERASE n="O" speed="230" id="7" organism_id="1" footprint=" 15" name="gp1-3.5" />
<SPECIES name="gp0.3" n="O" ID="8" organism="l" />
<SPECIES name="gpl0.4" n="O" ID="9" organism=" "/>
<SPECIES name="gp0.5" n="O" ID="10" organism="l" 1"/>
<SPECIES name="gp0.6A" n="O" ID=-"I " organism="l" />
<SPECIES name="gp0.7" n="O" ID="12" organism=" " />
<SPECIES name="gpl 1.1" n="O" ID=" 13" organism="l" />
<SPECIES name="gpl.2" n="O" ID="14" organism="l" />
<SPECIES name="gpl.3" n="O" ID="15" organism="l" />
<SPECIES name="gpl.4" n="O" ID="16" organism="l" />
<SPECIES name="gpl.5" n="O" ID="17" organism="" I/>
<SPECIES name="gpl.6" n="O" ID="18" organism="l" />
<SPECIES name="gpl.7" n="O" ID="19" organism="1" />
<SPECIES name="gpl.8" n="O" ID="20" organism="l" />
<SPECIES name="gp2.0" n="O" ID="21" organism=" 1" />
<SPECIES name="gp2.5" n="O" ID="22" organism= " l"/>
<SPECIES name="gp2.8" n="O" ID="23" organism="1" />
<SPECIES name="gp3.0" n="O" ID="24" organism="1" />
<SPECIES name="gp3.5" n="O" ID="25" organism="l" I/>
<SPECIES name="gp3.8" n="O" ID="26" organism="l" />
<SPECIES name="gp4A" n="O" ID="27" organism="1" />
<SPECIES name='gp4.2 " n="O" ID="28" organism="1" />
<SPECIES name="gp4.3" n="O" ID="29" organism="l" />
<SPECIES name="gp4.5" n="O" ID="30" organism="l" />
<SPECIES name="gp4.7" n="O" ID="31" organism="l" />
<SPECIES name="gp5.0" n="O" ID="32" organism="1" />
<SPECIES name="gp5.3" n="O" ID="33" organism="l" />
<SPECIES name="gp5.5" n="O" ID="34" organism="l" />
<SPECIES name="gp5.7" n="O" ID="35" organism="l" />
<SPECIES name="gp5.9" n="O" ID="36" organism=" 1 " />
<SPECIES name="gp6.0" n="O" ID="37" organism="1" />
<SPECIES name="gp6.3" n="O" ID="38" organism="l" />
<SPECIES name="gp6.5" n="O" ID="39" organism="l" />
<SPECIES name="gp6.7" n="O" ID="40" organism=" 1" />
<SPECIES name="gp7" n="O" ID="41" organism="l" 1 />
<SPECIES name="gp7.3" n="O" ID="42" organism="l" />
<SPECIES name="gp7.7" n="O" ID="43" organism="l" />
<SPECIES name="gp8" n="O" ID="44" organism="l" />
<SPECIES name="gp9" n="O" ID="45" organism="l" />
<SPECIES name="gpl0A" n="O" ID="46" organism=" " />
<SPECIES name="gpll" n="O" ID="47" organism="l" />
<SPECIES name="gpl2" n="O" ID="48" organism="l" />
<SPECIES name="gpl3" n="O" ID="49" organism="l" />
<SPECIES name="gpl4" n="O" ID="50" organism= " I"/>
<SPECIES name="gpl5" n="O" ID="51" organism="1" />
<SPECIES name="gpl6" n="O" ID="52" organism="l" />
<SPECIES name="gpl7" n="O" ID="53" organism="l" />
<SPECIES name="gp17.5" n="O" ID="54" organism="l" />
<SPECIES name="gpl8" n="O" ID="55" organism="1" />
<SPECIES name="gp18.5" n="O" ID="56" organism="I" />
<SPECIES name="gpl9" n="O" ID="57" organism="l" />
<SPECIES name="gp19.5" n="O" ID="58" organism="l" />
<REACTIONS>
<REACTION>
12+2>3+11 ;3.8E7
</REACTION>
<REACTION>
12+4>5+11;3.8E7
</REACTION>
<REACTION>
21+2>4;3.8E7
</REACTION>
<REACTION>
21+3>5;3.8E7
</REACTION>
<REACTION>
4>21+2;1.1
</REACTION>
<REACTION>
5>21+3;1.1
</REACTION>
<REACTION>
25+6>7;3.8E7
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</REACTION>
<REACTION>
7>6+25;3.5
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phagel" genome_length="39937" copy_number="3" entry_rate_constant="70" entry_offsite="850">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism_id=" 1">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="498" stop="548" startsite="542" name="A1l" organism_id="2">
<POLYMERASE polymeraselD="2" aon=" 1.5e7" aoff=".28" ainiton="0.4" runoff_percent=" 100" aelong="6" arecyc="0"/
<POLYMERASE polymeraselD="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraselD=-"4" aon="0" aoff="0" ainiton="O" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoff_percent="O" aelong="0" arecyc="O"/>
</PROMOTER>
<PROMOTER start="626" stop="676" startsite="670" name="A2" organism_id="2">
<POLYMERASE polymeraselD="2" aon=" 1.5e7" aoff=".28" ainiton="0.4" runoff_percent=" 100" aelong="6" arecyc="0"/
<POLYMERASE polymeraselD="3" aon="l.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoff_percent="O" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER star=-"750" stop="800" startsite="794" name="A3" organism_id="2">
<POLYIMERASE polymeraselD="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoffpercent="100" aelong="6" arecyc="0"/
<POLYMERASE polymeraselD="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoffpercent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start=" 1514" stop=" 1564" startsite=" 1558" name="B" organism_id="2">
<POLYMERASE polymeraselD="2" aon="l .5e7" aoff="2.8" ainiton="0.19" runoff_percent=" 100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraselD="3" aon=" 1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoffpercent="0" aelong="O" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoffpercent-"0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="3113" stop="3163" startsite="3157" name="C" organism_id="2">
<POLYMERASE polymeraselD="2" aon=" 1.5e7" aoff="2.8" ainiton="0.19" runoff_percent=" 100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraselD="3" aon=" 1.5e7" aoff="2.8" ainiton="0.19" runoffpercent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoffpercent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="5848" stop="5871" startsite="5866" name="phil.1A" organism_id=" ">
<POLYMERASE polymeraselD="6" aon="6E7" aoff=" 18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff="18" ainiton="0.875" runoffpercent="18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start-="5923" stop="5946" startsite="5941" name="phi l.1B" organismjid=" ">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
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<PROMOTER start="6409" stop="6432" startsite="6427" name="phi1.3" organism_id="1 ">
<POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoffpercent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7778" stop="7801" startsite="7796" name="phi 1.5" organismid="l ">
<POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7895" stop="7918" startsite="7913" name="phi1.6" organismid="1">
<POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoffpercent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="9107" stop="9130" startsite="9125" name="phi2.5" organismid="l">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent-"l18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER stavrt"ll 180" stop="11203" startsite=" 11198" name="phi3.8" organismjid="1">
<POLYMERASE polymeraseD=-"6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff=" 18" ainiton="0.875" runoff_percent" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER starl="12671" stop="12694" startsite="12689" name="phi4c" organism_id="1">
<POLYMERASE polymeraselD="6" aon="6e7" aoff="18" ainiton="3.5" runoffpercent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13341" stop=" 13364" startsite=" 13359" name="phi4.3" organism_id="1 ">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID=-"7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoffpercent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13915" stop="13938" startsite="13933" name="phi4.7" organismid="l">
<POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff.percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff="18" ainiton="0.875" runoffpercent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start=" 18545" stop=" 18568" startsite="18563" name="phi6.5" organism_id="1 ">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent=" 100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="21865" stop="21888" startsite="21883" name="phi9" organismid="l ">
<POLYMERASE polymeraselD="6" aon=" .82e8" aoff="0.2" ainiton="3.5" runoff.percent=" 100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff-percent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="22904" stop="22927" startsite="22922" name="phi 10" organismjd="1">
<POLYMERASE polymeraselD="6" aon="l.82e8" aoff="0.2" ainiton="3.5" runoff_percent=" 100" aelong="5.8"
arecyc="0.88" />
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<POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="27274" stop="27297" startsite="27292" name="phi 13" organism_id="1">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent=" 100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff-percent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="34566" stop="34589" startsite="34584" name="phil7" organismid="l">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent=" 100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff-percent-"42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="39229" stop="39252" startsite="39247" name="phiOR" organism_id=" ">
<POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<TERMINATOR start-"7546" stop="7610" stopsite-"7588" name="TE" organism="2">
<POLYMERASE ID="2" efficiency=" 1"/>
<POLYMERASE ID="3" efficiency="1l"/>
<POLYMERASE I:D="4" efficiency="l" />
<POLYMERASE ID="5" efficiency="1" />
<POLYMERASE I:D="6" efficiency="0" />
<POLYMERASE ID="7" efficiency="0" />
</TERMINATOR>
<TERMINATOR start="24158" stop="24230" stopsite="24209" name="Tphi" organism="l">
<POLYMERASE ID="2" efficiency="0" />
<POLYMERASE ID="3" efficiency="0" />
<POLYMERASE ID="4" efficiency="0" />
<POLYMERASE ID="5" efficiency="0" />
<POLYMERASE ID="6" efficiency="0.8" />
<POLYMERASE ID="7" efficiency="0.8" />
</TERMINATOR>
<RBS start-"910" stop="925" startsite="925" initstepsize="50" elongstepsize="" strength=" le7" stopsite="1278" protid="8"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="1262" stop="1277" startsite="1277" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1433" protid="9"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="1454" stop="1469" startsite="1469" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="1639" protid="10"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="1621" stop="1636" startsite="1636" initstepsize="50" elongstepsize="" strength=" e7" stopsite="1797" protid="ll"
initRateConstant="0.3" mmadeg="5.56e-3" />
<RBS start="2006" stop="2021" startsite="2021" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="3100" protid="12"
initRateConstant="0.3" mrnadeg="8.33e-3"/>
<RBS start-"3156" stop="3171" startsite="3171" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="5822" protid="6"
initRateConstant="0.3" mrnadeg="4.17e-3"/>
<RBS start="5992" stop="6007" startsite="6007" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6135" protid="13"
initRateConstant="0.3" mrnadeg=" 1.85e-3" />
<RBS start="6119" stop="6134" startsite="6134" initstepsize="50" elongstepsize="" strength="le7" stopsite="6394" protid="14"
initRateConstant="C'.3" mrnadeg="2.78e-3"/>
<RBS start="6460" stop="6475" startsite="6475" initstepsize="50" elongstepsize="" strength="le7" stopsite="7554" protid="15"
initRateConstant="01.3" mrnadeg="5.56e-3" />
<RBS start="7593" stop="7608" startsite="7608" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="7763" protid="16"
initRateConstant=-"0.3" mrnadeg="5.56e-3" />
<RBS start="7776" stop="7791" startsite="7791" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="7880" protid="17"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start"7891" stop="7906" startsite="7906" initstepsize="50" elongstepsize="" strength=" le7" stopsite="8166" protid="18"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start-"8150" stop="8165" startsite="8165" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8756" protid="19"
initRateConstant="0.3" mrnadeg="2.78e-3" />
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<RBS start="8734" stop="8749" startsite="8749" initstepsize="50" elongstepsize="" strength="le7" stopsite="8895" protid="20"
initRateConstant=-"0.3" mmadeg="4.17e-3" />
<RBS start="8879" stop="8894" startsite="8894" initstepsize="50" elongstepsize="" strength=" e7" stopsite="9092" protid="21"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="9136" stop="9152" startsite="9158" initstepsize="50" elongstepsize="" strength="1e7" stopsite="9856" protid="22"
initRateConstant="0.3" mrnadeg="1.52e-3" />
<RBS start="9840" stop="9855" startsite="9855" initstepsize="50" elongstepsize="" strength=" le7" stopsite="10276" protid="23"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="10242" stop="10257" startsite="10257" initstepsize="50" elongstepsize="" strength=" e7" stopsite="10706" protid="24"
initRateConstant="0.3" mrnadeg="4.17e-3"/>
<RBS start="10690" stop="10705" startsite="10705" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11161" protid="25"
initRateConstant="0.3" mmadeg=" 1.19e-3" />
<RBS start-" 11210" stop=" 11225" startsite=" 11225" initstepsize="50" elongstepsize="" strength="le7" stopsite=" 11590" protid="26"
initRateConstant="0.3" mmadeg="4.17e-3" />
<RBS start="11550" stop="11565" startsite="11565" initstepsize="50" elongstepsize="" strength=" e7" stopsite="13265" protid="27"
initRateConstant="0.3" mrnadeg="4.17e-3"/>
<RBS start="12973" stop="12988" startsite="12988" initstepsize="50" elongstepsize="" strength="le7" stopsite="13326" protid="28"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="13337" stop="13352" startsite="13352" initstepsize="50" elongstepsize="" strength="le7" stopsite="13564" protid="29"
initRateConstant=" .3" mmadeg="4.17e-3"/>
<RBS start="13575" stop="13584" startsite="13584" initstepsize="50" elongstepsize="" strength=" e7" stopsite="13853" protid="30"
initRateConstant="0.3" mmadeg="4.17e-3"/>
<RBS start=" 13912." stop=" 13927" startsite=" 13927" initstepsize="50" elongstepsize="" strength=" Ie7" stopsite=" 14334" protid="31"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=" 14338" stop=" 14353" startsite=" 14353" initstepsize="50" elongstepsize="" strength=" I e7" stopsite=" 16467" protid="32"
initRateConstant="0.3" mmadeg="3.33e-3" />
<RBS start="16468" stop="16483" startsite="16483" initstepsize="50" elongstepsize="" strength=" e7" stopsite="16838" protid="33"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="16839" stop="16851" startsite="16851" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17159" protid="34"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=" 17124" stop="17149" startsite="17149" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="17359" protid="35"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=" 17343" stop="17358" startsite="17358" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17517" protid="36"
initRateConstant="0.3" mrnadeg="4.17e-3"/>
<RBS start="17489" stop="17504" startsite="17504" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="18406" protid="37"
initRateConstant="0.3" mmadeg="2.78e-3" />
<RBS start=" 18379" stop="18394" startsite="18394" initstepsize="50" elongstepsize="" strength="le7" stopsite="18507" protid="38"
initRateConstant="0.3" mmadeg="4.17e-3" />
<RBS start="18590" stop="18605" startsite="18605" initstepsize="50" elongstepsize="" strength=" le7" stopsite="18859" protid="39"
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start-" 18860" stop="18864" startsite="18864" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="19131" protid="40"
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start=" 19114" stop="19129" startsite=" 19130" initstepsize="50" elongstepsize="" strength=" e7" stopsite=" 19531" protid="41"
initRateConstant="0.3" mrnadeg="2.38e-3"/>
<RBS start="19515" stop="19530" startsite="19530" initstepsize="50" elongstepsize="" strength=" e7" stopsite="19834" protid="42"
initRateConstant="0.3" mmadeg="2.38e-3" />
<RBS start-"19835" stop="19848" startsite="19848" initstepsize="50" elongstepsize="" strength=" e7" stopsite="20240" protid="43"
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="20224"' stop="20239" startsite="20239" initstepsize="50" elongstepsize="" strength=" e7" stopsite="21850" protid="44"
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start-"21935" stop="21950" startsite="21950" initstepsize="50" elongstepsize="" strength="le7" stopsite="22873" protid="45"
initRateConstant="C0.3" mrnadeg="0" />
<RBS start-"22942" stop="22967" startsite="22967" initstepsize="50" elongstepsize="" strength="le7" stopsite-"24004" protid="46"
initRateConstant="01.3" mmrnadeg="0" />
<RBS start="24213" stop="24228" startsite="24228" initstepsize="50" elongstepsize="" strength=" e7" stopsite="24818" protid="47"
initRateConstant="0.3" mrnadeg="0"/>
<RBS start="24827" stop="24842" startsite="24842" initstepsize="50" elongstepsize="" strength=" le7" stopsite="27226" protid="48"
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="27292" stop="27307" startsite="27307" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="27723" protid="49"
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="27707" stop="27722" startsite="27728" initstepsize="50" elongstepsize="" strength=" e7" stopsite="28318" protid="50"
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="28302" stop="28317" startsite="28325" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="30568" protid="51"
initRateConstant="0.3" mrnadeg="0"/>
<RBS start="30580" stop="30595" startsite="30595" initstepsize="50" elongstepsize="" strength="1e7" stopsite="34551" protid="52"
initRateConstant="0.3" mmadeg="1.67e-3" />
<RBS start="34609" stop="34624" startsite="34624" initstepsize="50" elongstepsize="" strength=" le7" stopsite="36285" protid="53"
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="36329" stop="36344" startsite-"36344" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36547" protid="54"
initRateConstant-"0.3" mmadeg="O" />
<RBS start="365311" stop="36546" startsite="36553" initstepsize="50" elongstepsize="" strength=" e7" stopsite="36822" protid="55"
initRateConstant="0.3" mmadeg="2.38e-3" />
<RBS start="36902" stop="36917" startsite="36917" initstepsize="50" elongstepsize="" strength="1e7" stopsite="37348" protid="56"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start-"37355" stop="37370" startsite="37370" initstepsize="50" elongstepsize="" strength="le7" stopsite="39130" protid="57"
initRateConstant="0.3" mmadeg="2.38e-3" />
<RBS start="39374" stop="39389" startsite="39389" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39538" protid="58"
initRateConstant="0.3" mrnadeg="2.38e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
Tabasco Input File for Alternative Degradation Fitst
<REQUEST>
<EXECUTE-SIMULATION runs=" " random_seed="34145" simulation_name="test-1" timestep="5" time_end="1500"
write_DNA="no" write_InitRNA="yes" write_Energy="yes" compDeg="no">
<CELL volume="8e-16" polymerase_interaction_model="CUSTOM">
<RIBOSOME initiad_number=-"10000" speed="45" footprint="40" />
<POLYMERASE n="1800" speed="45" id="2" organismid="2" footprint="15" name="coli Pol" />
<POLYMERASE n="O" speed="45" id="3" organismid="2" footprint=" 15" name="coli Pol-P" />
<POLYMERASE n="O" speed="45" id="4" organismid="2" footprint=" 15" name="coli Pol-2.0" />
<POLYMERASE n="0" speed="45" id="5" organism_id="2" footprint="15" name="coli Pol-P-2.0" />
<POLYMERASE n="O" speed="230" id="6" organismid="1" footprint="15" name="gpl" />
<POLYMERASE n="O" speed="230" id="7" organism_id=" 1" footprint=" 15" name="gp 1-3.5" />
<SPECIES name="gp0.3" n="O" ID="8" organism="l" />
<SPECIES name="gp0.4" n="O" ID="9" organism="l" />
<SPECIES name="gp0.5" n="O" ID="10" organism="l" />
<SPECIES name="gp0.6A" n="O" ID=" 11" organism="l" />
<SPECIES name="gp0.7" n="O" ID="12" organism="l" />
<SPECIES name="gpl.1" n="O" ID="13" organism=" " />
<SPECIES name="gpl.2" n="O" ID="14" organism="l" />
<SPECIES name="gpl.3" n="O" ID="15" organism=" " />
<SPECIES name="gpl.4" n="O" ID="16" organism="l" />
<SPECIES name="gpl.5" n="O" ID=" 17" organism=" 1" />
<SPECIES name="gpl.6" n="0" ID="18" organism="1" />
<SPECIES name="gpl.7" n="O" ID="19" organism="l" />
<SPECIES name="gpl.8" n="O" ID="20" organism="l" />
<SPECIES name="gp2.0" n="O" ID="21" organism=" " />
<SPECIES name="gp2.5" n="0" ID="22" organism="l" />
<SPECIES name="gp2.8" n="O" ID="23" organism="l" />
<SPECIES name="gp3.0" n="O" ID="24" organism=" " />
<SPECIES name="gp3.5" n="0" ID="25" organism="l" />
<SPECIES name="gp3.8" n="O" ID="26" organism=" " />
<SPECIES name="gp4A" n="0" ID="27" organism=" " />
<SPECIES name="gp4.2" n="O" ID="28" organism="l" />
<SPECIES name="gp4.3" n="O" ID="29" organism="l" />
<SPECIES name="gp4.5" n="O" ID="30" organism="l" 1"/>
<SPECIES name="gp4.7" n="O" ID="31" organism=" " />
<SPECIES name="gp5.0" n="O" ID="32" organism="1" />
<SPECIES name="gp5.3" n="0" ID="33" organism="l" />
<SPECIES name="gp5.5" n="O" ID="34" organism=" 1 "/>
<SPECIES name="gp5.7" n="O" ID="35" organism="l" />
<SPECIES name="gp5.9" n="O" ID="36" organism=" "/>
<SPECIES name="gp6.0" n="O" ID="37" organism="l" 1"/>
<SPECIES name="gp6.3" n="O" ID="38" organism=" 1" />
169
<SPECIES name="gp6.5" n="O" ID="39" organism="1" />
<SPECIES name="gp6.7" n="O" ID="40" organism=" />
<SPECIES name="gp7" n="O" ID="41" organism="l" />
<SPECIES name="gp7.3" n="O" ID="42" organism="l" />
<SPECIES name="gp7.7" n="O" ID="43" organism="l" />
<SPECIES name="gp8" n="O" ID="44" organism=" 1" />
<SPECIES name="gp9" n="O" ID="45" organism="l" />
<SPECIES name="gpl0A" n="O" ID="46" organism="l" />
<SPECIES name="gpl 1" n="O" ID="47" organism="l" />
<SPECIES name="gpl2" n="O" ID="48" organism="l" />
<SPECIES name="gpl3" n="O" ID="49" organism="1" />
<SPECIES name="gpl4" n="O" ID="50" organism="l" />
<SPECIES name="gpl5" n="O" ID="51" organism="l" />
<SPECIES name="'gpl6" n="O" ID="52" organism=" " />
<SPECIES name="gpl7" n="O" ID="53" organism="l" />
<SPECIES name="gpl7.5" n="O" ID="54" organism="l" />
<SPECIES name="gpl8" n="O" ID="55" organism="l" />
<SPECIES name="gpl8.5" n="O" ID="56" organism="l" />
<SPECIES name="gpl9" n="O" ID="57" organism="l" />
<SPECIES name="gpl9.5" n="O" ID="58" organism="l" />
<REACTIONS>
<REACTION>
12+2>3+11 ;3.8E7
</REACTION>
<REACTION>
12+4>5+1 1;3.8E7
</REACTION>
<REACTION>
21+2>4;3.8E7
</REACTION>
<REACTION>
21+3>5;3.8E7
</REACTION>
<REACTION>
4>21+2;1.1
</REACTION>
<REACTION>
5>21+3;1.1
</REACTION>
<REACTION>
25+6>7;3.8E7
</REACTION>
<REACTION>
7>6+25;3.5
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phagel" genomelength="39937" copy_number="3" entry_rate_constant="70" entry_offsite="850">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism_id="l">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff-percent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start-="498" stop="548" startsite="542" name="Al" organism_id="2">
<POLYMERASE polymeraselD="2" aon=" 1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
<POLYMERASE polymeraselD="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraselD="4" aon="O" aoff="0" ainiton="O" runoff_percent="O" aelong="O" arecyc="O"/>
<POLYMERASE polymeraselD="5" aon="O" aoff="O" ainiton="O" runoff_percent="O" aelong="O" arecyc="O"/>
</PROMOTER>
<PROMOTER start=:"626" stop="676" startsite="670" name="A2" organism_id="2">
<POLYNM[ERASE polymeraselD="2" aon=" 1.5e7" aoff=".28" ainiton="0.4" runoff_percent=" 100" aelong="6" arecyc="0"/
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<POLYMERASE polymeraseID="3" aon="l.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoffpercent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="750" stop="800" startsite="794" name="A3" organism_id="2">
<POLYMERASE polymeraseID="2" aon=" 1.5e7" aoff=".28" ainiton="0.4" runoffpercent="100" aelong="6" arecyc="0"/
<POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraseID=-"5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start=" 1514" stop=" 1564" startsite=" 1558" name="B" organism_id="2">
<POLYMERASE polymeraselD="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="3113" stop="3163" startsite="3157" name="C" organism_id="2">
<POLYMERASE polymeraseID="2" aon=" 1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="l 100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraselD="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraseID=-"5" aon="0" aoff="0" ainiton="0" runoffpercent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="5848" stop="5871" startsite="5866" name="phi 1.1A" organism_id=" 1">
<POLYMERASE polymeraseID="6" aon="6E7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="5923" stop="5946" startsite="5941" name="phil. B" organismid=" 1">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="6409" stop="6432" startsite="6427" name="phi 1.3" organismid=" 1">
<POLYMERASE polymeraselD="6" aon="6e7" aoff=" 18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon="6e7" aoff=" 18" ainiton="0.875" runoffpercent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7778" stop="7801" startsite="7796" name="phi1.5" organismid="1">
<POLYMERASE polymeraseID=-"6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7895" stop="7918" startsite="7913" name="phil.6" organismid=" ">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start-="9107" stop="9130" startsite="9125" name="phi2.5" organism_id="1">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start-="11180" stop=" 11203" startsite="11198" name="phi3.8" organism_id="1">
<POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff=" 18" ainiton="0.875" runoff_percent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start=" 12671" stop=" 12694" startsite=" 12689" name="phi4c" organismid=" ">
<POLYMERASE polymeraseID="6" aon="6e7" aoff=" 18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon="6e7" aoff=" 18" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13341" stop="13364" startsite="13359" name="phi4.3" organism_id="1 ">
<POLYMERASE polymeraselD="6" aon="l.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent=" 18" aelong= "1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13915" stop="13938" startsite="13933" name="phi4.7" organismid=" ">
<POLYMERASE polymeraselD="6" aon="6e7" aoff=" 18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon="6e7" aoff=" 18" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start-="18545" stop="18568" startsite="18563" name="phi6.5" organism_id="l">
<POLYMERASE polymeraseID="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="21865" stop="21888" startsite="21883" name="phi9" organism_id="1 ">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent=" 100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="22904" stop="22927" startsite="22922" name="phil0" organismid="1">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff-percent=" 100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon= "1.82e8" aoff="0.2" ainiton="0.875" runoffpercent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="27274" stop="27297" startsite="27292" name="phi13" organism_id="1">
<POLYMERASE polymeraseID="6" aon=" .82e8" aoff="0.2" ainiton="3.5" runoffpercent="100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent="42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="34566" stop="34589" startsite="34584" name="phil7" organism_id="l">
<POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoffpercent=" 100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoffpercent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="39229" stop="39252" startsite="39247" name="phiOR" organismid="l">
<POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff-percent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<TERMINATOR start="7546" stop="7610" stopsite="7588" name="TE" organism="2">
<POLYMERASE ID="2" efficiency="I" />
<POLYMERASE ID="3" efficiency=" " />
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<POLYMERASE ID="4" efficiency=" I" />
<POLYMERASE ID="5" efficiency=" 1l" />
<POLYMERASE ID="6" efficiency="O" />
<POLYMERASE ID="7" efficiency="O" />
</TERMINATOR>
<TERMINATOR start="24158" stop="24230" stopsite="24209" name="Tphi" organism="1">
<POLYMERASE ID="2" efficiency="0" />
<POLYMERASE ID="3" efficiency="O"/>
<POLYMERASE ID="4" efficiency="O" />
<POLYMERASE ID="5" efficiency="0" />
<POLYMERASE ID="6" efficiency="0.8"/>
<POLYMERASE ID="7" efficiency="0.8" />
<TfERMINATOR>
<RBS start="910" sitop="925" startsite="925" initstepsize="50" elongstepsize="" strength="le7" stopsite="1278" protid="8"
initRateConstant="0.3" mmrnadeg="4.17e-3" />
<RBS start="1262" stop="1277" startsite="1277" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="1433" protid="9"
initRateConstant="D.3" mrnadeg="4.17e-3" />
<RBS start="1454" stop="1469" startsite="1469" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1639" protid="10"
initRateConstant="0.3" mmadeg="4.17e-3"/>
<RBS start=-"1621" stop="1636" startsite="1636" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="1797" protid=" l"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="2006" stop="2021" startsite="2021" initstepsize="50" elongstepsize="" strength=" le7" stopsite="3100" protid=" 12"
initRateConstant="0.3" mrnadeg="4.17e-3" I>
<RBS start="3156" stop="3171" startsite="3171" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite-"5822" protid="6"
initRateConstant="0.3" mrnadeg="3.33e-3"/>
<RBS start="5992" stop="6007" startsite="6007" initstepsize="50" elongstepsize="" strength="le7" stopsite="6135" protid="13"
initRateConstant-"0.3" mrnadeg=" 1.1 le-3" />
<RBS start="6119" stop="6134" startsite="6134" initstepsize="50" elongstepsize="" strength="le7" stopsite="6394" protid="14"
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="6460" stop="6475" startsite="6475" initstepsize="50" elongstepsize="" strength=" le7" stopsite="7554" protid="15"
initRateConstant="0.3" mmadeg="5.56e-3" />
<RBS start="7593" stop="7608" startsite="7608" initstepsize="50" elongstepsize="" strength="le7" stopsite-"7763" protid="16"
initRateConstant="0.3" mrnadeg="5.56e-3" I>
<RBS start="7776" stop="7791" startsite="7791" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="7880" protid="17"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="7891" stop="7906" startsite="7906" initstepsize="50" elongstepsize="" strength="le7" stopsite="8166" protid="18"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start-"8150" stop="8165" startsite="8165" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="8756" protid="19"
initRateConstant="0.3" mmadeg="1.85e-3"/>
<RBS start="8734" stop="8749" startsite="8749" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8895" protid="20"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="8879" stop="8894" startsite="8894" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="9092" protid="21"
initRateConstant-"0.3" mmadeg="O" />
<RBS start="9136" stop="9152" startsite="9158" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="9856" protid="22"
initRateConstant="0.3" mmrnadeg="1.39e-3" />
<RBS start="9840" stop="9855" startsite="9855" initstepsize="50" elongstepsize="" strength=" le7" stopsite="10276" protid="23"
initRateConstant="C0.3" mrnadeg="4.17e-3"/>
<RBS start=" 10242" stop="10257" startsite="10257" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="10706" protid="24"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start-" 10690" stop=" 10705" startsite=" 10705" initstepsize="50" elongstepsize="" strength="le7" stopsite="11161" protid="25"
initRateConstant="0.3" mmadeg="0" />
<RBS start=" 11210" stop="11225" startsite="11225" initstepsize="50" elongstepsize="" strength="le7" stopsite="11590" protid="26"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="11550" stop="11565" startsite-"11565" initstepsize="50" elongstepsize="" strength=" le7" stopsite="13265" protid="27"
initRateConstant="0.3" mmadeg="4.17e-3"/>
<RBS start=" 12973"' stop="12988" startsite="12988" initstepsize="50" elongstepsize-"" strength=" I e7" stopsite="13326" protid="28"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=" 13337" stop="13352" startsite-="13352" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="13564" protid="29"
initRateConstant="0.3" mmadeg="4.17e-3" />
<RBS start="13575" stop="13584" startsite="13584" initstepsize="50" elongstepsize="" strength=" le7" stopsite="13853" protid="30"
initRateConstant-"0.3" mrnadeg="4.17e-3" />
<RBS start=" 13912" stop="13927" startsite="13927" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="14334" protid="31"
initRateConstant="0.3" mmrnadeg="4.17e-3" />
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<RBS start="14338" stop="14353" startsite="14353" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16467" protid="32"
initRateConstant="0.3" mmadeg="2.78e-3" />
<RBS start=" 16468" stop="16483" startsite="16483" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="16838" protid="33"
initRateConstant="0.3" mmadeg="4.17e-3" />
<RBS start="16839" stop="16851" startsite="16851" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="17159" protid="34"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="17124" stop="17149" startsite=" 17149" initstepsize="50" elongstepsize="" strength="1e7" stopsite=" 17359" protid="35"
initRateConstant="0.3" mmadeg="4.17e-3" />
<RBS start=" 17343" stop="17358" startsite-="17358" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="17517" protid="36"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start" 17489" stop="17504" startsite="17504" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18406" protid="37"
initRateConstant="0.3" mmadeg="2.38e-3"/>
<RBS start="18379" stop="18394" startsite="18394" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="18507" protid="38"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="18590" stop="18605" startsite="18605" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="18859" protid="39"
initRateConstant="0.3" mmadeg="2.08e-3"/>
<RBS start=" 18860" stop="18864" startsite="18864" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="19131" protid="40"
initRateConstant="0.3" mmadeg="2.08e-3" />
<RBS start="19114." stop=" 19129" startsite=" 19130" initstepsize="50" elongstepsize="" strength="1e7" stopsite-" 19531" protid="41"
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start-" 19515" stop="19530" startsite="19530" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="19834" protid="42"
initRateConstant="0.3" mrnadeg="2.08e-3"/>
<RBS start="19835" stop=" 19848" startsite=" 19848" initstepsize="50" elongstepsize="" strength=" le7" stopsite="20240" protid="43"
initRateConstant="0.3" mmadeg="2.08e-3"/>
<RBS start-"20224" stop="20239" startsite="20239" initstepsize="50" elongstepsize="" strength="1e7" stopsite="21850" protid="44"
initRateConstant="0.3" mmadeg="5.56e-3" />
<RBS start-"21935" stop="21950" startsite="21950" initstepsize="50" elongstepsize="" strength="le7" stopsite="22873" protid="45"
initRateConstant="0.3" mmadeg="0" />
<RBS start="22942" stop="22967" startsite="22967" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="24004" protid="46"
initRateConstant="0.3" mmadeg="0"/>
<RBS start="24213" stop="24228" startsite="24228" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="24818" protid="47"
initRateConstant="0.3" mmadeg="0" />
<RBS start-"24827" stop="24842" startsite="24842" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27226" protid="48"
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start-"27292" stop="27307" startsite="27307" initstepsize="50" elongstepsize="" strength=" e7" stopsite="27723" protid="49"
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="27707" stop="27722" startsite="27728" initstepsize="50" elongstepsize="" strength="1e7" stopsite="28318" protid="50"
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="28302" stop="28317" startsite="28325" initstepsize="50" elongstepsize="" strength="1e7" stopsite="30568" protid="51"
initRateConstant="0.3" mmrnadeg="0" />
<RBS start="30580" stop="30595" startsite="30595" initstepsize="50" elongstepsize="" strength="1e7" stopsite="34551" protid="52"
initRateConstant="C.3" mrnadeg="1.28e-3" />
<RBS start="34609" stop="34624" startsite="34624" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="36285" protid="53"
initRateConstant="C(.3" mmrnadeg="2.08e-3" />
<RBS start="36329" stop="36344" startsite="36344" initstepsize="50" elongstepsize="" strength="le7" stopsite="36547" protid="54"
initRateConstant="0.3" mmadeg="0" />
<RBS start-"36531" stop="36546" startsite="36553" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36822" protid="55"
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="36902" stop="36917" startsite="36917" initstepsize="50" elongstepsize="" strength=" e7" stopsite="37348" protid="56"
initRateConstant="0.3" mrnadeg="3.33e-3" />
<RBS start-"37355"' stop="37370" startsite-"37370" initstepsize="50" elongstepsize="" strength=" e7" stopsite="39130" protid="57"
initRateConstant="0.3" mmadeg="2.08e-3" />
<RBS start="39374" stop="39389" startsite="39389" initstepsize="50" elongstepsize="" strength=" e7" stopsite="39538" protid="58"
initRateConstant="0.3" mmadeg="2.08e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
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<EXECUTE-SIMULATION runs=" 1" random seed="34145" simulation_name="test-1" time_step="5" time_end="1500"
write_DNA="no" write_InitRNA="yes" write_Energy="yes" compDeg="yes">
<CELL volume="Se-16" polymerase_interaction_model="DOWNSTREAMFAILOFF">
<RIBOSOME initial_number=-"10000" speed="45" footprint="40" />
<POLYMERASE n=" 1800" speed="45" id="2" organismid="2" footprint=" 15" name="coli Pol" />
<POLYMERASE n="0" speed="45" id="3" organismid="2" footprint= "15" name="coli Pol-P" />
<POLYMERASE n="0" speed="45" id="4" organismid="2" footprint=" 15" name="coli Pol-2.0" />
<POLYMERASE n="0" speed="45" id="5" organismid="2" footprint=" 15" name="coli Pol-P-2.0" />
<POLYMERASE n="0" speed="230" id="6" organism_id=" 1" footprint="15" name="gpl "/>
<POLYMERASE n="0" speed="230" id="7" organism_id="1" footprint=" 15" name="gp1-3.5" />
<SPECIES name="gp0.3" n="O" ID="8" organism="l" />
<SPECIES name="gp0.4" n="O" ID="9" organism="l" />
<SPECIES name="gp0.5" n="0" ID=" 10" organism=" " />
<SPECIES name="gp0.6A" n="O" ID=" 11" organism=" 1/>
<SPECIES name="gp0.7" n="O" ID="12" organism=" " />
<SPECIES name=" gp 1.1" n="0" ID=" 13" organism=" 1" />
<SPECIES name="gpl.2" n="O" ID="14" organism="l" />
<SPECIES name="gpl.3" n="O" ID="15" organism="l" />
<SPECIES name="gpl.4" n="O" ID="16" organism="1" />
<SPECIES name="gpl.5" n="O" ID="17" organism="I" />
<SPECIES name="gpl.6" n="O" ID="18" organism="l" />
<SPECIES name="gpl.7" n="O" ID="19" organism="l" />
<SPECIES name="gpl.8" n="O" ID="20" organism="l" 1"/>
<SPECIES name="gp2.0" n="O" ID="21" organism=" 1" />
<SPECIES name="gp2.5" n="0" ID="22" organism="1" />
<SPECIES name="gp2.8" n="O0" ID="23" organism="l" />
<SPECIES name="gp3.0" n="O" ID="24" organism="l" />
<SPECIES name="gp3.5" n="O" ID="25" organism="l " />
<SPECIES name="gp3.8" n="O" ID="26" organism="l " />
<SPECIES name="gp4A" n="O" ID="27" organism=" " />
<SPECIES name="gp4.2" n="O0" ID="28" organism="l " />
<SPECIES name="gp4.3" n="O" ID="29" organism="l" />
<SPECIES name="gp4.5" n="O" ID="30" organism="l" />
<SPECIES name="gp4.7" n="O" ID="31" organism=" 1" />
<SPECIES name="gp5.0" n="O" ID="32" organism="l" I/>
<SPECIES name="gp5.3" n="O" ID="33" organism="l" />
<SPECIES name="gp5.5" n="O" ID="34" organism=" " />
<SPECIES name=" gp5.7" n="O" ID="35" organism=" "/>
<SPECIES name="gp5.9" n="O0" ID="36" organism="l" />
<SPECIES name="gp6.0" n="O" ID="37" organism=" 1" />
<SPECIES name="gp6.3" n="0" ID="38" organism=" 1" />
<SPECIES name="gp6.5" n="O0" ID="39" organism="l " />
<SPECIES name="gp6.7" n="0" ID="40" organism="l" 1"/>
<SPECIES name="gp7" n="O0" ID="41" organism="l" />
<SPECIES name="gp7.3" n="O" ID="42" organism="l" />
<SPECIES name="gp7.7" n="O" ID="43" organism="l" />
<SPECIES name="gp8" n="O" ID="44" organism="l" />
<SPECIES name="gp9" n="O0" ID="45" organism="l" />
<SPECIES name="gpl0A" n="0" ID="46" organism="l" />
<SPECIES name="gpl 1" n="O" ID="47" organism="l" I/>
<SPECIES name="gpl2" n="O0" ID="48" organism=" " />
<SPECIES name="gpl3" n="O" ID=-"49" organism="l" />
<SPECIES name="gpl4" n="0" ID="50" organism="l" />
<SPECIES name="gp15" n="0" ID="51" organism="l" />
<SPECIES name="gpl6" n="0" ID="52" organism="l" />
<SPECIES name="gp17" n="0" ID="53" organism=" " />
<SPECIES name="gpl7.5" n="O" ID="54" organism="l" />
<SPECIES name="gpl8" n="O" ID="55" organism="l" />
<SPECIES name="gpl8.5" n="0" ID="56" organism=" " />
<SPECIES name="gpl9" n="O" ID="57" organism="1" />
<SPECIES name="gpl9.5" n="O0" ID="58" organism="l" />
<REACTIONS>
<REACTION>
12+2>3+11;3.8E7
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</REACTION>
<REACTION>
12+4>5+11;3.8E7
</REACTION>
<REACTION>
21+2>4;3.8E7
</REACTION>
<REACTION>
21+3>5;3.8E7
</REACTION>
<REACTION>
4>21+2;1.1
</REACTION>
<REACTION>
5>21+3;1.1
</REACTION>
<REACTION>
25+6>7;3.8E7
</REACTION>
<REACTION>
7>6+25;3.5
</REACTION>
</REACTIONS>
<DNASYSTEM name="phagel" genome_length="39937" copynumber=-"3" entry_rate_constant="70" entry_offsite="850">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism_id="1">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" I>
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent=" 18" aelong="1.45"
arecyc="0.22" />
<dPROMOTER>
<PROMOTER start="498" stop="548" startsite="542" name="Al" organism_id="2">
<POLYMERASE polymeraselD="2" aon=" 1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="O"/
<POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="626" stop="676" startsite="670" name="A2" organismijd="2">
<POLYMERASE polymeraselD="2" aon=" 1.5e7" aoff=".28" ainiton="0.4" runoff percent=" 100" aelong="6" arecyc="0"/
<POLYMERASE polymeraselD="3" aon=" .5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="O" runoffpercent-"0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="750" stop="800" startsite="794" name="A3" organism_id="2">
<POLYMERASE polymeraselD="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff.percent=-"100" aelong="6" arecyc="O"/
<POLYMERASE polymeraselD="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoff_percent-"0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start=" 1514" stop="1564" startsite="1558" name="B" organismid="2">
<POLYMERASE polymeraselD="2" aon=" 1.5e7" aoff="2.8" ainiton="0.19" runoffpercent=" 100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraselD="3" aon=" 1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="3113" stop="3163" startsite="3157" name="C" organismjd="2">
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<POLYMERASE polymeraselD="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoffpercent=" 100" aelong="6"
arecyc="O"/>
<POLYMERASE polymeraselD="3" aon=" 1.5e7" aoff="2.8" ainiton="0.19" runoff-percent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoffpercent="0" aelong="O" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="O" runoff percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start-"5848" stop="5871" startsite="5866" name="phi 1.1A" organismid="l ">
<POLYMERASE polymeraselD="6" aon="6E7" aoff="18" ainiton="3.5" runoffpercent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff.percent-"18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="5923" stop="5946" startsite="5941" name="phil.1B" organismid="l">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="6409" stop="6432" startsite="6427" name="phil.3" organismid="l">
<POLYMERASE polymeraselD="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon="6e7" aoff=" 18" ainiton="0.875" runoffpercent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start-"7778" stop="7801" startsite="7796" name="phil.5" organismid="1">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent-" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7895" stop="7918" startsite="7913" name="phil.6" organism_id="l ">
<POLYMERASE polymeraseID="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="9107" stop="9130" startsite="9125" name="phi2.5" organismid=" ">
<POLYMERASE polymeraseID="6" aon=" .82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" I>
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="l.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start=" 11180" stop=" 11203" startsite=" 11198" name="phi3.8" organism_id="l">
<POLYMERASE polymeraselD="6" aon="6e7" aoff=" 18" ainiton="3.5" runoffpercent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start=" 12671" stop="12694" startsite=" 12689" name="phi4c" organism_id=" ">
<POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff=" 18" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start=" 13341" stop=" 13364" startsite=" 13359" name="phi4.3" organismid=" ">
<POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start=" 13915" stop="13938" startsite="13933" name="phi4.7" organism_id=" ">
<POLYMERASE polymeraselD="6" aon="6e7" aoff="18" ainiton="3.5" runoffpercent="50" aelong="5.8"
arecyc="0.88" />
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<POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoffpercent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="18545" stop="18568" startsite=" 18563" name="phi6.5" organismid=" I">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent=" 100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="21865" stop="21888" startsite="21883" name="phi9" organismid="l">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon= "1.82e8" aoff="0.2" ainiton="0.875" runoffpercent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start-"22904" stop="22927" startsite="22922" name="phil0" organismid="l ">
<POLYMERASE polymeraseID="6" aon=" .82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="27274" stop="27297" startsite="27292" name="phil3" organismid="l">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon=" .82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="34566" stop="34589" startsite="34584" name="phil7" organism_id="l">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoffpercent="42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="39229" stop="39252" startsite="39247" name="phiOR" organism_id="l">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoffpercent=" 100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<TERMINATOR start="7546" stop="7610" stopsite="7588" name="TE" organism="2">
<POLYMERASE ID="2" efficiency="l" />
<POLYMERASE ID="3" efficiency="l" />
<POLYMERASE ID="4" efficiency="l" />
<POLYMERASE ID="5" efficiency="l"/>
<POLYMERASE ID="6" efficiency="0" />
<POLYMERASE ID="7" efficiency="0" />
</TERMINATOR>
<TERMINATOR start-"24158" stop="24230" stopsite="24209" name="Tphi" organism="l ">
<POLYMERASE ID="2" efficiency="0" />
<POLYMERASE ID="3" efficiency="0" />
<POLYMERASE ID="4" efficiency="0"/>
<POLYMERASE ID="5" efficiency="0" />
<POLYMERASE ID="6" efficiency="0.8" />
<POLYMERASE ID="7" efficiency="0.8" />
</TERMINATOR>
<RBS start="910" stop="925" startsite="925" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1278" protid="8"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start=" 1262" stop="1277" startsite="1277" initstepsize="50" elongstepsize="" strength=" l e7" stopsite="1433" protid="9"
initRateConstant-"0.3" mrnadeg="4.17e-3" I>
<RBS start=-"1454" stop="1469" startsite="1469" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="1639" protid="10"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=" 1621" stop="1636" startsite="1636" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1797" protid="11"
initRateConstant="0.3" mrnadeg="4.17e-3" />
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<RBS start="2006" stop="2021" startsite="2021" initstepsize="50" elongstepsize="" strength="le7" stopsite-"3100" protid="12"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="3156" stop="3171" startsite="3171" initstepsize="50" elongstepsize="" strength="1e7" stopsite="5822" protid="6"
initRateConstant="0.3" mmrnadeg="2.78e-3" />
<RBS start="5992" stop="6007" startsite="6007" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6135" protid="13"
initRateConstant="0.3" mmadeg="1.67e-3" />
<RBS start="6119" stop="6134" startsite="6134" initstepsize="50" elongstepsize="" strength="le7" stopsite="6394" protid="14"
initRateConstant="0.3" mmadeg="2.38e-3" />
<RBS start="6460" stop="6475" startsite="6475" initstepsize="50" elongstepsize="" strength=" e7" stopsite="7554" protid="15"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start-"7593" stop="7608" startsite="7608" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7763" protid="16"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="7776" stop="7791" startsite="7791" initstepsize="50" elongstepsize="" strength=" e7" stopsite="7880" protid="17"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="7891" stop="7906" startsite="7906" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="8166" protid="18"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="8150" stop="8165" startsite="8165" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="8756" protid="19"
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="8734" stop="8749" startsite="8749" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8895" protid="20"
initRateConstant="0.3" mmadeg="4.17e-3" />
<RBS start="8879" stop="8894" startsite="8894" initstepsize="50" elongstepsize="" strength=" e7" stopsite="9092" protid="21"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="9136" stop="9152" startsite="9158" initstepsize="50" elongstepsize="" strength="le7" stopsite="9856" protid="22"
initRateConstant="0.3" mrnadeg=" 1.1 le-3"/>
<RBS start="9840" stop="9855" startsite="9855" initstepsize="50" elongstepsize="" strength="le7" stopsite="10276" protid="23"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start-"10242" stop="10257" startsite="10257" initstepsize="50" elongstepsize="" strength="le7" stopsite="10706" protid="24"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=-"10690" stop="10705" startsite="10705" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite=" 11161" protid="25"
initRateConstant="0.3" mrnadeg="0" />
<RBS start=" 11210" stop="11225" startsite="11225" initstepsize="50" elongstepsize="" strength=" le7" stopsite="11590" protid="26"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start-" 11550" stop=" 11565" startsite=" 11565" initstepsize="50" elongstepsize="" strength=" e7" stopsite=" 13265" protid="27"
initRateConstant-"0.3" mmrnadeg="4.17e-3"/>
<RBS start="12973" stop="12988" startsite="12988" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="13326" protid="28"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=" 13337" stop="13352" startsite="13352" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="13564" protid="29"
initRateConstant="0.3" mmadeg="4.17e-3" />
<RBS start="13575" stop="13584" startsite="13584" initstepsize="50" elongstepsize="" strength="le7" stopsite="13853" protid="30"
initRateConstant="0.3" mmrnadeg="4.17e-3" />
<RBS start" 13912" stop="13927" startsite-" 13927" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="14334" protid="31"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=" 14338" stop="14353" startsite="14353" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="16467" protid="32"
initRateConstant="0.3" mrnadeg="2.78e-3" />
<RBS start="16468" stop="16483" startsite="16483" initstepsize="50" elongstepsize="" strength="le7" stopsite="16838" protid="33"
initRateConstant="0.3" mmrnadeg="4.17e-3" />
<RBS start="16839" stop="16851" startsite="16851" initstepsize="50" elongstepsize="" strength=" e7" stopsite="17159" protid="34"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start-="17124" stop="17149" startsite="17149" initstepsize="50" elongstepsize="" strength=" e7" stopsite="17359" protid="35"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=" 17343" stop=" 17358" startsite=" 17358" initstepsize="50" elongstepsize="" strength=" le7" stopsite=" 17517" protid="36"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=" 17489" stop="17504" startsite="17504" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="18406" protid="37"
initRateConstant="0.3" mmadeg="2.08e-3" />
<RBS start=" 18379" stop="18394" startsite="18394" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="18507" protid="38"
initRateConstant="0.3" mmadeg="4.17e-3" />
<RBS start-" 18590" stop="18605" startsite="18605" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="18859" protid="39"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=" 18860" stop="18864" startsite="18864" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="19131" protid="40"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start=" 19114" stop="19129" startsite="19130" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="19531" protid="41"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="19515" stop="19530" startsite="19530" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19834" protid="42"
initRateConstant="0.3" mmadeg="4.17e-3" />
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<RBS start="19835" stop="19848" startsite="19848" initstepsize="50" elongstepsize="" strength="1e7" stopsite="20240" protid="43"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="20224" stop="20239" startsite="20239" initstepsize="50" elongstepsize="" strength="1e7" stopsite="21850" protid="44"
initRateConstant="0.3" mmadeg="5.56e-3" />
<RBS start="21935" stop="21950" startsite="21950" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="22873" protid="45"
initRateConstant-"0.3" mmadeg="0" />
<RBS start-"22942" stop="22967" startsite="22967" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24004" protid="46"
initRateConstant="0.3" mrnadeg="O" />
<RBS start-"24213" stop="24228" startsite="24228" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="24818" protid="47"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24827" stop="24842" startsite="24842" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="27226" protid="48"
initRateConstant="0.3" mmadeg="4.17e-3"/>
<RBS start="27292" stop="27307" startsite="27307" initstepsize="50" elongstepsize="" strength="le7" stopsite="27723" protid="49"
initRateConstant-"0.3" mrnadeg="4.17e-3" />
<RBS start-"27707" stop="27722" startsite="27728" initstepsize="50" elongstepsize="" strength="1e7" stopsite="28318" protid="50"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start-"28302" stop="28317" startsite="28325" initstepsize="50" elongstepsize="" strength="1e7" stopsite="30568" protid="51"
initRateConstant="0.3" mmadeg="0" />
<RBS start="30580" stop="30595" startsite="30595" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="34551" protid="52"
initRateConstant="0.3" mrnadeg="1.11e-3"/>
<RBS start="34609" stop="34624" startsite="34624" initstepsize="50" elongstepsize="" strength=" le7" stopsite="36285" protid="53"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="36329" stop="36344" startsite="36344" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="36547" protid="54"
initRateConstant="0.3" mrnadeg="0" />
<RBS start-"36531" stop="36546" startsite="36553" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36822" protid="55"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="36902" stop="36917" startsite="36917" initstepsize="50" elongstepsize="" strength="1e7" stopsite="37348" protid="56"
initRateConstant="0.3" mrnadeg="3.33e-3" />
<RBS start="37355" stop="37370" startsite="37370" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39130" protid="57"
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="39374" stop="39389" startsite="39389" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="39538" protid="58"
initRateConstant="0.3" mrnadeg="4.17e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
Tabasco Input File for Traffic Jam Model Fits
<REQUEST>
<EXECUTE-SIMULATION runs="1" random_seed="34145" simulation_name="test-1" time_step="5" time_end="1500"
write_DNA="no" write_InitRNA="yes" write_Energy="yes" compDeg="yes">
<CELL volume="8e- 16" polymeraseinteraction_model="TRAFFIC_JAM">
<RIBOSOME initial_number="10000" speed="45" footprint="40" />
<POLYMERASE n="1800" speed="45" id="2" organism_id="2" footprint=" 15" name="coli Pol" />
<POLYMERASE n="O" speed="45" id="3" organismid="2" footprint="15" name="coli Pol-P" />
<POLYMERASE n="O" speed="45" id="4" organism_id="2" footprint-"15" name="coli Pol-2.0" />
<POLYMERASE n="O" speed="45" id="5" organismid="2" footprint="15" name="coli Pol-P-2.0" />
<POLYMERASE n="0" speed="230" id="6" organism_id=" 1" footprint=" 15" name="gp 1" />
<POLYMERASE n="O" speed="230" id="7" organism_id="1" footprint=" 15" name="gp 1-3.5" />
<SPECIES name="gp0.3" n="0" ID="8" organism="l" />
<SPECIES name="gp0.4" n="O" ID="9" organism="l" />
<SPECIES name="gp0.5" n="O0" ID="10" organism=" 1" />
<SPECIES name="gp0.6A" n="O0" ID=" 11" organism="l" />
<SPECIES name="gp0.7" n="O" ID=" 12" organism="1" />
<SPECIES name="gpl.1" n="O" ID=" 13" organism="l" />
<SPECIES name="gpl.2" n="0" ID="14" organism="l" />
<SPECIES name="gpl.3" n="0" ID="15" organism="1" />
<SPECIES name="gpl.4" n="O" ID="16" organism=" " />
<SPECIES name="gpl.5" n="O" ID="17" organism=" " />
<SPECIES name="gpl.6" n="O" ID="18" organism="l" />
<SPECIES name="gpl.7" n="0" ID="19" organism="l" />
<SPECIES name="gpl.8" n="O" ID="20" organism="1" />
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<SPECIES name="gp2.0" n="O" ID="21" organism="l" />
<SPECIES name="gp2.5" n="O" ID="22" organism="l" />
<SPECIES name="gp2.8" n="O" ID="23" organism="l" />
<SPECIES name="gp3.0" n="O" ID="24" organism="l" />
<SPECIES name="gp3.5" n="O" ID="25" organism="l" />
<SPECIES name="gp3.8" n="O" ID="26" organism="l" />
<SPECIES name="gp4A" n="O" ID="27" organism="l" />
<SPECIES name="gp4.2" n="O" ID="28" organism="l" />
<SPECIES name="gp4.3" n="O" ID="29" organism="l" />
<SPECIES name="gp4.5" n="O" ID="30" organism="l" />
<SPECIES name="gp4.7" n="O" ID="31" organism=" 1" />
<SPECIES name="gp5.0" n="O" ID="32" organism="l" />
<SPECIES name="gp5.3" n="O" ID="33" organism="l" />
<SPECIES name="gp5.5" n="O" ID="34" organism="l" />
<SPECIES name="gp5.7" n="O" ID="35" organism="l" />
<SPECIES name="gp5.9" n="O" ID="36" organism="l" />
<SPECIES name="gp6.0" n="O" ID="37" organism="l" />
<SPECIES name="gp6.3" n="O" ID="38" organism="l" />
<SPECIES name="gp6.5" n="O" ID="39" organism="l" />
<SPECIES name="gp6.7" n="O" ID="40" organism=" 1" />
<SPECIES name="gp7" n="O" ID="41" organism=" " />
<SPECIES name="gp7.3" n="O" ID="42" organism="l" />
<SPECIES name="gp7.7" n="O" ID="43" organism="l" />
<SPECIES name="gp8" n="O" ID="44" organism="l" />
<SPECIES name="gp9" n="O" ID="45" organism=" 1" />
<SPECIES name="gpl0A" n="O" ID="46" organism="l" />
<SPECIES name="gpll" n="O" ID="47" organism="l" />
<SPECIES name="gpl2" n="O" ID="48" organism="l" />
<SPECIES name="gpl3" n="O" ID="49" organism="l" />
<SPECIES name="gpl4" n="O" ID="50" organism="l" />
<SPECIES name="gpl5" n="O" ID="51" organism="1" />
<SPECIES name="gpl6" n="O" ID="52" organism="l" />
<SPECIES name="gpl7" n="O" ID="53" organism="l" />
<SPECIES name="gpl7.5" n="O" ID="54" organism="l" />
<SPECIES name="gpl8" n="O" ID="55" organism="1" />
<SPECIES name="gpl8.5" n="O" ID="56" organism="l" />
<SPECIES name="gpl9" n="O" ID="57" organism="l" />
<SPECIES name="gpl9.5" n="O" ID="58" organism=" " />
<REACTIONS>
<REACTION>
12+2>3+1 1;3.8E7
</REACTION>
<REACTION>
12+4>5+11 ;3.8E7
</REACTION>
<REACTION>
21+2>4;3.8E7
</REACTION>
<REACTION>
21+3>5;3.8E7
</REACTION>
<REACTION>
4>21+2;1.1
</REACTION>
<REACTION>
5>21+3;1. 1
</REACTION>
<REACTION>
25+6>7;3.8E7
</REACTION>
<REACTION>
7>6+25;3.5
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phagel" genome_length="39937" copynumber="3" entry_rate_constant="70" entry_offsite="850">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism_id="l">
<POLYMERASE polymeraselD="6" aon="l.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="498" stop="548" startsite="542" name="Al" organismjid="2">
<POLYMERASE polymeraselD="2" aon=" 1.5e7" aoff=".28" ainiton="0.4" runoff_percent=" 100" aelong="6" arecyc="0"/
<POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraseID="4" aon="O" aoff="O" ainiton="0" runoffpercent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="O" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="626" stop="676" startsite="670" name="A2" organismid="2">
<POLYMERASE polymeraseID="2" aon=" 1.5e7" aoff=".28" ainiton="0.4" runoff_percent=" 100" aelong="6" arecyc="O"/
<POLYMERASE polymeraselD="3" aon=" 1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent"0O" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoffpercent-"0" aelong="O" arecyc="0"/>
</PROMOTER>
<PROMOTER start="750" stop="800" startsite="794" name="A3" organismid="2">
<POLYMERASE polymeraselD="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
<POLYMERASE polymeraselD="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoffpercent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent="O" aelong="O" arecyc="0"/>
<POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="O" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start-="1514" stop="1564" startsite="1558" name="B" organismid="2">
<POLYMERASE polymeraselD="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoffpercent="100" aelong="6"
arecyc="O"/>
<POLYMERASE polymeraseID="3" aon=" 1.5e7" aoff="2.8" ainiton="0. 19" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="O" runoff_percent="O" aelong="O" arecyc="O"/>
<POLYMvIERASE polymeraselD="5" aon="0" aoff="O" ainiton="0" runoff_percent-"0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start-="3113" stop="3163" startsite="3157" name="C" organism_id="2">
<POLYMERASE polymeraselD="2" aon="1.5e7" aoff="2.8" ainiton="0. 19" runoff_percent="100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraselD="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoff_percent="O" aelong="O" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="O" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER startz="5848" stop="5871" startsite="5866" name="phi 1. A" organismid=" 1">
<POLYMERASE polymeraseID="6" aon="6E7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff="18" ainiton="0.875" runoffpercent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="5923" stop="5946" startsite="5941" name="phil.1B" organism id=" 1">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start=="6409" stop="6432" startsite="6427" name="phi 1.3" organismid=" 1">
<POLYMERASE polymeraselD="6" aon="6e7" aoff=" 18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoffpercent="18" aelong="1.45"
arecyc="0.22" />
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</PROMOTER>
<PROMOTER start:="7778" stop="7801" startsite="7796" name="phil.5" organism_id=" 1 ">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7895" stop="7918" startsite="7913" name="phil.6" organism_id="l">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent=" 18" aelong="l1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start:="9107" stop="9130" startsite="9125" name="phi2.5" organism_id=" 1">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start:="11180" stop="11203" startsite="11198" name="phi3.8" organismid="l">
<POLYMERASE polymeraselD="6" aon="6e7" aoff=" 18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff=" 18" ainiton="0.875" runofLpercent="18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start:="12671" stop="12694" startsite="12689" name="phi4c" organismid="1">
<POLYMERASE polymeraselD="6" aon="6e7" aoff=" 18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff="18" ainiton="0.875" runoffpercent"l18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start-="13341" stop="13364" startsite=" 13359" name="phi4.3" organismid=" 1">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start:=" 13915" stop="13938" startsite="13933" name="phi4.7" organismid="1">
<POLYMERASE polymeraselD="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff="18" ainiton="0.875" runoffpercent="18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start:="18545" stop="18568" startsite="18563" name="phi6.5" organismid="1">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoffpercent=" 100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent-"42" aelong="l1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start-="21865" stop="21888" startsite="21883" name="phi9" organismid=" 1">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="22904" stop="22927" startsite="22922" name="phil0" organismid="">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start:="27274" stop="27297" startsite="27292" name="phil3" organismid=" 1">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="34566" stop="34589" startsite="34584" name="phil7" organismid=" 1">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoffpercent="42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="39229" stop="39252" startsite="39247" name="phiOR" organismid=" ">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent=" 100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<TERMINATOR start="7546" stop="7610" stopsite="7588" name="TE" organism="2">
<POLYMERASE ID)="2" efficiency="l" />
<POLYMERASE ID)="3" efficiency=" 1"/>
<POLYMERASE ID)="4" efficiency="l" />
<POLYMERASE ID)="5" efficiency=" 1"/>
<POLYMERASE II)="6" efficiency="0" />
<POLYMERASE ID)="7" efficiency="0" />
</TERMINATOR>
<TERMINATOR start="24158" stop="24230" stopsite="24209" name="Tphi" organism="l">
<POLYMERASE ID="2" efficiency="0" />
<POLYMERASE ID)="3" efficiency="0" />
<POLYMERASE ID="4" efficiency="0" />
<POLYMERASE ID)="5" efficiency="O" />
<POLYMERASE ID="6" efficiency="0.8" />
<POLYMERASE ID="7" efficiency="0.8" />
</TERMINATOR>
<RBS start="910" stop="925" startsite="925" initstepsize="50" elongstepsize="" strength=" le7" stopsite="1278" protid="8"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="1262" stop="1277" startsite="1277" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="1433" protid="9"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="1454" stop="1469" startsite="1469" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="1639" protid="10"
initRateConstant="0.3" mrnadeg="8.33e-3"/>
<RBS start="1621" stop="1636" startsite="1636" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="1797" protid=" l"
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="2006" stop="2021" startsite="2021" initstepsize="50" elongstepsize="" strength="le7" stopsite="3100" protid="12"
initRateConstant="0.3" mrnadeg="1.67e-2" />
<RBS start="3156" stop="3171" startsite="3171" initstepsize="50" elongstepsize="" strength="1e7" stopsite="5822" protid="6"
initRateConstant-"0.3" mmadeg="1.67e-2" />
<RBS start="5992" stop="6007" startsite="6007" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6135" protid="13"
initRateConstant="0.3" mmadeg="3.33e-3" />
<RBS start="6119" stop="6134" startsite="6134" initstepsize="50" elongstepsize="" strength="le7" stopsite="6394" protid="14"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="6460" stop="6475" startsite="6475" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7554" protid="15"
initRateConstant="0.3" mmadeg= "1.67e-2" />
<RBS start="7593" stop="7608" startsite="7608" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7763" protid="16"
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="7776" stop="7791" startsite="7791" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="7880" protid="17"
initRateConstant="0.3" mmadeg="5.56e-3" />
<RBS start="7891" stop="7906" startsite="7906" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8166" protid="18"
initRateConstant-"0.3" mrnadeg="5.56e-3" />
<RBS start="8150" stop="8165" startsite="8165" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8756" protid="19"
initRateConstant="0.3" mmadeg="3.33e-3" />
<RBS start="8734" stop="8749" startsite="8749" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="8895" protid="20"
initRateConstant="0.3" mmadeg="5.56e-3" />
<RBS start="8879" stop="8894" startsite="8894" initstepsize="50" elongstepsize="" strength="le7" stopsite="9092" protid="21"
initRateConstant="0.3" mmadeg="0" />
<RBS start="9136" stop="9152" startsite="9158" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="9856" protid="22"
initRateConstant="0.3" mrnadeg="2.78e-3" />
<RBS start="9840" stop="9855" startsite="9855" initstepsize="50" elongstepsize="" strength="1e7" stopsite="10276" protid="23"
initRateConstant-="0.3" mrnadeg="5.56e-3" />
<RBS start=" 10242" stop=" 10257" startsite=" 10257" initstepsize="50" elongstepsize="" strength=" le7" stopsite=" 10706" protid="24"
initRateConstant="0.3" mmadeg="5.56e-3"/>
<RBS start="10690" stop="10705" startsite="10705" initstepsize="50" elongstepsize="" strength=" e7" stopsite="11161" protid="25"
initRateConstant="0.3" mmadeg=" 1.11 e-3" />
<RBS start="11210" stop="11225" startsite="11225" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11590" protid="26"
initRateConstant="C0.3" mmadeg="5.56e-3" />
<RBS start="11550" stop="11565" startsite="11565" initstepsize="50" elongstepsize="" strength=" e7" stopsite="13265" protid="27"
initRateConstant="0.3" mmadeg="5.56e-3"/>
<RBS start-"12973" stop="12988" startsite="12988" initstepsize="50" elongstepsize="" strength="le7" stopsite="13326" protid="28"
initRateConstant="C0.3" mmadeg="5.56e-3"/>
<RBS start="13337" stop="13352" startsite="13352" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13564" protid="29"
initRateConstant="C0.3" mmadeg="5.56e-3"/>
<RBS start=" 13575" stop="13584" startsite="13584" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13853" protid="30"
initRateConstant="0.3" mrnadeg="5.56e-3"/>
<RBS start="13912" stop="13927" startsite="13927" initstepsize="50" elongstepsize="" strength="1e7" stopsite="14334" protid="31"
initRateConstant="0.3" mrnadeg="5.56e-3"/>
<RBS start="14338" stop="14353" startsite="14353" initstepsize="50" elongstepsize="" strength=" e7" stopsite="16467" protid="32"
initRateConstant="0C.3" mmadeg="2.78e-3"/>
<RBS start="16468" stop="16483" startsite="16483" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16838" protid="33"
initRateConstant="C0.3" mrnadeg="5.56e-3"/>
<RBS start="16839" stop="16851" startsite="16851" initstepsize="50" elongstepsize="" strength="1e7" stopsite=" 17159" protid="34"
initRateConstant="(0.3" mrnadeg="5.56e-3" />
<RBS start-"17124" stop="17149" startsite="17149" initstepsize="50" elongstepsize="" strength=" e7" stopsite="17359" protid="35"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start=" 17343" stop="17358" startsite="17358" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="17517" protid="36"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start=" 17489" stop="17504" startsite="17504" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18406" protid="37"
initRateConstant="0C.3" mmadeg="4.17e-3" />
<RBS start=" 18379" stop="18394" startsite="18394" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="18507" protid="38"
initRateConstant="01.3" mrnadeg="5.56e-3" />
<RBS start="18590" stop="18605" startsite="18605" initstepsize="50" elongstepsize="" strength=" e7" stopsite="18859" protid="39"
initRateConstant="0C.3" mmadeg="5.56e-3"/>
<RBS start="18860" stop="18864" startsite="18864" initstepsize="50" elongstepsize="" strength=" e7" stopsite="19131" protid="40"
initRateConstant="0l.3" mmadeg="8.33e-3" />
<RBS start="19114" stop="19129" startsite="19130" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19531" protid="41"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="19515" stop="19530" startsite="19530" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19834" protid="42"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="19835" stop="19848" startsite="19848" initstepsize="50" elongstepsize="" strength="1e7" stopsite="20240" protid="43"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="20224" stop="20239" startsite="20239" initstepsize="50" elongstepsize="" strength="1e7" stopsite="21850" protid="44"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="21935" stop="21950" startsite="21950" initstepsize="50" elongstepsize="" strength="1e7" stopsite="22873" protid="45"
initRateConstant="0.3" mrnadeg="l.11lle-3" />
<RBS start="22942" stop="22967" startsite="22967" initstepsize="50" elongstepsize="" strength=" e7" stopsite="24004" protid="46"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24213" stop="24228" startsite="24228" initstepsize="50" elongstepsize="" strength="le7" stopsite="24818" protid="47"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24827" stop="24842" startsite="24842" initstepsize="50" elongstepsize="" strength=" e7" stopsite="27226" protid="48"
initRateConstant="0.3" mrnadeg="8.33e-3"/>
<RBS start="27292" stop="27307" startsite="27307" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="27723" protid="49"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="27707" stop="27722" startsite="27728" initstepsize="50" elongstepsize="" strength="le7" stopsite="28318" protid="50"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="28302" stop="28317" startsite="28325" initstepsize="50" elongstepsize="" strength="le7" stopsite="30568" protid="51"
initRateConstant-"0.3" mrnadeg="0" />
<RBS start="30580" stop="30595" startsite="30595" initstepsize="50" elongstepsize="" strength=" le7" stopsite="34551" protid="52"
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="34609" stop="34624" startsite="34624" initstepsize="50" elongstepsize="" strength=" le7" stopsite="36285" protid="53"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="36329" stop="36344" startsite="36344" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="36547" protid="54"
initRateConstant="0.3" mmadeg=" 1.1 le-3" />
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<RBS start="36531" stop="36546" startsite="36553" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36822" protid="55"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="36902" stop="36917" startsite="36917" initstepsize="50" elongstepsize="" strength="1e7" stopsite="37348" protid="56"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="37355" stop="37370" startsite="37370" initstepsize="50" elongstepsize="" strength="le7" stopsite="39130" protid="57"
initRateConstant="0.3" mmadeg="8.33e-3"/>
<RBS start="39374"' stop="39389" startsite="39389" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39538" protid="58"
initRateConstant="0.3" mmadeg="8.33e-3"/>
</DNASYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
Tabasco Input File for Upstream Falloff Fits
<REQUEST>
<EXECUTE-SIMULATION runs=" 1" random_seed="34145" simulation_name="test-1" time_step="5" time_end=" 1500"
write_DNA="no" write_InitRNA="yes" writeEnergy="yes" compDeg="yes">
<CELL volume="8e-16" polymerase_interaction_model="UPSTREAM_FALL_OFF">
<RIBOSOME initial_number=" 10000" speed="45" footprint="40" />
<POLYMERASE n:=" 1800" speed="45" id="2" organismid="2" footprint=" 15" name="coli Pol" />
<POLYMERASE n:="O" speed="45" id="3" organism_id="2" footprint="15" name="coli Pol-P" />
<POLYMERASE n:="0" speed="45" id="4" organism_id="2" footprint=" 15" name="coli Pol-2.0" />
<POLYMERASE n:="O" speed="45" id="5" organism_id="2" footprint=" 15" name="coli Pol-P-2.0" />
<POLYMERASE n="O" speed="230" id="6" organismid="1" footprint="15" name="gpl" />
<POLYMERASE n:="O" speed="230" id="7" organismjid="l" footprint="15" name="gpl-3.5" />
<SPECIES name="gp0.3" n="O" ID="8" organism="" />
<SPECIES name="gp0.4" n="O" ID="9" organism="1" />
<SPECIES name="gp0.5" n="O" ID="10" organism="l" />
<SPECIES name="gp0.6A" n="O" ID=" 1" organism="l" />
<SPECIES name="gp0.7" n="O" ID="12" organism="l" />
<SPECIES name="gpl .1" n="O" ID="13" organism="l" />
<SPECIES name="gpl.2" n="O" ID="14" organism="l" />
<SPECIES name="gpl.3" n="O" ID="15" organism="l" />
<SPECIES name="gpl.4" n="O" ID="16" organism="l" />
<SPECIES name="gpl.5" n="O" ID="17" organism=" " />
<SPECIES name="gpl.6" n="O" ID="18" organism="l" />
<SPECIES name="gpl.7" n="O" ID="19" organism="l" />
<SPECIES name="gpl.8" n="O" ID="20" organism="l" />
<SPECIES name="gp2.0" n="O" ID="21" organism=" " />
<SPECIES name="gp2.5" n="O" ID="22" organism="l" />
<SPECIES name="gp2.8" n="O" ID="23" organism=" 1 />
<SPECIES name="gp3.0" n="O" ID="24" organism=" 1"/>
<SPECIES name="gp3.5" n="O" ID="25" organism=" 1"/>
<SPECIES name="gp3.8" n="O" ID="26" organism=" "/>
<SPECIES name="gp4A" n="O" ID="27" organism="l" />
<SPECIES name="gp4.2" n="O" ID="28" organism=" 1"/>
<SPECIES name="gp4.3" n="O" ID="29" organism=" 1" />
<SPECIES name="gp4.5" n="O" ID="30" organism=" "/>
<SPECIES name="gp4.7" n="O" ID="31" organism="l" 1"/>
<SPECIES name="gp5.0" n="O" ID="32" organism=" I"/>
<SPECIES name="gp5.3" n="O" ID="33" organism="l" 1"/>
<SPECIES name="gp5.5" n="O" ID="34" organism=" " />
<SPECIES name="gp5.7" n="O" ID="35" organism="l" />
<SPECIES name="gp5.9" n="O" ID="36" organism="l" />
<SPECIES name="gp6.0" n="O" ID="37" organism="l" />
<SPECIES name="gp6.3" n="O" ID="38" organism="l" />
<SPECIES name="gp6.5" n="O" ID="39" organism=" "/>
<SPECIES name="gp6.7" n="O" ID="40" organism="l" />
<SPECIES name="gp7" n="O" ID="41" organism="l" />
<SPECIES name="gp7.3" n="O" ID="42" organism="l" />
<SPECIES name="gp7.7" n="O" ID="43" organism="l" />
<SPECIES name="gp8" n="O" ID="44" organism=" 1" />
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<SPECIES name="gp9" n="O" ID="45" organism="l" 1"/>
<SPECIES name="gpl0A" n="O" ID="46" organism="l" />
<SPECIES name="gpll" n="O" ID="47" organism="1" />
<SPECIES name="gpl2" n="O" ID="48" organism="1" />
<SPECIES name="gpl3" n="O" ID="49" organism="1" />
<SPECIES name="gpl4" n="O0" ID="50" organism="l" />
<SPECIES name="gpl5" n="0" ID="51" organism="l" />
<SPECIES name="gpl6" n="O" ID="52" organism="l" />
<SPECIES name="gp17" n="O" ID="53" organism="l" />
<SPECIES name="gpl7.5" n="O" ID="54" organism="l" />
<SPECIES name="gpl8" n="O" ID="55" organism="l" />
<SPECIES name="gpl8.5" n="0" ID="56" organism="l" />
<SPECIES name="gpl9" n="O" ID="57" organism="l" />
<SPECIES name="gpl9.5" n="O" ID="58" organism="l" />
<REACTIONS>
<REACTION>
12+2>3+11 ;3.8E7
</REACTION>
<REACTION>
12+4>5+11 ;3.8E7
</REACTION>
<REACTION>
21+2>4;3.8E7
</REACTION>
<REACTION>
21+3>5;3.8E7
</REACTION>
<REACTION>
4>21+2;1.1
</REACTION>
<REACTION>
5>21+3;1.1
</REACTION>
<REACTION>
25+6>7;3.8E7
</REACTION>
<REACTION>
7>6+25;3.5
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phagel" genome_length="39937" copy_number="3" entry_rate_constant="70" entry_offsite="850">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism_id="l">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="l.82e8" aoff="0.2" ainiton="0.875" runoffpercent="18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="498" stop="548" startsite="542" name="Al" organism_id="2">
<POLYMERASE polymeraselD="2" aon="l.5e7" aoff=".28" ainiton="0.4" runoffpercent="100" aelong="6" arecyc="0"/
<POLYMERASE polymeraselD="3" aon=" l.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6"
arecyc="0.19"/>
<POLYMERASE polymeraseID="4" aon="O" aoff="0" ainiton="O" runofLpercent="0" aelong="O" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="0" aoff="0" ainiton="0" runoffpercent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="626" stop="676" startsite="670" name="A2" organism_id="2">
<POLYMERASE polymeraselD="2" aon=" 1.5e7" aoff=".28" ainiton="0.4" runoff_percent=" 100" aelong="6" arecyc="O"/
<POLYMERASE polymeraselD="3" aon=" 1.5e7" aoff=".28" ainiton="0.4" runoffpercent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="O" runoff-percent="O" aelong="0" arecyc="0"/>
<POLYMERASE polymeraselD="5" aon="O" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="750" stop="800" startsite="794" name="A3" organismid="2">
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<POLYMERASE polymeraselD="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent=" 100" aelong="6" arecyc="0"/
<POLYMERASE polymeraselD="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoffpercent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoffpercent="0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent-"0" aelong="0" arecyc="O"/>
</PROMOTER>
<PROMOTER start="1514" stop="1564" startsite="1558" name="B" organismjid="2">
<POLYMERASE polymeraseID="2" aon=" 1.5e7" aoff="2.8" ainiton="0.19" runoff_percent=" 100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraselD="3" aon=" .5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraselD="4" aon="0" aoff="0" ainiton="0" runoffpercent="0" aelong="0" arecyc="0"I>
<POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="3113" stop="3163" startsite="3157" name="C" organism_id="2">
<POLYMERASE polymeraseID="2" aon="l.5e7" aoff="2.8" ainiton="0. 19" runoff_percent=" 100" aelong="6"
arecyc="0"/>
<POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff.percent="70" aelong="6"
arecyc="0. 19"/>
<POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoffpercent-"0" aelong="0" arecyc="0"/>
<POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="5848" stop="5871" startsite="5866" name="phi 1.1A" organismid=" 1">
<POLYMERASE polymeraseID="6" aon="6E7" aoff="18" ainiton="3.5" runoffpercent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff="18" ainiton="0.875" runoffpercent=" 18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="5923" stop="5946" startsite="5941" name="phil.1B" organism_id=" 1">
<POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent-" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="6409" stop="6432" startsite="6427" name="phi 1.3" organism_id=" 1">
<POLYMERASE polymeraselD="6" aon="6e7" aoff=" 18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon="6e7" aoff=" 18" ainiton="0.875" runoffpercent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7778" stop="7801" startsite="7796" name="phi1.5" organismid=" ">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff-percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7895" stop="7918" startsite="7913" name="phi 1.6" organism_id="1 ">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoffpercent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start-"9107" stop="9130" startsite="9125" name="phi2.5" organismid="1">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="11180" stop="11203" startsite=" 11198" name="phi3.8" organismid="1">
<POLYMERASE polymeraselD="6" aon="6e7" aoff=" 18" ainiton="3.5" runoffpercent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent=" 18" aelong="1.45"
arecyc="0.22" />
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</PROMOTER>
<PROMOTER start="12671" stop="12694" startsite="12689" name="phi4c" organismid="1">
<POLYMERASE polymeraselD="6" aon="6e7" aoff=" 18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent-"l18" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start=" 13341" stop=" 13364" startsite-" 13359" name="phi4.3" organismjd=" 1 ">
<POLYMERASE polymeraseID=-"6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent=" 18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start-" 13915" stop="13938" startsite=" 13933" name="phi4.7" organism_id="1 ">
<POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon="6e7" aoff=" 18" ainiton="0.875" runoff_percent="18" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="18545" stop="18568" startsite="18563" name="phi6.5" organism_id=" ">
<POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoffpercent=" 100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoffpercent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="21865" stop="21888" startsite="21883" name="phi9" organism_id="l ">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoff_percent=" 100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="22904" stop="22927" startsite="22922" name="phil0" organism_id=" ">
<POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff-percent="100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoffpercent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="27274" stop="27297" startsite="27292" name="phi 13" organismid=" ">
<POLYMERASE polymeraselD="6" aon=" 1.82e8" aoff="0.2" ainiton="3.5" runoffpercent=" 100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="34566" stop="34589" startsite="34584" name="phil7" organism_id=" ">
<POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraseID="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoffpercent="42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="39229" stop="39252" startsite="39247" name="phiOR" organism_id="1 ">
<POLYMERASE polymeraselD="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8"
arecyc="0.88" />
<POLYMERASE polymeraselD="7" aon=" 1.82e8" aoff="0.2" ainiton="0.875" runoff-percent="42" aelong=" 1.45"
arecyc="0.22" />
</PROMOTER>
<TERMINATOR start="7546" stop="7610" stopsite="7588" name="TE" organism="2">
<POLYMERASE ID="2" efficiency="1" />
<POLYMERASE ID="3" efficiency="1" />
<POLYMERASE ID="4" efficiency="1" />
<POLYMERASE ID="5" efficiency="1" />
<POLYMERASE ID="6" efficiency="O" />
<POLYMERASE ID="7" efficiency="0" />
</TERMINATOR>
<TERMINATOR start="24158" stop="24230" stopsite="24209" name="Tphi" organism="l">
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<POLYMERASE ID="2" efficiency="0" />
<POLYMERASE ID="3" efficiency="0"/>
<POLYMERASE ID="4" efficiency="0" />
<POLYMERASE ID="5" efficiency="0" />
<POLYMERASE ID="6" efficiency="0.8" />
<POLYMERASE ID="7" efficiency="0.8" />
</TERMINATOR>
<RBS start="910" stop="925" startsite="925" initstepsize="50" elongstepsize="" strength=" e7" stopsite="1278" protid="8"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="1262" stop="1277" startsite="1277" initstepsize="50" elongstepsize="" strength=" e7" stopsite="1433" protid="9"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="1454" stop="1469" startsite="1469" initstepsize="50" elongstepsize="" strength=" e7" stopsite="1639" protid="10"
initRateConstant="0.3" mmadeg="8.33e-3" h/>
<RBS start="1621" stop="1636" startsite="1636" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="1797" protid=" l"
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="2006" stop="2021" startsite="2021" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="3100" protid="12"
initRateConstant="0.3" mrnadeg=" 1.67e-2" />
<RBS start="3156" stop="3171" startsite="3171" initstepsize="50" elongstepsize="" strength="1e7" stopsite="5822" protid="6"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="5992" stop="6007" startsite="6007" initstepsize="50" elongstepsize="" strength=" e7" stopsite="6135" protid="13"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="6119" stop="6134" startsite="6134" initstepsize="50" elongstepsize="" strength=" e7" stopsite="6394" protid="14"
initRateConstant-"0.3" mmadeg="2.08e-3" I/>
<RBS start="6460" stop="6475" startsite="6475" initstepsize="50" elongstepsize="" strength="le7" stopsite="7554" protid="15"
initRateConstant="0.3" mmadeg="8.33e-3" />
<RBS start="7593" stop="7608" startsite="7608" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="7763" protid="16"
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS star="7776" stop="7791" startsite="7791" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="7880" protid="17"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="7891" stop="7906" startsite="7906" initstepsize="50" elongstepsize="" strength=" e7" stopsite="8166" protid="18"
initRateConstant="0.3" mrnadeg="5.56e-3"/>
<RBS start="8150" stop="8165" startsite="8165" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="8756" protid="19"
initRateConstant="0.3" mrnadeg="1.11e-3" />
<RBS start="8734" stop="8749" startsite="8749" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8895" protid="20"
initRateConstant="0.3" mmadeg="5.56e-3" />
<RBS start="8879" stop="8894" startsite="8894" initstepsize="50" elongstepsize="" strength=" le7" stopsite="9092" protid="21"
initRateConstant="0.3" mmadeg="0" />
<RBS start-"9136" stop="9152" startsite="9158" initstepsize="50" elongstepsize="" strength=" e7" stopsite="9856" protid="22"
initRateConstant="0.3" mmadeg="0" />
<RBS start="9840" stop="9855" startsite="9855" initstepsize="50" elongstepsize="" strength=" e7" stopsite="10276" protid="23"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="10242" stop="10257" startsite-="10257" initstepsize="50" elongstepsize="" strength=" e7" stopsite="10706" protid="24"
initRateConstant="0.3" mrnadeg="5.56e-3"/>
<RBS start=" 10690" stop="10705" startsite="10705" initstepsize="50" elongstepsize="" strength="1e7" stopsite=" 11161" protid="25"
initRateConstant-"0.3" mrnadeg="0" />
<RBS start=" 11210" stop="11225" startsite="11225" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11590" protid="26"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start=" 11550" stop=" 11565" startsite=" 11565" initstepsize="50" elongstepsize="" strength=" le7" stopsite=" 13265" protid="27"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="12973" stop="12988" startsite-"12988" initstepsize="50" elongstepsize="" strength=" e7" stopsite="13326" protid="28"
initRateConstant="0.3" mmadeg="5.56e-3" />
<RBS start=" 13337" stop=" 13352" startsite=" 13352" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite=" 13564" protid="29"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start=" 13575" stop=" 13584" startsite=" 13584" initstepsize="50" elongstepsize="" strength=" le7" stopsite="13853" protid="30"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start=" 13912" stop="13927" startsite="13927" initstepsize="50" elongstepsize="" strength="1e7" stopsite="14334" protid="31"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start=" 14338" stop=" 14353" startsite=" 14353" initstepsize="50" elongstepsize="" strength=" le7" stopsite=" 16467" protid="32"
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start="16468" stop="16483" startsite="16483" initstepsize="50" elongstepsize="" strength=" e7" stopsite="16838" protid="33"
initRateConstant="0.3" mmadeg="5.56e-3" />
<RBS start="16839" stop="16851" startsite="16851" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="17159" protid="34"
initRateConstant="0.3" mrnadeg="5.56e-3" />
190
<RBS start=" 17124" stop=" 17149" startsite=" 17149" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite=" 17359" protid="35"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start-" 17343" stop="17358" startsite="17358" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="17517" protid="36"
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="17489" stop="17504" startsite="17504" initstepsize="50" elongstepsize="" strength="le7" stopsite="18406" protid="37"
initRateConstant="0.3" mrnadeg="O" />
<RBS start=" 18379" stop="18394" startsite="18394" initstepsize="50" elongstepsize="" strength=" le7" stopsite="18507" protid="38"
initRateConstant= "0.3" mmadeg="5.56e-3" />
<RBS start="18590" stop="18605" startsite="18605" initstepsize="50" elongstepsize="" strength="le7" stopsite-"18859" protid="39"
initRateConstant="0.3" mmadeg="5.56e-3" />
<RBS start=" 18860" stop="18864" startsite="18864" initstepsize="50" elongstepsize="" strength=" le7" stopsite="19131" protid="40"
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start-="19114" stop="19129" startsite="19130" initstepsize="50" elongstepsize="" strength=" Ie7" stopsite="19531" protid="41"
initRateConstant="0.3" mrnadeg="l.39e-3"/>
<RBS start="19515" stop=" 19530" startsite="19530" initstepsize="50" elongstepsize="" strength="le7" stopsite="19834" protid="42"
initRateConstant-"0.3" mrnadeg="1.39e-3"/>
<RBS start="19835" stop="19848" startsite="19848" initstepsize="50" elongstepsize="" strength="1e7" stopsite="20240" protid="43"
initRateConstant="0.3" mrnadeg="1.39e-3"/>
<RBS start="20224" stop="20239" startsite="20239" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="21850" protid="44"
initRateConstant="0.3" mmadeg="1.19e-3" />
<RBS start="21935" stop="21950" startsite="21950" initstepsize="50" elongstepsize="" strength="1e7" stopsite="22873" protid="45"
initRateConstant="0.3" mmadeg="0" />
<RBS start="22942" stop="22967" startsite="22967" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24004" protid="46"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24213" stop="24228" startsite="24228" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24818" protid="47"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24827" stop="24842" startsite="24842" initstepsize="50" elongstepsize="" strength=" le7" stopsite="27226" protid="48"
initRateConstant="0.3" mmadeg="1.39e-3"/>
<RBS start="27292" stop="27307" startsite="27307" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27723" protid="49"
initRateConstant="0.3" mmadeg="1.39e-3" />
<RBS start-"27707" stop="27722" startsite="27728" initstepsize="50" elongstepsize="" strength="le7" stopsite="28318" protid="50"
initRateConstant="0.3" mmadeg="1.39e-3" />
<RBS start-"28302" stop="28317" startsite="28325" initstepsize="50" elongstepsize="" strength="1e7" stopsite="30568" protid="51"
initRateConstant="0.3" mmadeg="0" />
<RBS start-"30580" stop="30595" startsite="30595" initstepsize="50" elongstepsize="" strength=" le7" stopsite="34551" protid="52"
initRateConstant="0.3" mrnadeg="0" />
<RBS start="34609" stop="34624" startsite="34624" initstepsize="50" elongstepsize="" strength=" l1e7" stopsite="36285" protid="53"
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start="36329" stop="36344" startsite="36344" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="36547" protid="54"
initRateConstant="0.3" mmadeg="0" />
<RBS start="36531" stop="36546" startsite="36553" initstepsize="50" elongstepsize="" strength=" 1 e7" stopsite="36822" protid="55"
initRateConstant="0.3" mmrnadeg="1.39e-3" />
<RBS start="36902" stop="36917" startsite="36917" initstepsize="50" elongstepsize="" strength="1e7" stopsite="37348" protid="56"
initRateConstant="0.3" mmadeg="1.28e-3" />
<RBS start="37355" stop="37370" startsite="37370" initstepsize="50" elongstepsize="" strength=" 1e7" stopsite="39130" protid="57"
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start-"39374" stop="39389" startsite="39389" initstepsize="50" elongstepsize="" strength=" e7" stopsite="39538" protid="58"
initRateConstant="0.3" mmrnadeg="1.39e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
